{"text": "Early - stage HCC patients are considered for potentially curative options such as resection , ablation , and transplantation .Despite recent advances in early detection and diagnosis , only 30%-40 % of patients with HCC may benefit from radical therapies .", "label": "", "metadata": {}, "score": "18.143154"}
{"text": "The definitive treatment for HCC has evolved primarily to be surgery , orthotopic liver transplantation , percutaneous ablation , or partial transarterial chemoembolization ( TACE ) [ 2 ] .", "label": "", "metadata": {}, "score": "21.53001"}
{"text": "Percutaneous Ablation .Patients with early HCC who are not candidates for resection or liver transplantation , are treated preferentially with percutaneous ablation , that is considered as a minimally invasive option with low mortality , low rates of complications , and good outcomes in overall survival [ 115 - 117 ] .", "label": "", "metadata": {}, "score": "26.826328"}
{"text": "Patients with well preserved liver function and a single HCC , waiting for at least one year , may benefit from surgical resection but for shorter waiting times the economic investment is controversial .", "label": "", "metadata": {}, "score": "28.182274"}
{"text": "Due to the implementation of prevention programs for HCC , patients are usually diagnosed in early stage .Nevertheless , some are detectable at an intermediate or advanced stage with preserved liver function or not , multinodular disease exceeding the Milan criteria , with or without symptoms or extrahepatic spread manifested by absence of portal / node invasion or distant metastasis .", "label": "", "metadata": {}, "score": "31.688667"}
{"text": "In HCC , prognosis is greatly influenced by underlying liver dysfunction and treatment itself , as well as tumor stage , while in other solid tumors , it is generally only related to tumor stage [ 2 ] .", "label": "", "metadata": {}, "score": "32.59578"}
{"text": "The excellent results of liver transplantation for early HCC are curtailed by the increasing dropout rate while waiting for a donor , thus worsening outcome when analysed on an intention to treat basis .", "label": "", "metadata": {}, "score": "32.98194"}
{"text": "These include LT , resection , locoregional , and systemic therapies .For a solitary HCC with preserved liver function and low hepatic vein pressure gradient , liver resection still remains the first choice .", "label": "", "metadata": {}, "score": "33.102013"}
{"text": "RADIATION THERAPY FOR HCC .Historically , treatment with conventionally fractionated ( 1.8 - 2 Gy / fraction over several weeks ) and 2-dimensionally - planned radiation is associated with high rates of local progression and short median survival duration .", "label": "", "metadata": {}, "score": "33.88161"}
{"text": "Palliative approaches include systemic chemotherapy , immunotherapy , and hormonal compounds .However , just 1/3 of HCC patients will be candidates from curative treatment .", "label": "", "metadata": {}, "score": "34.12502"}
{"text": "Liver transplantation is the treatment of choice for selected patients with hepatocellular carcinoma ( HCC ) on a background of chronic liver disease .Liver resection or locoregional ablative therapies may be indicated for patients with preserved synthetic function without significant portal hypertension .", "label": "", "metadata": {}, "score": "34.43907"}
{"text": "For shorter waiting times , only percutaneous treatment confers a relevant survival advantage .Surgical resection and orthotopic liver transplantation ( OLT ) are considered the first treatment options for hepatocellular carcinoma ( HCC ) although the best treatment strategy has not been established .", "label": "", "metadata": {}, "score": "34.45711"}
{"text": "Treatments for HCC were chosen either in accordance to the guidelines or taking into account specific neoplastic , clinical and biochemical features of each patient .", "label": "", "metadata": {}, "score": "34.65336"}
{"text": "[ 2,3 ] For more than 80 % of patients with advanced - stage HCC , chemotherapy is usually ineffective because liver dysfunction enhances chemotherapy - induced hepatotoxicity and portal hypertension with splenomegaly enhances cytopenias .", "label": "", "metadata": {}, "score": "35.117245"}
{"text": "Number of \" early \" HCC patients treated in adherence with the AASLD guidelines .OLTx : orthotopic liver transplantation ; RFTA : radiofrequency - mediated thermal ablation ; PEI : percutaneous ethanol injection ; TACE : transcatheter arterial chemoembolization ; BSC : best supportive care .", "label": "", "metadata": {}, "score": "35.458942"}
{"text": "Eligible patients have locally advanced HCC that is unsuitable for resection , transplantation , or radiofrequency ablation , or is unsuitable for TACE or refractory to TACE ( BCLC Intermediate [ B ] or Advanced [ C ] ) .", "label": "", "metadata": {}, "score": "35.482605"}
{"text": "In the revised version of the BCLC system , released by the AASLD [ 13 ] , patients diagnosed at the best stages are defined as follows : . \" very early \" when single node HCC , smaller than 2 cm , in Child - Pugh A class , with no symptoms and lack of change in performance status ; . \" In the AASLD guidelines , patients with \" very early \" disease are candidates for resection , unless they have portal hypertension and/or increased bilirubin levels , in which case either liver transplantation or locoregional percutaneous treatments are recommended , depending on their age and associated diseases .", "label": "", "metadata": {}, "score": "35.509266"}
{"text": "Surgery is feasible for patients with preserved liver function and single tumours but it is too risky in subjects with impaired hepatic function and/or multiple HCC sites .", "label": "", "metadata": {}, "score": "35.543766"}
{"text": "The proportion of patients with \" very early \" HCC is only 3 % in a large series collected by primary referral centers involved in recruiting patients with non advanced disease .", "label": "", "metadata": {}, "score": "35.99164"}
{"text": "While metastatic lung tumors ( particularly those from colorectal cancer ) are reported to require dose escalation due to relatively low radiosensitivity [ 56 ] , increasing the dose for HCC tumors may not be necessary .", "label": "", "metadata": {}, "score": "36.067764"}
{"text": "Survival data for the non - treatment arm were derived from prospective studies on the prognosis of patients diagnosed with asymptomatic HCC without vascular invasion or extrahepatic spread : one and two year survival rates of 80 % and 65 % , respectively .", "label": "", "metadata": {}, "score": "36.375225"}
{"text": "Same considerations apply also to the group of \" very early \" HCC .RESECTION followed in terms of efficacy , then percutaneous treatments , while survival was lowest in patients treated with TACE or BSC .", "label": "", "metadata": {}, "score": "36.468285"}
{"text": "However , recently updated guidelines slightly differ in diagnostic criteria .Apart from liver transplantation , the only cure of both HCC and underlying liver cirrhosis , all the other treatments have to match with higher rate of HCC recurrence .", "label": "", "metadata": {}, "score": "36.500633"}
{"text": "Comprehensive demographic , aetiological and staging data along with treatment details were made available .Staging HCC with gadoxetic acid - enhanced MRI improves treatment outcomes in patients with early disease .", "label": "", "metadata": {}, "score": "36.575043"}
{"text": "Risk Factors .Besides HCV and HBV , other risk factors have been reported to be involved in the development of HCC .Any agent leading to chronic injury and eventually cirrhosis constitutes an oncogenic agent [ 20 ] .", "label": "", "metadata": {}, "score": "37.14544"}
{"text": "For those who are unsuitable for resection , transplantation , or ablation , definitive radiotherapy or radiotherapy can be administered as a bridge to transplantation [ 20 - 22 ] .", "label": "", "metadata": {}, "score": "37.465622"}
{"text": "Finally , although the risk of procedure - related bleeding is probably increased [ 10 ] , generally diagnosis of HCC in BCS still needs histological confirmation [ 8 , 9 ] .", "label": "", "metadata": {}, "score": "37.531105"}
{"text": "That is why , for cirrhotic patients , surveillance is strongly recommended to detect early HCC allowing an increase of patients suitable for curative treatment and then limit tumor - related dead .", "label": "", "metadata": {}, "score": "37.583588"}
{"text": "Liver Resection .Noncirrhotic patients or Child - Pugh A cirrhotic patients with a well - preserved liver function , a single nodule , and normal portal pressure are eligible for surgical resection [ 98 - 100 ] .", "label": "", "metadata": {}, "score": "37.731556"}
{"text": "Understanding the carcinogenic process and the mastery of the staging systems remain essential keys in diagnosis and treatment of HCC .Recent advances in diagnosis and new treatments have made important impacts on the disease by increasing survival rates and improving quality of life for HCC patients .", "label": "", "metadata": {}, "score": "37.80571"}
{"text": "Number of \" very early \" HCC patients treated in adherence with the AASLD indications .OLTx : orthotopic liver transplantation ; RFTA : radiofrequency - mediated thermal ablation ; .", "label": "", "metadata": {}, "score": "37.880913"}
{"text": "STAGING EARLY HCC WITH GADOXETIC ACID - ENHANCED MAGNETIC RESONANCE IMAGING & IMPROVEMENT IN SURVIVAL .Abstract presented at the International Liver CongressTM 2014 .K.Hui et al .", "label": "", "metadata": {}, "score": "38.044655"}
{"text": "In fact , perioperative mortality in cirrhotics after HCC resection is about 2%-3 % .Moreover , there is a risk of tumor recurrence after surgery of about 70 % at 5 years , enclosing both true recurrence and the novo tumours [ 25 - 39 ] .", "label": "", "metadata": {}, "score": "38.11081"}
{"text": "Although less stringent , there is a risk of HCC development also in non - cirrhotic chronic hepatitis and treated viral hepatitis , for which an annual screening is generally performed [ 1 - 4 ] .", "label": "", "metadata": {}, "score": "38.315216"}
{"text": "Identification of HCC in patients with cirrhosis was based on the radiological and histological criteria , and recommendations upon detection of nodular lesion during US surveillance were based on the size of the nodule [ 91 ] .", "label": "", "metadata": {}, "score": "38.608383"}
{"text": "In humans , 90 % HCC cases arise as complication of chronic liver disease / cirrhosis with fibrosis playing a major predisposing role [ 42 ] .", "label": "", "metadata": {}, "score": "38.648582"}
{"text": "Then , since radiological diagnostic criteria have been shaped and established [ 1 ] , HCC diagnosis is now made only on radiological criteria in the majority of the cases [ 1 - 4 ] .", "label": "", "metadata": {}, "score": "38.715034"}
{"text": "The diagnostic criteria of HCC has recently had a dramatic evolution during recent years .HCC diagnosis is now made only on radiological criteria in the majority of the cases .", "label": "", "metadata": {}, "score": "38.73314"}
{"text": "As an alternative , primary liver resection and \" salvage OLT \" ( performed when recurrence or decompensation after resection occurs ) have been postulated to save organs .", "label": "", "metadata": {}, "score": "38.98945"}
{"text": "However , there is no general consensus in the different system and geographic variations exists [ 41 ] .For HCC , several staging systems ( Table 1 ) have been developed and generally take into account tumor characteristics such as tumor size , number , vascular invasion and metastasis , and also the severity of the underlying cirrhosis [ 1 , 69 ] .", "label": "", "metadata": {}, "score": "39.018703"}
{"text": "HCC diagnosis is considerable interest to clinician 's evaluation patients with liver cirrhosis [ 84 ] .Generally , HCC appears with setting of cirrhosis with underlying chronic viral hepatitis ( B or C ) or alcoholism and more recently with nonalcoholic steatohepatitis [ 85 ] .", "label": "", "metadata": {}, "score": "39.019314"}
{"text": "Intermediate stage ( B ) with asymptomatic multinodular HCC is suitable for chemoembolization treatment .In advanced stage ( C ) with symptomatic tumors and/or an invasive tumoral pattern ( alteration of the general state / portal vein thrombosis / metastases ) , the sorafenib is the standard treatment proposed .", "label": "", "metadata": {}, "score": "39.44617"}
{"text": "With exception of HBV and AF , all other etiological risk factors are associated with cirrhosis .It is generally believed that the majority of HCCs develop in a progressively from acute hepatitis through various stages of chronic hepatitis , to cirrhosis , to HCC [ 26 ] .", "label": "", "metadata": {}, "score": "39.448944"}
{"text": "Survival curves in patients with early HCC .( OLTx : orthotopic liver transplantation ; RFTA : radiofrequency - mediated thermal ablation ; PEI : percutaneous ethanol injection ; TACE : transcatheter arterial chemoembolization ; BSC : best supportive care ) .", "label": "", "metadata": {}, "score": "39.96383"}
{"text": "In patients with cirrhosis selected on liver functional status , the main predictors for survival are tumor size , multiplicity , and vascular invasion .Recurrence remains problematic occurring in 70 % at 5 years ; true recurrence / intrahepatic metastases generally occur within 2 years of resection ; if greater than 2 years it is generally regarded as a de novo tumor or late recurrence [ 39 ] .", "label": "", "metadata": {}, "score": "40.141983"}
{"text": "In addition , the prognosis of HCC is greatly influenced by underlying liver dysfunction and treatment itself in addition to tumor stage .Since they are closely linked to treatment approach , it is important to understand these differences in interpreting outcomes from various reports .", "label": "", "metadata": {}, "score": "40.163948"}
{"text": "Limited data were available about the prognostic significance of local recurrence ... .Outcomes of side - to - side conversion hepaticojejunostomy for biliary anastomotic stricture after right - liver living donor liver transplantation .", "label": "", "metadata": {}, "score": "40.299057"}
{"text": "However , tumor recurrence rates were high , up to 70 % , and progression to liver failure was common [ 6 , 8 - 10 ] .", "label": "", "metadata": {}, "score": "40.456024"}
{"text": "Two imaging dynamic studies can be considered to be HCC , and diagnosis confirmation is required using biopsy or fine - needle aspiration or both of them .", "label": "", "metadata": {}, "score": "40.500263"}
{"text": "Adjuvant therapies included surgical resection and percutaneous ablation as they provide a more extensive tumour load reduction than chemoembolisation .The model takes into account the heterogeneity of HCC candidates according to their tumour stage / liver functional impairment and the variable duration of the waiting times throughout the world .", "label": "", "metadata": {}, "score": "40.674904"}
{"text": "HCC treatment .Apart from LT , the only cure of both HCC and underlying liver cirrhosis , all the other treatments have to match with higher rate of HCC recurrence .", "label": "", "metadata": {}, "score": "40.792267"}
{"text": "Therapy .Therapeutic approaches are conventionally classified as curative and palliative .The choice of treatment depends on the tumor characteristics , liver function , and presence or not of metastasis or vascular invasion .", "label": "", "metadata": {}, "score": "41.20077"}
{"text": "Advanced HCC that is symptomatic , exhibiting vascular invasion and/or has extrahepatic disease have a short median survival of 6 months with 25 % surviving a year [ 60 ] .", "label": "", "metadata": {}, "score": "41.31421"}
{"text": "While patients with liver metastatic disease have relatively normal liver function and tolerate radiation , patients with HCC have pre - existing liver dysfunction , and radiation tolerance is less well established .", "label": "", "metadata": {}, "score": "41.41595"}
{"text": "Oldhafer KJ , Chavan A , Fruhauf NR , et al .Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma : marked tumor necrosis , but no survival benefit ?", "label": "", "metadata": {}, "score": "41.422234"}
{"text": "However , being low the number of patients with \" very early \" HCC we might have missed the expected difference in survival among treatment groups and prospective validation analysis is needed to define the best treatment in this subgroup of patients .", "label": "", "metadata": {}, "score": "41.559055"}
{"text": "Target population and adjuvant treatments .The study focused on HCC candidates for OLT as the primary treatment option .We did not consider Child - Pugh 's C class cirrhotic patients with coincidental tumours because their dropout rate is mostly related to life threatening decompensation of cirrhosis rather than tumour progression .", "label": "", "metadata": {}, "score": "41.688553"}
{"text": "Both should be discouraged in decompensated liver disease and in case of macroscopic vascular invasion or extrahepatic spread [ 65 - 80 ] .An alternative to TACE is radioembolization .", "label": "", "metadata": {}, "score": "41.801216"}
{"text": "It provides a high - quality graft and removes a competing HCC recipient from the waiting list .But higher recurrence rates and reduced survival have been reported when compared to cadaveric LT [ 31 - 33 ] .", "label": "", "metadata": {}, "score": "42.293724"}
{"text": "Given these limitations , radiation therapy is usually not curative .Compared to other local therapies , the clinical data supporting evidence for radiotherapy in HCC patients are extremely limited [ 18 ] .", "label": "", "metadata": {}, "score": "42.40076"}
{"text": "Among these studies , a Japanese multicenter group is conducting a study of SBRT for previously untreated solitary HCC patients who are unfit for resection or ablation ( primarily BCLC stage 0 and A ) .", "label": "", "metadata": {}, "score": "42.419952"}
{"text": "Different staging systems will be more suitable , depending on where and why they are used [ 18 ] .For instance , it is now generally accepted that the CLIP system works better for advanced HCC and the BCLC for early disease undergoing surgery and in non cirrhotics [ 19 , 20 ] .", "label": "", "metadata": {}, "score": "42.426323"}
{"text": "A well - demarcated enhancement due to contrast retention indicating congestion is seen in portal phase ( C ) .Focal liver reaction has primarily been evaluated using CT , and it can also be recognized on magnetic resonance imaging ( MRI ) .", "label": "", "metadata": {}, "score": "42.490532"}
{"text": "In contrast , the latter concept may be reasonable for small HCCs , because intrahepatic recurrences frequently occur after treatment ( 68 % in 5 years ) [ 46 ] and they are repeatedly treated while underlying cirrhosis progressively develops over time .", "label": "", "metadata": {}, "score": "42.71335"}
{"text": "Primary liver resection and salvage transplantation or primary liver transplantation in patients with single , small hepatocellular carcinoma and preserved liver function : An outcome oriented decision analysis .", "label": "", "metadata": {}, "score": "42.716236"}
{"text": "The main patient groups that should be considered for adjuvant chemotherapy are those being transplanted for extended criteria or have a high risk of recurrence based on the explant pathology .", "label": "", "metadata": {}, "score": "42.88985"}
{"text": "Parallel to the development of research concerning pathological and histological pathways leading to HCC , many drugs and hormonal therapy have been tested as agents inhibiting important signaling pathways in tumor cells and also angiogenesis in systemic therapy for HCC .", "label": "", "metadata": {}, "score": "42.9804"}
{"text": "HCC diagnosis update .The diagnostic criteria of HCC has recently had a dramatic evolution during recent years [ 1 - 4 , 24 ] .", "label": "", "metadata": {}, "score": "42.99939"}
{"text": "Using normal tissue complication probability models [ 44 ] , prescribed doses can be prospectively assigned while maintaining the same estimated risk of liver complication .", "label": "", "metadata": {}, "score": "43.150604"}
{"text": "HCC is an end result of some chronic infections with the hepatitis B ( HBV ) or the hepatitis C ( HCV )Figure 1 [ 7 - 9 ] .", "label": "", "metadata": {}, "score": "43.16706"}
{"text": "HCC is typically a complication of cirrhosis , although it can rarely develop in the absence of cirrhosis [ 1 - 4 ] .Known underlying diseases at risk for HCC development are chronic viral hepatitis C and B , alcoholic hepatitis , non- alcoholic fatty liver disease , autoimmune hepatitis , hemochromatosis , alpha-1-antitrypsin deficiency , Wilson 's disease , Budd - Chiari syndrome ( BCS ) .", "label": "", "metadata": {}, "score": "43.28598"}
{"text": "The latter approach was combined with liver resection in 23 patients .Follow up was performed every 3 months using ultrasound or MRI .Combined liver resection in cirrhosis was performed in 5 patients with Child A , in 2 patients with Child B , and none in Child C cirrhosis .", "label": "", "metadata": {}, "score": "43.29802"}
{"text": "Cost effectiveness analysis of percutaneous treatments for non - surgical hepatocellular carcinoma versus conservative management while on the waiting list for liver transplantation .Cost effectiveness ratio and marginal effectiveness in terms of gains in life expectancy are shown according to length of waiting time .", "label": "", "metadata": {}, "score": "43.36299"}
{"text": "Recipient patients respond to treatment with an improved quality of life .It can be used as bridge to RFA and resection .Comparison between the survival of HCC patients in advanced stage either not treated or treated with ineffective systemic agents , survival after ( 90)Y - RE is encouraging and warrants future clinical trials [ 122 - 125 ] .", "label": "", "metadata": {}, "score": "43.41192"}
{"text": "Patients of reference case No 1 underwent resection and entered the waiting list state .Three transition states were considered thereafter : ( a ) receiving OLT and entering the post - transplantation state ; ( b ) developing any contraindication for OLT and entering the dropout state ; or ( c ) dying of tumour progression or complications of cirrhosis .", "label": "", "metadata": {}, "score": "43.860313"}
{"text": "These were the exciting findings of a study presented at the International Liver CongressTM 2014 .According to Dr Reeves , \" Early recurrence of HCC after curative treatment is frequent and thought to represent a metastasis from the primary tumour that was actually present before treatment was started .", "label": "", "metadata": {}, "score": "43.889217"}
{"text": "In this patient population , in whom there was accompanying main portal vein tumour thrombus ( MPVTT ) and compensated liver cirrhosis , percutaneous RFA significantly prolonged long - term survival compared with no treatment .", "label": "", "metadata": {}, "score": "44.293434"}
{"text": "Since this result was common to \" early \" HCCs , it will be commented later .The picture is slightly different for patients with \" early \" disease , who account for a substantial share of HCCs .", "label": "", "metadata": {}, "score": "44.322647"}
{"text": "HBV antiviral therapy reduces risk of recurrence by 41 % and overall mortality by 73 % , mainly because death from liver failure is reduced by 77 % [ 74 ] .", "label": "", "metadata": {}, "score": "44.436348"}
{"text": "Over the past decade , medical management of the patient with chronic liver disease has improved .As a consequence , HCC is an important complication of cirrhosis and a leading indication for liver transplantation ( LT ) , accounting for approximately a third of patients on transplant waiting lists [ 4 ] .", "label": "", "metadata": {}, "score": "44.5291"}
{"text": "However , an exception is HCC developing in BCS .In fact , the radiological pattern of regenerative nodules in BCS is similar to that of HCC [ 7 ] .", "label": "", "metadata": {}, "score": "44.656235"}
{"text": "The HCC remains a malignant disease leading to death .Significant progress has been made in the management of the disease .Because of its complexity , a multidisciplinary approach must be implemented to support the different aspects in HCC .", "label": "", "metadata": {}, "score": "44.70276"}
{"text": "The differences in patient characteristics or treatment availability by country are closely linked to the treatment approaches used in each county .Currently , early HCC diagnosis is increasingly feasible in countries with wider implementation of surveillance policies , which enables the application of curative treatments .", "label": "", "metadata": {}, "score": "45.272984"}
{"text": "An additional point to make is that the percentage of patients with \" early \" disease treated according to the AASLD guidelines , albeit higher than in \" very early \" HCC , remained relatively small .", "label": "", "metadata": {}, "score": "45.344955"}
{"text": "Nevertheless , patients who have limited tumor burden but are not suitable for radical therapies usually undergo TACE despite its relatively low efficacy .Improving the outcomes of these patients is one of the major challenges in HCC management .", "label": "", "metadata": {}, "score": "45.462646"}
{"text": "Because HCC is such an extremely diverse and heterogeneous disease , improving patient outcomes has proved a difficult undertaking .A number of existing therapeutic options have been subjected to rigorous study but have not shown any patient benefit .", "label": "", "metadata": {}, "score": "45.687885"}
{"text": "( 2 ) Variations in outcome of transplantation .Survival after OLT was modelled to include a five year survival rate as low as 50 % as the worst scenario .", "label": "", "metadata": {}, "score": "45.808174"}
{"text": "Intra - arterial delivery of chemotherapeutic agents ( especially doxorubicin combined with others agents ) and blocking ( embolizing ) the small blood vessels feeding the tumor are the process treatment used by TACE .", "label": "", "metadata": {}, "score": "45.967007"}
{"text": "Since chronic viral B and C are known to be the most common causes of carcinogenesis , prevention of HCC requires an effective risk control of infection due to these factors .", "label": "", "metadata": {}, "score": "45.972305"}
{"text": "The center of the tumor receives as high as 125 % of the prescribed dose .INDICATIONS FOR SBRT .Although the indications for SBRT for hepatic malignancy have evolved , the role of SBRT in HCC is less clear .", "label": "", "metadata": {}, "score": "45.985188"}
{"text": "In Asia where HCC has a high incidence , only 10 - 15 % of newly diagnosed patients undergo resection therapy .In Western countries , only 5 - 10 % are candidates for resection surgery .", "label": "", "metadata": {}, "score": "46.06217"}
{"text": "Harnois DM , Steers J , Andrews JC , et al .Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma .Liver Transpl Surg 1999 ; 5 : 192 -9 .", "label": "", "metadata": {}, "score": "46.315063"}
{"text": "In fact , a retrospective study described the long - term imaging appearance of 42 small hypervascular HCCs following SBRT [ 68 ] .Cautious and continuous observation until tumor regrowth is required to evaluate the true effect of this treatment .", "label": "", "metadata": {}, "score": "46.455246"}
{"text": "Subsequent studies on an independent cohort of 206 HCC patients and 194 patients with CHB and cirrhosis validated that these 3 genes were able to identify HCC with an accuracy of 82.5 % , 81.5 % and 71.8 % , respectively .", "label": "", "metadata": {}, "score": "46.532272"}
{"text": "For that , new strategies must be implemented in diversifying the classification criteria .Histological causes and molecular changes leading to HCC should provide new tools to be included in the stratification criteria .", "label": "", "metadata": {}, "score": "46.547935"}
{"text": "Results from the Eastern and Western literature have been conflicting and no conclusions can be drawn .The aim of the present study was to review the long - term outcome of curative hepatectomy for HCC - CC ... .", "label": "", "metadata": {}, "score": "46.665047"}
{"text": "Resection is the treatment of choice in noncirrhotics .Noncirrhotic HCC accounts for 5 % of cases in the West and 40 % of cases in Asia .", "label": "", "metadata": {}, "score": "46.702465"}
{"text": "Therefore , although there are no studies on its benefit when applied during the waiting list , we discourage this procedure prior to OLT .26 Finally , chemoembolisation is the standard antitumoral treatment for HCC prior to OLT in most transplant programs .", "label": "", "metadata": {}, "score": "46.966446"}
{"text": "HCC Staging .Staging system of cancers for classification of HCC provides a guide to patient assessment and to direct therapeutic interventions [ 66 , 67 ] .", "label": "", "metadata": {}, "score": "47.196457"}
{"text": "The risk of cancer development from chronic or cirrhosis varies according to the degree of fibrosis [ 21 ] .Main causes of liver cirrhosis are alcohol use , chronic hepatitis B and C , and nonalcoholic steatohepatitis [ 22 - 25 ] .", "label": "", "metadata": {}, "score": "47.29775"}
{"text": "Individually these studies report no effect .Antiviral potency and the ability to produce a sustained viral response ( SVR ) in HCV appear to be associated with reducing the risk of HCC recurrence [ 76 ] .", "label": "", "metadata": {}, "score": "47.306755"}
{"text": "It is important that this type of reaction following SBRT to the liver is recognized , and it should not be misinterpreted as local recurrence , because the duration of tumor viability after SBRT overlaps with this time period [ 63 , 65 ] .", "label": "", "metadata": {}, "score": "47.573265"}
{"text": "Key findings from the studies include : . the need for centrally - coordinated screening programmes across Europe .the potential of gadoxetic acid - enhanced MRI to more accurately stage HCC patients with early disease to ensure each patient receives the optimum treatment .", "label": "", "metadata": {}, "score": "47.61347"}
{"text": "Timely and effective diagnosis of HCC is critically important because surgical resection in early disease remains the only cure , \" said Dr Reeves .\" Hence , the identification of early stages of disease in high - risk individuals for the development of HCC would greatly improve clinical outcomes . \" In this context , this signature is being validated in an ongoing prospective study .", "label": "", "metadata": {}, "score": "47.657604"}
{"text": "This endpoint can occur in patients who have otherwise fairly well functioning pretreatment livers and can be fatal once it occurs ( \" classic \" RILD )", "label": "", "metadata": {}, "score": "47.7751"}
{"text": "Undiscounted results did not statistically differ from those discounted at 3 % .Cost effectiveness analysis of surgical resection for hepatocellular carcinoma versus conservative management while on the waiting list for liver transplantation .", "label": "", "metadata": {}, "score": "47.86346"}
{"text": "Limited data are available regarding risk factors and prognostic significance of incomplete ablation ... .The impact of family history of hepatocellular carcinoma on its patients ' survival .", "label": "", "metadata": {}, "score": "48.124447"}
{"text": "It is found to allow patients diagnosis in a resectable stage improving then the long - term survival [ 89 , 95 ] .Under these conditions , biopsy is not required avoiding the 10 - 20 % false negative rate from histological samples and the risk for tumor seeding .", "label": "", "metadata": {}, "score": "48.59886"}
{"text": "PATHOLOGICAL AND RADIOLOGICAL FEATURES OF HCC AND NORMAL LIVER AFTER SBRT .Effect of SBRT to normal liver parenchyma .Normal liver changes after high - dose irradiation have been recognized to have the histopathologic features of veno - occlusive disease ( VOD ) [ 61 , 62 ] .", "label": "", "metadata": {}, "score": "48.675632"}
{"text": "Probability of being transplanted and overall survival .The probability of being transplanted and the overall survival are depicted in figs 2 and 3 .Surgical resection increased the transplantation rate from 3.7 % to 10.7 % for waiting lists of six and 24 months , respectively .", "label": "", "metadata": {}, "score": "48.846954"}
{"text": "Treatment differences by country are also prominent for organ transplantation .Orthotopic liver transplantation offers the best chance for cure , particularly in patients with decompensated liver disease .", "label": "", "metadata": {}, "score": "48.92959"}
{"text": "- resection and radiofrequency ablation ( RFA ) are good options for treating recurrent HCC .This study compared the efficacy of these two modalities in the treatment of intrahepatic HCC recurrence after hepatectomy ... .", "label": "", "metadata": {}, "score": "48.939873"}
{"text": "Epidemiological , genetic and clinical data presented at the International Liver Congress TM 2014 are collectively focussed on different approaches designed to improve the diagnosis , staging and treatment of hepatocellular carcinoma ( HCC ) .", "label": "", "metadata": {}, "score": "49.008564"}
{"text": "This study investigated the outcomes of different surgical approaches in hepatocellular carcinoma ( HCC ) patients with PVTT ... .Technical note on complete excision of choledochal cysts .", "label": "", "metadata": {}, "score": "49.167233"}
{"text": "Abstract .Background : Survival after liver transplantation for early hepatocellular carcinoma ( HCC ) is worsened by the increasing dropout rate while waiting for a donor .", "label": "", "metadata": {}, "score": "49.36509"}
{"text": "Earlier studies involving SBRT for liver tumors included not only HCC but also cholangiocarcinoma and metastatic liver tumors , which made it difficult to compare the results between studies .", "label": "", "metadata": {}, "score": "49.68437"}
{"text": "EI is better indicated when RFA in not technically feasible .Trans - arterial chemoembolization ( TACE ) is the recommended treatment for BCLC stage B multinodular asymptomatic tumors without vascular invasion or extrahepatic spread .", "label": "", "metadata": {}, "score": "49.712807"}
{"text": "Currently the incidence of HCC is climbing rapidly and in a current climate of organ shortage has led to the re - evaluation of locoregional therapies and resectional surgery to manage the case load .", "label": "", "metadata": {}, "score": "49.77735"}
{"text": "In addition , data suggest a possibility that SBRT can be an alternative option for HCC unfit for other local therapies .However , information on optimal treatment indications , doses , and methods remains limited .", "label": "", "metadata": {}, "score": "49.84127"}
{"text": "Moreover , the survival of patients in favorable stages must be greater than unfavorable stages ( monotonicity of gradients ) [ 70 ] .Among the staging systems , the most used for the HCC are Okuda classification , TNM classification , CLIP classification , BCLC classification , French classification , CUPI classification , and JIS classification ( Table 1 ) .", "label": "", "metadata": {}, "score": "49.847057"}
{"text": "This uncertainty prompted us to conduct a decision analysis to address the clinical benefits and cost effectiveness of adjuvant treatment .The model applies the best curative therapies available for the selected strata of HCC candidates for OLT and considers a waiting time between six and 24 months .", "label": "", "metadata": {}, "score": "49.939568"}
{"text": "View Article PubMed .Livraghi T , Meloni F , Di Stasi M , Rolle E , Solbiati L , Tinelli C , Rossi S : Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis : is resection still the treatment of choice ?", "label": "", "metadata": {}, "score": "49.972065"}
{"text": "Figure 7 Typical focal liver reaction 4 mo after stereotactic body radiation therapy seen on gadoxetate acid - enhanced magnetic resonance imaging .An axial view of radiation dose distribution ( A ) .", "label": "", "metadata": {}, "score": "50.008606"}
{"text": "Finally , patients in the non - treatment arm directly entered the waiting list state without antitumoral treatment where the three transitional states were again considered .", "label": "", "metadata": {}, "score": "50.188255"}
{"text": "If feasible , we prefer the percutaneous approach , because it has the best comfort for the patient .In case of superficial tumors , the laparoscopic approach is of advantage to protect the adjacent organs from injury .", "label": "", "metadata": {}, "score": "50.241653"}
{"text": "4 , 6- 8 These values have prompted most hepatologists to favour OLT as firstline treatment .However , the shortage of donors and the increasing demand of organs have lengthened waiting times to more than six or 12 months in Europe and USA , respectively .", "label": "", "metadata": {}, "score": "50.243263"}
{"text": "Some mechanisms such as chromosomal loss , oxidative stress , a decreased retinoic acid level in the liver , altered DNA methylation , and genetic susceptibility can be regarded as causes of alcohol leading to HCC [ 28 - 39 ] .", "label": "", "metadata": {}, "score": "50.30053"}
{"text": "Worldwide 78 % of HCC are viral related with 53 % attributed to HBV and 25 % to HCV [ 70 ] .Risk of HCC recurrence after treatment is increased with progression of active hepatitis and fibrosis .", "label": "", "metadata": {}, "score": "50.44727"}
{"text": "The frequency of HCC in alcoholics is rather low and far less than that of tumors of the upper digestive tract [ 27 ] .No agreement exists on the dose - effect relationship between alcohol intake and risk of HCC , but some experts defined it as a proven risk factor for HCC when the daily consumption is estimated at 50 to 75 g per day .", "label": "", "metadata": {}, "score": "50.534492"}
{"text": "View Article .Llovet JM , Bru C , Bruix J : Prognosis of hepatocellular carcinoma : The BCLC staging classification .Semin Liver Dis 1999 , 19 ( 3 ) : 329 - 38 .", "label": "", "metadata": {}, "score": "50.568222"}
{"text": "After evaluation of those HCC patients in the CT+MR group with gadoxetic acid - MRI , a total of 74 HCC nodules were additionally detected in 53 ( 16.4 % ) patients , escalating the BCLC staging in 34 ( 10.5 % ) of the patients .", "label": "", "metadata": {}, "score": "50.59122"}
{"text": "Conclusion .patients with very early \" HCC were very few in this analysis .Backgrounds .The last 10 years have seen a proliferation of attempts to provide HCC patients with reliable staging and prognostic systems to overcome the inefficiency of the classical Child - Pugh [ 1 ] , Okuda [ 2 ] and tumor - node - metastasis ( TNM ) [ 3 ] staging systems .", "label": "", "metadata": {}, "score": "50.63174"}
{"text": "Although quality of life is an important outcome in calculating cost effectiveness , reliable data on HCC patients waiting for a liver donor are not available and thus this analysis was not addressed .", "label": "", "metadata": {}, "score": "50.692543"}
{"text": "\" Percutaneous RFA , performed under radiological guidance , is a minimally invasive , repeatable procedure with few complications . \"\" In the treatment of hepatocellular carcinoma ( HCC ) , where less than 40 % of patients are candidates for surgery , and the rate of recurrence after curative surgery is high , percutaneous techniques like RFA are very important . \"", "label": "", "metadata": {}, "score": "50.80662"}
{"text": "By adhering to the Milan criteria of undertaking LT for HCC with a solitary tumor .Staging .A staging system for HCC poses problems because the presence of liver disease and tumor varies due to the different epidemiological backgrounds and risk factors .", "label": "", "metadata": {}, "score": "50.840424"}
{"text": "A.Giorgio et al .HEPATOCELLULAR CARCINOMA ( HCC )INVADING PORTAL VENOUS SYSTEM IN CIRRHOSIS : 7 YEARS RESULTS OF PERCUTANEOUS RADIOFREQUENCY ABLATION OF HCC AND MAIN PORTAL VEIN TUMOR THROMBUS ( MPVTT ) .", "label": "", "metadata": {}, "score": "50.853493"}
{"text": "Results .\" Very early \" HCC were 3 % ; Cox multivariate analysis did not identify variables independently associated with survival .The patients following AASLD recommendations ( 20 % ) did not show longer survival .", "label": "", "metadata": {}, "score": "50.91903"}
{"text": "T. Livraghi , F. Meloni , M. Di Stasi et al . , \" Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis : is resection still the treatment of choice ? \"", "label": "", "metadata": {}, "score": "50.979286"}
{"text": "It is doubtful whether the trend toward an earlier diagnosis of HCC observed in centers where surveillance of cirrhotics is performed would significantly modify the overall figure [ 21 ] , given that this did not happen in our series , at least until 2004 .", "label": "", "metadata": {}, "score": "51.187843"}
{"text": "Int J Radiat Oncol Biol Phys .[PubMed ] [ DOI ] .Gunv\u00e9n P , Jonas E , Blomgren H , Rutkowska E , Karlsson K , Lax I , Levitt S. Undetectable late hepatic sequelae after hypofractionated stereotactic radiotherapy for liver tumors .", "label": "", "metadata": {}, "score": "51.219032"}
{"text": "The Kaplan - Meier method was used to estimate overall survival ( median and 95 % CI ) , defined as the interval between HCC diagnosis and death or last follow - up visit .", "label": "", "metadata": {}, "score": "51.33336"}
{"text": "So the development of molecular biology has enabled significant progress to improve the knowledge on molecular mechanisms of carcinogenic .HCC is known to be a result of the evolution process of a large number of genetic and epigenetic alterations that some are observed at neoplastic stages [ 20 , 28 , 42 , 49 ] .", "label": "", "metadata": {}, "score": "51.380672"}
{"text": "HCC is an unique chemoresistant tumor and until 2007 no systemic drug was recommended for its management .In the early 1990s , a number of randomised controlled studies assessed the role of adjuvant chemotherapy but no benefit or efficacy was demonstrated .", "label": "", "metadata": {}, "score": "51.430397"}
{"text": "Out of this patient population with early disease , 323 were additionally evaluated with gadoxetic acid - MRI ( CT+MR group ) ; 377 were not ( CT group ) .", "label": "", "metadata": {}, "score": "51.619972"}
{"text": "The most common site of first recurrence was the liver outside the irradiated volume , providing the rationale for studies combining regional or systemic therapies with SBRT .", "label": "", "metadata": {}, "score": "51.80021"}
{"text": "After intravenous injection , Gd - EOB - DTPA is gradually taken up by hepatocytes and is eventually excreted via the biliary pathway .Hepatocyte - phase Gd - EOB - DTPA - enhanced MRI can be used for the detection or characterization of hepatic lesions and potentially for the measurement of hepatocyte function .", "label": "", "metadata": {}, "score": "51.822243"}
{"text": "In the 1980s , patients presenting with large HCC were considered good candidates for LT as they were in better condition than patients with chronic liver disease and were more likely to survive the perioperative period but they had large or multifocal tumors .", "label": "", "metadata": {}, "score": "51.865845"}
{"text": "The shorter waiting time for LDLT may remove the observation period that occurs on the waiting list to assess tumor biology and a 3 month cooling off period has been advocated before undertaking LDLT .", "label": "", "metadata": {}, "score": "51.882214"}
{"text": "Whether LSM can predict the functional liver reserve in patients undergoing liver resection is not certain ... .A retrospective study on risk factors associated with failed endoscopic treatment of biliary anastomotic stricture after right - lobe living donor liver transplantation with duct - to - duct anastomosis .", "label": "", "metadata": {}, "score": "51.9011"}
{"text": "204 - 213 , 2010 .View at Google Scholar .R. Lencioni , D. Cioni , L. Crocetti , et al . , \" Percutaneous ablation of hepatocellular carcinoma : state - of - the - art , \" Liver Transplantation , vol .", "label": "", "metadata": {}, "score": "51.903343"}
{"text": "Figure 1 : The Barcelona - Cl\u00ednic Liver Cancer ( BCLC ) staging system for HCC .M : metastasis classification ; N : node classification ; PST : performance status ; RFA : radiofrequency ablation ; TACE : transarterial chemoembolization .", "label": "", "metadata": {}, "score": "52.013847"}
{"text": "HCC is a worldwide clinical and social issue and typically a complicates cirrhosis .The incidence of HCC is increasing , not only in the general population of patients with cirrhosis , but particularly in some subgroups of patients , like those with human immunodeficiency virus infection or thalassemia .", "label": "", "metadata": {}, "score": "52.024567"}
{"text": "In fact , to our knowledge there are not well designed studies comparing radioembolization with neither TACE nor sorafenib [ 81 - 84 ] .LT is actually a consolidated therapeutic option for HCC because it cures both tumor and underlying cirrhosis [ 1 - 4 ] .", "label": "", "metadata": {}, "score": "52.44207"}
{"text": "The general principle of palliative treatment is to prevent the blood supply to the HCC by blockage of the arterial system of liver .These treatments include transarterial embolization ( TAE ) , transarterial chemoembolization ( TACE ) , intra - artery chemotherapy ( IACT ) , and radiotherapy ( external and internal ) [ 119 , 120 ] .", "label": "", "metadata": {}, "score": "52.462894"}
{"text": "A total of four prospective studies that exclusively evaluated HCC , as well as other retrospective studies demonstrated promising treatment effects ( Table 3 ) .", "label": "", "metadata": {}, "score": "52.482857"}
{"text": "Patient 's selection is essential for TACE because it avoid side effects leading to liver failure and death [ 89 ] .Randomized control trials have shown benefit of TACE .", "label": "", "metadata": {}, "score": "52.541897"}
{"text": "It has been investigated in a total of 722 patients with HCC covering a period of ten years .It accounts for both Child - Pugh classification and Japan tumour node metastasis ( TNM ) staging .", "label": "", "metadata": {}, "score": "52.59495"}
{"text": "From January 2005 to January 2012 , among 3144 consecutive cirrhosis patients , 772 had HCC with MPVTT ; of these , 70 patients had a single HCC with MPVTT and were therefore eligible for percutaneous RFA .", "label": "", "metadata": {}, "score": "52.67083"}
{"text": "Hepatocellular carcinoma ( HCC ) with bile duct tumour thrombus ( BDTT ) is rare .The aim of the present study was to determine the prognosis of HCC with BDTT after a hepatectomy ... .", "label": "", "metadata": {}, "score": "52.69754"}
{"text": "A laparoscopic approach to resection in cirrhotics has been proposed by some to reduce the operative insult and the risk of decompensation [ 42 ] .", "label": "", "metadata": {}, "score": "52.745308"}
{"text": "132 - 140 , 2012 .View at Google Scholar .R. Adam , D. Azoulay , D. Castaing et al . , \" Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis : a reasonable strategy ? \"", "label": "", "metadata": {}, "score": "52.85376"}
{"text": "Surgical resection would have required a right lobectomy .Percutaneous ablative therapy was impossible due to involvement of the biliary system and large vessels near the tumor .", "label": "", "metadata": {}, "score": "52.87739"}
{"text": "the lack of any significant difference with respect to the compliance to the AASLD guidelines ; .Discussion .Whether or not either of these two systems is clearly superior , supporters of the BCLC maintain indeed that this system is the only one to link the patient 's stage with a clear - cut treatment indication .", "label": "", "metadata": {}, "score": "53.052563"}
{"text": "11 , pp . 1 - 8 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .L. Capussotti , A. Ferrero , L. Vigan\u00f2 , R. Polastri , and M. Tabone , \" Liver resection for HCC with cirrhosis : surgical perspectives out of EASL / AASLD guidelines , \" European Journal of Surgical Oncology , vol .", "label": "", "metadata": {}, "score": "53.147858"}
{"text": "These advances , particularly stereotactic body radiation therapy ( SBRT ) , have been critical in improving local control or potential cure in liver lesions not amenable to first - line surgical resection or radiofrequency ablation .", "label": "", "metadata": {}, "score": "53.160843"}
{"text": "[PubMed ] [ DOI ] .Jonas S , Bechstein WO , Steinm\u00fcller T , Herrmann M , Radke C , Berg T , Settmacher U , Neuhaus P. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis .", "label": "", "metadata": {}, "score": "53.24283"}
{"text": "Living donor liver transplantation : The ethics and the practice .Hepatology .[PubMed ] [ DOI ] .Sarasin FP , Majno PE , Llovet JM , Bruix J , Mentha G , Hadengue A. Living donor liver transplantation for early hepatocellular carcinoma : A life - expectancy and cost - effectiveness perspective .", "label": "", "metadata": {}, "score": "53.33217"}
{"text": "[PubMed ] [ DOI ] Affiliated with .Abstract .Background .A consensus on the most reliable staging system for hepatocellular carcinoma ( HCC ) is still lacking but the most used is a revised Barcelona Clinic Liver Cancer ( BCLC ) system , adopted by the American Association for the Study of Liver Diseases ( AASLD ) .", "label": "", "metadata": {}, "score": "53.334084"}
{"text": "Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver : accuracy of ultrasonography in transplant patients .J Ultrasound Med .[PubMed ] [ DOI ] .", "label": "", "metadata": {}, "score": "53.36641"}
{"text": "Radiation - induced liver disease ( RILD ) is a dose - limiting complication of liver irradiation .This could be an important issue , particularly in patients with HCC , primarily in the context of underlying liver cirrhosis .", "label": "", "metadata": {}, "score": "53.403305"}
{"text": "In general , SBRT and other local therapies can complementarily divide the roles between each modality .SBRT is feasible even for lesions that are not eligible for surgery or percutaneous ablation .", "label": "", "metadata": {}, "score": "53.505123"}
{"text": "Percutaneous treatments increased the probability of being transplanted and the seven year survival in all waiting times .These benefits became clinically relevant when the waiting time exceeded one year .", "label": "", "metadata": {}, "score": "53.574726"}
{"text": "Caution must be exercised in patients with HCC derived from pre - existing liver disease , because patients with more severe liver disease are significantly less likely to tolerate radiation [ 60 ] , which can manifest as \" nonclassic \" RILD .", "label": "", "metadata": {}, "score": "53.60549"}
{"text": "Chronic infection with HCV appears to increase the rate of HCC development in a similar way to HBV .The risk does not change with genotype ( G ) but a recent meta - analysis suggests that HCV G1b maybe more at risk of HCC transformation [ 75 ] .", "label": "", "metadata": {}, "score": "53.67004"}
{"text": "However , recently updated guidelines slightly differ in diagnostic criteria [ 2 - 4 ] .Figure 3 A new typical hepatocellular carcinoma found at computed tomography during follow up another hepatocellular carcinoma treated with radiofrequency ablation ( central lesion ) .", "label": "", "metadata": {}, "score": "53.801712"}
{"text": "Patients in intermediate stage to advanced stage with portal vein thrombosis ( PVT ) can be treated by yttrium-90 radioembolization ( 90Y - RE ) .", "label": "", "metadata": {}, "score": "53.83889"}
{"text": "Recurrence reasons are complex and depend on the size and differentiation of tumor , intrahepatic metastases undetectable at resection time , vascular invasion , and satellites nodules .", "label": "", "metadata": {}, "score": "53.839462"}
{"text": "Accordingly , these patients were modelled to receive percutaneous treatment , which was identified as cost effective in all scenarios .It could be argued that PEI is not the sole effective therapy for non - surgical HCC and that other widely used alternatives such as RF thermal ablation , 26 , 37 chemoembolisation , 13- 18 or even chemotherapy 38 could be modelled .", "label": "", "metadata": {}, "score": "53.847847"}
{"text": "Over one third of the patients ( 36 % ) are treated with TACE , outside the AASLD indications , and 13 % undergo medical treatment and/or BSC .", "label": "", "metadata": {}, "score": "53.895985"}
{"text": "Treatment strategy for recurrent hepatocellular carcinoma : salvage transplantation , repeated resection , or radiofrequency ablation ?Albert C Y Chan Division of HepatoBiliary and Pancreatic surgery and Liver Transplantation , Department of Surgery , Hong Kong , China Liver Transpl 19:411 - 9 .", "label": "", "metadata": {}, "score": "53.92105"}
{"text": "Am J Pathol .[PubMed ] [ DOI ] .Herfarth KK , Hof H , Bahner ML , Lohr F , H\u00f6ss A , van Kaick G , Wannenmacher M , Debus J. Assessment of focal liver reaction by multiphasic CT after stereotactic single - dose radiotherapy of liver tumors .", "label": "", "metadata": {}, "score": "53.95542"}
{"text": "Outcomes of living donor liver transplantation for patients with preoperative type 1 hepatorenal syndrome and acute hepatic decompensation .Kenneth S H Chok Department of Surgery , University of Hong Kong , Hong Kong , China Liver Transpl 18:779 - 85 .", "label": "", "metadata": {}, "score": "54.0185"}
{"text": "Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection : analysis of 71 patients .J Hepatol 1997 ; 27 : 862 -70 .", "label": "", "metadata": {}, "score": "54.09696"}
{"text": "Patients with \" very early \" HCC survived longer ( median 60 months , 95 % CI 47 - 72 ) than patients with \" early \" disease ( 42 months , 95 % CI 38 - 46 ) .", "label": "", "metadata": {}, "score": "54.138138"}
{"text": "HCC Epidemiology .HCC is the most common primary liver cancer .The annual number of new cases of HCC worldwide is over one million , making it the 5th most common cancer worldwide and the 3rd leading cause of cancer - related death , preceded only by the lung and stomach cancers [ 1 - 6 ] .", "label": "", "metadata": {}, "score": "54.209435"}
{"text": "BMC Gastroenterol .[PubMed ] [ DOI ] .Omata M , Tateishi R , Yoshida H , Shiina S. Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods : Ethanol injection therapy and radiofrequency ablation .", "label": "", "metadata": {}, "score": "54.298187"}
{"text": "However , it does not include important prognostic parameters such as the unifocal , multifocal , or diffuse state of the tumor , existence of a portal vein thrombosis or distant metastasis and the alpha - fetoprotein ( AFP ) rate .", "label": "", "metadata": {}, "score": "54.410072"}
{"text": "Prevention of HCV infection requires the reduction of risky behavior and the improvement of hygiene by the widespread use of disposable syringes and needless reduction of transmission among injecting drug users and also the screening of blood donors and organ donors [ 47 , 48 ] .", "label": "", "metadata": {}, "score": "54.656487"}
{"text": "Systemic therapies have not unfortunately provided benefit effect or increased survival for patients with advanced HCC .Several clinical trials have been conducted on these agents searching an optimal therapy against advanced HCC , but there is no currently defined as a standard formula effective against advanced HCC .", "label": "", "metadata": {}, "score": "54.741592"}
{"text": "[PubMed ] [ DOI ] .Kulik L , Abecassis M. Living donor liver transplantation for hepatocellular carcinoma .Gastroenterology .2004 ; 127 : S277-S282 .", "label": "", "metadata": {}, "score": "54.751415"}
{"text": "In addition to conformal photon external - beam delivery , data suggest improved outcomes with proton or charged - particle therapies [ 69 - 71 ] , particularly for large tumors .", "label": "", "metadata": {}, "score": "54.82529"}
{"text": "6 , pp .557 - 563 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . F. Y. Yao , S. Breitenstein , C. E. Broelsch , et al . , \" Does a patient qualify for liver transplantation after the down - staging of hepatocellular carcinoma ? \"", "label": "", "metadata": {}, "score": "54.86046"}
{"text": "Percutaneous radiofrequency ablation ( RFA ) is an effective and safe treatment for small hepatocellular carcinoma ( HCC ) .The technique provides excellent overall survival and tumour - to - progression rates , according to the results of a 10 year follow - up study in a population of Chinese patients presented at the International Liver CongressTM 2014 .", "label": "", "metadata": {}, "score": "55.024776"}
{"text": "Small hepatocellular carcinoma in cirrhosis : randomized comparison of radio - frequency thermal ablation versus percutaneous ethanol injection .Radiology .[PubMed ] [ DOI ] .", "label": "", "metadata": {}, "score": "55.138107"}
{"text": "270 - 285 , 1991 .View at Google Scholar \u00b7 View at Scopus .P. Moreno , E. Jaurrieta , J. Figueras et al . , \" Orthotopic liver transplantation : treatment of choice in cirrhotic patients with hepatocellular carcinoma ? \" Transplantation Proceedings , vol .", "label": "", "metadata": {}, "score": "55.27423"}
{"text": "An internal validation analysis was also performed in a set of 100 consecutive \" early \" HCC patients diagnosed in an more recent time period ( included from January 2002 and December 2004 ) .", "label": "", "metadata": {}, "score": "55.402534"}
{"text": "According to these results , it is indicated that a high local control rate for SBRT similar to other standard local therapies can achieve equivalent overall survival .", "label": "", "metadata": {}, "score": "55.435246"}
{"text": "For optimal results TACE needs to be as selective as possible , producing sustained and high localised concentrations within the tumor minimizing systemic exposure .Alternative ways to be delivering chemotherapy instead of the standard ethiodized oil ( lipiodol ) suspensions are drug - eluting beads [ 58 ] .", "label": "", "metadata": {}, "score": "55.45243"}
{"text": "17 , supplement 2 , pp .S26-S33 , 2011 .View at Google Scholar . F. Y. Yao , L. Ferrell , N. M. Bass et al . , \" Liver transplantation for hepatocellular carcinoma : expansion of the tumor size limits does not adversely impact survival , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "55.53367"}
{"text": "RFA can be performed percutaneously , laparoscopically , or at open surgery depending on tumor location [ 46 , 47 ] .Overall 10 - 25 % of tumors will not be suitable for RFA because of location such as subcapsular , adjacent to the gall bladder or major vessels which increases the risk of complication and inadequate ablation because of heat sink .", "label": "", "metadata": {}, "score": "55.6084"}
{"text": "Conclusion .In short , the data deriving from this analysis of one of the largest available databases on HCC demonstrate that : . patients with \" very early \" HCC are presently very few , probably too few to make a definition of this stage of the disease clinically useful .", "label": "", "metadata": {}, "score": "55.628487"}
{"text": "6 , pp .688 - 703 , 1997 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .I. W. Graziadei , H. Sandmueller , P. Waldenberger et al . , \" Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome , \" Liver Transplantation , vol .", "label": "", "metadata": {}, "score": "55.635048"}
{"text": "TAE and IACT are known to have an anticancer activity but no effect in increasing survival [ 4 ] .TACE is the most widely used for unrespectable HCC and one of the most used techniques to control liver cancer around the world .", "label": "", "metadata": {}, "score": "55.676125"}
{"text": "The tumor invading the vena cava is enhanced in arterial phase and shows a defect in portal phase on dynamic computed tomography ( A and B ) .", "label": "", "metadata": {}, "score": "55.754925"}
{"text": "At present , there is little evidence on whether the immunosuppression regime should be completely changed to a mTOR inhibitor or whether these agents should be added to the preexisting immunosuppressive regime when recurrent HCC presents post LT [ 35 , 78 , 79 ] .", "label": "", "metadata": {}, "score": "55.94467"}
{"text": "[PubMed ] [ DOI ] .Fujiki M , Aucejo F , Kim R. Adjuvant treatment of hepatocellular carcinoma after orthotopic liver transplantation : do we really need this ?", "label": "", "metadata": {}, "score": "55.961716"}
{"text": "In this study , the overall survival rate was 73 % in 3 years , which was comparable to outcomes treated with surgery or percutaneous ablation , considering these candidates were medically unfit for radical therapies .", "label": "", "metadata": {}, "score": "56.045235"}
{"text": "Llovet JM , Bruix J , Fuster J , et al .Liver transplantation for treatment of small hepatocellular carcinoma : the tumor - node - metastasis classification does not have prognostic power .", "label": "", "metadata": {}, "score": "56.0703"}
{"text": "[PubMed ] [ DOI ] .Poon RT , Fan ST , Lo CM , Liu CL , Lam CM , Yuen WK , Yeung C , Wong J. Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis : is it justified ?", "label": "", "metadata": {}, "score": "56.08303"}
{"text": "Eur J Gastroenterol Hepatol .[PubMed ] [ DOI ] .Welker MW , Bechstein WO , Zeuzem S , Trojan J. Recurrent hepatocellular carcinoma after liver transplantation - an emerging clinical challenge .", "label": "", "metadata": {}, "score": "56.12233"}
{"text": "View at Google Scholar \u00b7 View at Scopus .C. Camm\u00e0 , V. di Marco , G. Cabibbo et al . , \" Survival of patients with hepatocellular carcinoma in cirrhosis : a comparison of BCLC , CLIP and GRETCH staging systems , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "56.135254"}
{"text": "Blood tests showed that his liver function was similar before and after the treatment .No adhesion was encountered in the liver transplantation performed six months later ... .", "label": "", "metadata": {}, "score": "56.155167"}
{"text": "10 , pp .1301 - 1311 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. E. Majno , F. P. Sarasin , G. Mentha , and A. Hadengue , \" Primary liver resection and salvage transplantation or primary liver transplantation in patients with single , small hepatocellular carcinoma and preserved liver function : an outcome - oriented decision analysis , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "56.195503"}
{"text": "Age related mortality in the periods of time considered was negligible .Dropout rate .Data on dropout rate of HCC candidates for OLT are rarely reported .", "label": "", "metadata": {}, "score": "56.197205"}
{"text": "4 , pp .400 - 402 , 2012 .View at Publisher \u00b7 View at Google Scholar . Y. K. Cho , J. K. Kim , W. T. Kim , and J. W. Chung , \" Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma : a markov model analysis , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "56.465134"}
{"text": "BCLC is the only system of stratification in which each group is correlated with a mode of specific treatment ( Figure 2 ) .This advantage of linking the stage of HCC patient with appropriate treatment allows it to offer as the best classification system validated especially in patients with early HCC [ 68 ] .", "label": "", "metadata": {}, "score": "56.526825"}
{"text": "In case of persons already infected chronically with a HCC risk development , appropriate way is to select patient at risk for treatment and not a mass vaccination [ 46 ] .", "label": "", "metadata": {}, "score": "56.672043"}
{"text": "Screening and recall policy .Surveillance of HCC is important simply because as little is HCC size at diagnosis as high is the probability of curative treatment .", "label": "", "metadata": {}, "score": "56.681446"}
{"text": "When referring to the literature on HCC treatment outcomes , it is important to carefully understand the differences in patient characteristics in each report , because these factors significantly affect outcomes as well as clinical application of various treatments .", "label": "", "metadata": {}, "score": "56.87345"}
{"text": "Once exclusion of the list had occurred , median survival was modelled to be less than one year .Outcomes of patients effectively transplanted were obtained from the best results of groups applying restrictive selection criteria .", "label": "", "metadata": {}, "score": "57.01362"}
{"text": "Careful patient selection is required and SBRT should be considered only after thorough discussion within a multi - disciplinary team , with all legitimate treatment options also considered .", "label": "", "metadata": {}, "score": "57.041405"}
{"text": "Abstract presented at the International Liver CongressTM 2014 .L.Zhang et al .LONG TERM OUTCOMES AND PROGNOSTIC ANALYSIS OF SMALL HEPATOCELLULAR CARCINOMA TREATED WITH RADIOFREQUENCY ABLATION : 10 YEARS FOLLOW UP IN CHINESE PATIENTS .", "label": "", "metadata": {}, "score": "57.190952"}
{"text": "12 This sharply worsens the outcome when assessing OLT results on an intention to treat basis .Several adjuvant antitumoral therapies have been administered to patients on the waiting list for liver transplantation to reduce tumour growth .", "label": "", "metadata": {}, "score": "57.229424"}
{"text": "71 - 80 , 2005 .View at Google Scholar .V. Mazzaferro , E. Regalia , R. Doci et al . , \" Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis , \" New England Journal of Medicine , vol .", "label": "", "metadata": {}, "score": "57.31563"}
{"text": "This aim of this study is to determine the risk factors in failed endoscopic retrograde cholangiography ( ERC ) ... .High - intensity focused ultrasound ablation : an effective bridging therapy for hepatocellular carcinoma patients .", "label": "", "metadata": {}, "score": "57.46115"}
{"text": "Survival outcome of re - resection for recurrent liver metastases of colorectal cancer : a retrospective study .Kenneth S H Chok Department of Surgery , The University of Hong Kong , Hong Kong , China ANZ J Surg 84:545 - 9 .", "label": "", "metadata": {}, "score": "57.52016"}
{"text": "A cut - off value of 20 ng / mL corresponded in a sensitivity of 64 % and a specificity of 91 % , while a sensitivity of 17 % and specificity of 99 % for the cut - off value of 400 ng / mL. Generally , diagnosis confirms HCC in values over 400 ng / mL , although this value was only found in 20 % of HCC patients .", "label": "", "metadata": {}, "score": "57.62201"}
{"text": "Oral nucleoside / nucleotide analogs without hepatitis B immune globulin after liver transplantation for hepatitis B .James Fung Department of Medicine , The University of Hong Kong , Queen Mary Hospital , Hong Kong , China Am J Gastroenterol 108:942 - 8 .", "label": "", "metadata": {}, "score": "57.804146"}
{"text": "patients with \" early \" disease are a relatively sizable share of all HCC patients diagnosed .For them using the AASLD guidelines coincides with better survival ; as for the types of treatment , these can be placed in order of efficiency , with OLTx at the top and TACE , generally used in patients with more advanced disease , at the bottom .", "label": "", "metadata": {}, "score": "57.85574"}
{"text": "Hepatitis B ( HBV ) infection increases the risk of HCC recurrence particularly for the patient who is HBeAg + and/or has a high serum HBV DNA level [ 71 , 72 ] .", "label": "", "metadata": {}, "score": "57.87377"}
{"text": "Hepatocellular carcinoma ( HCC ) is the fifth most common cancer and the third cause of cancer - related mortality worldwide .Its incidence is clearly arising comprised by the prevalence of major risk factors mainly hepatitis B and hepatitis C. The population at risk is composed of chronic liver patients at the stage of extensive fibrosis or cirrhosis .", "label": "", "metadata": {}, "score": "58.055405"}
{"text": "The aim of this study is to compare the outcomes of side - to - side hepaticojejunostomy with those of end - to - side hepaticojejunostomy ... .", "label": "", "metadata": {}, "score": "58.098255"}
{"text": "( 1 ) Variations in the dropout rate .( a ) Best scenario : treatment achieves a relative reduction of 20 % in the dropout rate from the reference case of the treatment arm .", "label": "", "metadata": {}, "score": "58.209213"}
{"text": "[PubMed ] [ DOI ] .Belghiti J , Hiramatsu K , Benoist S , Massault P , Sauvanet A , Farges O. Seven hundred forty - seven hepatectomies in the 1990s : an update to evaluate the actual risk of liver resection .", "label": "", "metadata": {}, "score": "58.212784"}
{"text": "Tumor stage was retrospectively correlated with the BCLC system [ 5 ] , given the availability of reliable data on patients ' symptoms and performance status in the original data base .", "label": "", "metadata": {}, "score": "58.274353"}
{"text": "The activation of this signaling pathway in HCC is initiated by the IGF II by a loss of promoter - specific imprinting and reactivation of fetal promoters , reduced expression of IGF - binding protein , and/or activation of the IGF II-2R , which mediates IGF - II degradation .", "label": "", "metadata": {}, "score": "58.314674"}
{"text": "Radioembolization using yttrium-90 ( 90Y ) labelled microspheres a beta emitter , appears promising , and may also be effective as a precursor to radical therapy with outcomes similar to TACE [ 30 , 63 ] and Sorafenib [ 64 ] .", "label": "", "metadata": {}, "score": "58.410107"}
{"text": "[PubMed ] [ DOI ] .Mela M , Mancuso A , Burroughs AK .Review article : hepatocellular carcinoma : indications for liver transplantation .", "label": "", "metadata": {}, "score": "58.433952"}
{"text": "5 ] .Currently , a number of pilot and advanced - phase studies of long - acting octreotide LAR depot in advanced HCC are being conducted in Europe and the United States to assess tumor response .", "label": "", "metadata": {}, "score": "58.43795"}
{"text": "In fact , UCSF criteria on explant identified retrospectively a cohort of patients whose survival was not significantly different from those of patient transplanted for HCC inside the Milan criteria [ 93 ] .", "label": "", "metadata": {}, "score": "58.461967"}
{"text": "View Article PubMed .Seror O , N'Kontchou G , Tin Tin Htar M , Durand - Zaleski I , Trinchet JC , Sellier N , Beaugrand M : Ethanol versus radiofrequency ablation for the treatment of small hepatocellular carcinoma in patients with cirrhosis : a retrospective study of efficacy and cost .", "label": "", "metadata": {}, "score": "58.51191"}
{"text": "Rapid measurement of indocyanine green retention by pulse spectrophotometry : a validation study in 70 patients with Child - Pugh A cirrhosis before hepatectomy for hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "58.55027"}
{"text": "Long - term survival of 5 years can be achieved in 60 - 70 % of patients who have undergone resection depending on the stage of disease .", "label": "", "metadata": {}, "score": "58.722866"}
{"text": "\u03b2 -catenin mutations seem to be correlated to the etiology of the HCC .In HBV- and HCV - related HCC \u03b2 -catenin mutations , rates are still subject to discussion .", "label": "", "metadata": {}, "score": "58.796"}
{"text": "In HCC .ml progression free survival rates at 6 months , 1 year , and 3 years of 83 % , 72 % , and 68 % respectively , with overall survival at 1 year , and 3 years of 92.9 % and 58.6 % have been reported .", "label": "", "metadata": {}, "score": "58.80196"}
{"text": "Results .Therefore , these patients accounted overall for the 28 % of all cases diagnosed at the units participating in the study .OLTx : orthotopic liver transplantation ; RFTA : radiofrequency - mediated thermal ablation ; .", "label": "", "metadata": {}, "score": "58.855194"}
{"text": "Probability of being transplanted ( A ) and seven year intention to treat survival ( B ) comparing patients with hepatocellular carcinoma undergoing percutaneous treatment versus conservative management while on the waiting list for liver transplantation .", "label": "", "metadata": {}, "score": "58.89332"}
{"text": "AFP is used as a screening test because HCC may secrete elevated rate of AFP .Many studies of AFP in HCC surveillance revealed that its sensitivity is estimated at 39 - 64 % , it specificity to 76 - 91 % , and its positive predictive value to 9 - 32 % .", "label": "", "metadata": {}, "score": "58.98148"}
{"text": "The dose per fraction was determined based on the effective volume of normal liver irradiated ( Veff ) .For patients with a high Veff ( 25%-60 % ) , doses from 30 - 45 Gy ( 5 to 7.5 Gy \u00d7 6 ) were delivered .", "label": "", "metadata": {}, "score": "59.100662"}
{"text": "This constitutes a major drawback of this treatment because of the scarcity of donors that is crucial in Asia .As a consequence , the MELD ( Model of End - Stage liver Disease ) scoring system has been adopted to allocate organs for the patient in waiting list for liver transplantation .", "label": "", "metadata": {}, "score": "59.105217"}
{"text": "[PubMed ] [ DOI ] .Sala M , Fuster J , Llovet JM , Navasa M , Sol\u00e9 M , Varela M , Pons F , Rimola A , Garc\u00eda - Valdecasas JC , Br\u00fa C. High pathological risk of recurrence after surgical resection for hepatocellular carcinoma : an indication for salvage liver transplantation .", "label": "", "metadata": {}, "score": "59.12085"}
{"text": "Length of waiting time ranged from six to 24 months .Percutaneous treatment increased life expectancy by 5.2 - 6.7 months with a marginal cost of approximately $ 20 000/year of life gained in all cases , remaining cost effective for all waiting times .", "label": "", "metadata": {}, "score": "59.151638"}
{"text": "238 , no .4 , pp .508 - 519 , 2003 .View at Google Scholar \u00b7 View at Scopus .P. E. Majno , R. Adam , H. Bismuth et al . , \" Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis , \" Annals of Surgery , vol .", "label": "", "metadata": {}, "score": "59.25889"}
{"text": "There is no consensus limit to tumor number or size [ 25 ] .Predictors of downstaging failure are tumors with an infiltrative pattern [ 26 ] and an AFP . ng / mL [ 27 ] .", "label": "", "metadata": {}, "score": "59.292946"}
{"text": "The patients included in RFTA and RESECTION groups did not revealed significant differences in terms of Child - Pugh class or number and size of HCC lesions .", "label": "", "metadata": {}, "score": "59.33418"}
{"text": "These were different from the results reported on other species .[ 18F]FAC may not be a potential alternative tracer for [ 11C]ACT in PET / CT evaluation of HCC in human subjects ... .", "label": "", "metadata": {}, "score": "59.42588"}
{"text": "In geographic locations without AFB1 exposure as Western countries TP53 mutations are found in around 20 % of HCCs [ 50 ] .Except TP53 , research is conducted on other genes such as AXIN1 and CTNNB1 to determine the role of their mutations in the occurrence of HCC .", "label": "", "metadata": {}, "score": "59.46548"}
{"text": "[PubMed ] [ DOI ] .Lencioni R , Cioni D , Crocetti L , Franchini C , Pina CD , Lera J , Bartolozzi C. Early - stage hepatocellular carcinoma in patients with cirrhosis : long - term results of percutaneous image - guided radiofrequency ablation .", "label": "", "metadata": {}, "score": "59.47693"}
{"text": "Other factors may also affect treatment outcomes .Some reports on SBRT for HCC use TACE as a part of their treatment , or for validation of tumor location in each treatment session by visualizing the tumor with lipiodol on computed tomography ( CT ) , while other reports treat patients with SBRT alone .", "label": "", "metadata": {}, "score": "59.47798"}
{"text": "Taken together , \" very early \" and \" early \" HCC patients showed the following characteristics : . a median overall survival of 46 months ( 95 % CI 42 - 50 ) ; .", "label": "", "metadata": {}, "score": "59.48288"}
{"text": "For the BCLC staging system , however , the bottom line is : can we be fully confident that the proposed stage - related treatment indications are so helpful that adhering to them will give patients the best possible chances of survival ?", "label": "", "metadata": {}, "score": "59.605743"}
{"text": "Moreover , initial experiences tended to offer LT as the last therapeutic chance when resection was not feasible .In fact , till the first half of nineties , the discouraging results of some experiences had questioned the possibility of LT efficacy as HCC treatment .", "label": "", "metadata": {}, "score": "59.64745"}
{"text": "The Okuda staging system has been widely used since 1985 .It uses four criteria of ascites , albumin , bilirubin , and tumor size to assess liver functional status and tumor stage .", "label": "", "metadata": {}, "score": "59.670673"}
{"text": "Outline .Radiofrequency ablation ( RFA ) has become an established method for the treatment of inoperable liver tumors .Even with aggressive surgical treatment , a large percentage of small tumors can not be resected .", "label": "", "metadata": {}, "score": "59.832394"}
{"text": "Examples of patients who could not be treated with other local therapies but received SBRT are shown in Figures 3 - 5 .Figure 2 Computed tomography sections demonstrating typical locations treated with stereotactic body radiation therapy .", "label": "", "metadata": {}, "score": "59.934494"}
{"text": "View at Google Scholar .L. Andreana , G. Isgr\u00f2 , M. Pleguezuelo , et al . , \" Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis , \" World Journal of Hepatology , vol .", "label": "", "metadata": {}, "score": "59.972046"}
{"text": "View at Google Scholar .J. M. Alamo , L. Barrera , M. D. Casado et al . , \" Efficacy , tolerance , and safety of mammalian target of rapamycin inhibitors as rescue immunosuppressants in liver transplantation , \" Transplantation Proceedings , vol .", "label": "", "metadata": {}, "score": "60.017403"}
{"text": "[PubMed ] [ DOI ] .Lin SM , Lin CJ , Lin CC , Hsu CW , Chen YC .Randomised controlled trial comparing percutaneous radiofrequency thermal ablation , percutaneous ethanol injection , and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less .", "label": "", "metadata": {}, "score": "60.031162"}
{"text": "Furthermore , it enables patients to remain on the list for frequently curative transplantation while waiting for donated livers to become available .SBRT OUTCOMES AND OPTIMAL DOSES .", "label": "", "metadata": {}, "score": "60.10801"}
{"text": "216 - 222 , 1999 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. G. O'Grady , R. J. Polson , K. Rolles , R. Y. Calne , and R. Williams , \" Liver transplantation for malignant disease , \" Annals of Surgery , vol .", "label": "", "metadata": {}, "score": "60.134842"}
{"text": "Many therapies have been used as a \" bridge \" to transplantation , and SBRT has also been evaluated as a means to bridge to transplantation .", "label": "", "metadata": {}, "score": "60.145706"}
{"text": "For those patients who have portal invasion , systemic chemotherapy ( e.g . , sorafenib ) can be added to definitive radiotherapy .SBRT .Numerous advances in external - beam radiation therapy allow for more accurate targeting , and make aggressive dose - fractionation strategies possible using techniques such as SBRT .", "label": "", "metadata": {}, "score": "60.152393"}
{"text": "4 , pp .288 - 294 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. Pokorny , M. Gnant , S. Rasoul - Rockenschaub et al . , \" Does additional doxorubicin chemotherapy improve outcome in patients with hepatocellular carcinoma treated by liver transplantation ? \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "60.26389"}
{"text": "Generally , if there is no response after two TACE sessions , alternative treatment strategies should be considered , which in the majority will be systemic therapy .", "label": "", "metadata": {}, "score": "60.2995"}
{"text": "In the univariate analysis , the choice of treatment , overall , shows a borderline impact on survival .However , when patients who underwent OLTx , that should not be indicated in this stage of the disease with very few exceptions , and those who underwent BSC are disregarded , any difference disappears .", "label": "", "metadata": {}, "score": "60.36245"}
{"text": "In a recent work , Wang et al analyzed a large cohort of patients to assess the impact on survival of treatment choice in the different BCLC stages [ 27 ] .", "label": "", "metadata": {}, "score": "60.42028"}
{"text": "A better understanding of the molecular and histological responsible for the occurrence of the disease should allow the development of new diagnostics and treatments more effective in the treatment of HCC . A. I. Gomaa , S. A. Khan , M. B. Toledano , I. Waked , and S. D. Taylor - Robinson , \" Hepatocellular carcinoma : epidemiology , risk factors and pathogenesis , \" World Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "60.426582"}
{"text": "[PubMed ] [ DOI ] .Ibarra RA , Rojas D , Snyder L , Yao M , Fabien J , Milano M , Katz A , Goodman K , Stephans K , El - Gazzaz G. Multicenter results of stereotactic body radiotherapy ( SBRT ) for non - resectable primary liver tumors .", "label": "", "metadata": {}, "score": "60.429707"}
{"text": "[PubMed ] [ DOI ] .Yao FY , Xiao L , Bass NM , Kerlan R , Ascher NL , Roberts JP .Liver transplantation for hepatocellular carcinoma : validation of the UCSF - expanded criteria based on preoperative imaging .", "label": "", "metadata": {}, "score": "60.51751"}
{"text": "These distinct areas were observed with clear demarcation between the irradiated and nonirradiated liver .Radiographic normal tissue changes caused by irradiation have been described after SBRT in the absence of clinical manifestations of RILD .", "label": "", "metadata": {}, "score": "60.52237"}
{"text": "Early \" disease .Surgical resection obtained a median survival of 52 months ( CI 45 - 58 ) , RFTA of 62 months and PEI of 44 months ( CI 37 - 50 ) .", "label": "", "metadata": {}, "score": "60.579655"}
{"text": "[PubMed ] [ DOI ] .Castroagud\u00edn JF , Molina - P\u00e9rez E , Ferreiro - Iglesias R , Abdulkader I , Otero - Ant\u00f3n E , Tom\u00e9 S , Varo - P\u00e9rez E. Late recurrence of hepatocellular carcinoma after liver transplantation : is an active surveillance for recurrence needed ?", "label": "", "metadata": {}, "score": "60.588432"}
{"text": "\" Medical News Today .MediLexicon , Intl ., 15 Apr. 2014 .Web .14 Feb. 2016 .APA European Association for the Study of the Liver .", "label": "", "metadata": {}, "score": "60.600075"}
{"text": "4 , pp .2296 - 2298 , 1995 .View at Google Scholar \u00b7 View at Scopus .V. Mazzaferro , E. Regalia , R. Doci et al . , \" Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis , \" The New England Journal of Medicine , vol .", "label": "", "metadata": {}, "score": "60.614357"}
{"text": "[PubMed ] [ DOI ] . O'Connor JK , Trotter J , Davis GL , Dempster J , Klintmalm GB , Goldstein RM .Long - term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation .", "label": "", "metadata": {}, "score": "60.660988"}
{"text": "62 - 75 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. M. Llovet , C. Br\u00fa , and J. Bruix , \" Prognosis of hepatocellular carcinoma : the BCLC staging classification , \" Seminars in Liver Disease , vol .", "label": "", "metadata": {}, "score": "60.774826"}
{"text": "For example , SBRT has been shown to be a highly effective and well - tolerated treatment in patients with medically inoperable or high - risk operable stage I non - small cell lung cancer [ 23 ] .", "label": "", "metadata": {}, "score": "60.88836"}
{"text": "Meta - analysis : surveillance with ultrasound for early - stage hepatocellular carcinoma in patients with cirrhosis .Aliment Pharmacol Ther .[PubMed ] [ DOI ] .", "label": "", "metadata": {}, "score": "60.93087"}
{"text": "10 , article 475 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. F. Perz , G. L. Armstrong , L. A. Farrington , Y. J. F. Hutin , and B. P. Bell , \" The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide , \" Journal of Hepatology , vol .", "label": "", "metadata": {}, "score": "60.991226"}
{"text": "P.Johnson et al .AN INTERNATIONAL COLLABORATIVE STUDY ASSESSING THE ROLE OF AETIOLOGY & STAGE IN SURVIVAL IN HCC - IMPLICATIONS FOR SCREENING .Abstract presented at the International Liver CongressTM 2014 .", "label": "", "metadata": {}, "score": "60.998535"}
{"text": "Phase 2 open - label study of single - agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B - endemic Asian population : presence of lung metastasis predicts poor response .", "label": "", "metadata": {}, "score": "61.110775"}
{"text": "Gastroenterology .[PubMed ] [ DOI ] .Brown RS .Live donors in liver transplantation .Gastroenterology .[PubMed ] [ DOI ] .", "label": "", "metadata": {}, "score": "61.130558"}
{"text": "321 - 328 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. Camm\u00e0 , V. Di Marco , A. Orlando et al . , \" Treatment of hepatocellular carcinoma in compensated cirrhosis with radio - frequency thermal ablation ( RFTA ) : a prospective study , \" Journal of Hepatology , vol .", "label": "", "metadata": {}, "score": "61.14273"}
{"text": "Preoperative [ ( 18 ) F]FDG PET may predict microvascular invasion .The addition of [ ( 11 ) C]acetate improves the overall sensitivity of PET , but it has no incremental value in predicting microvascular invasion ... .", "label": "", "metadata": {}, "score": "61.145737"}
{"text": "In contrast , most SBRT series reported a local control rate of 70%-100 % , which implies that the effect of SBRT takes a considerable time to cause tumor cell death .", "label": "", "metadata": {}, "score": "61.19191"}
{"text": "Some chemoprevention agents are also used in the HCC prevention .They differ by country but also the underlying disease and the results are unreliable according to the desired effect .", "label": "", "metadata": {}, "score": "61.19551"}
{"text": "We here report on our experience of RFA using a percutaneous , laparoscopic , or open surgical approach for the treament of liver tumors .Between december 2000 and June 2005 , we performed 157 ablations in 102 patients .", "label": "", "metadata": {}, "score": "61.21167"}
{"text": "4 , pp .899 - 906 , 2000 .View at Google Scholar \u00b7 View at Scopus . D. Fuks , S. Dokmak , V. Paradis , M. Diouf , F. Durand , and J. Belghiti , \" Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence : an intention - to - treat analysis , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "61.322556"}
{"text": "[PubMed ] [ DOI ] .Sanuki - Fujimoto N , Takeda A , Ohashi T , Kunieda E , Iwabuchi S , Takatsuka K , Koike N , Shigematsu N. CT evaluations of focal liver reactions following stereotactic body radiotherapy for small hepatocellular carcinoma with cirrhosis : relationship between imaging appearance and baseline liver function .", "label": "", "metadata": {}, "score": "61.339417"}
{"text": "However , CT or MR should be preferred for surveillance of patients for which US is not adequate because of technical reasons or in liver transplantation ( LT ) waiting list [ 1 - 4 ] .", "label": "", "metadata": {}, "score": "61.439514"}
{"text": "Promising thermal ablative strategies include microwave producing large areas of ablation with less heat sink and high intensity focused US ( HIFU ) that can be used in patients with ascites .", "label": "", "metadata": {}, "score": "61.461056"}
{"text": "9 , 11 In our model , exclusions from the waiting list included both death or OLT , contraindications derived from tumour progression ( vascular invasion , lymph node involvement , or metastases ) , or liver functional impairment ( that is , progressive hepatorenal syndrome ) .", "label": "", "metadata": {}, "score": "61.503395"}
{"text": "A 3-gene signature that can be identified from analysis of a blood sample was able to reliably identify hepatocellular carcinoma ( HCC ) with a high degree of sensitivity and specificity , according to the results of a study presented at the International Liver CongressTM 2014 .", "label": "", "metadata": {}, "score": "61.510628"}
{"text": "Bridging therapy is utilised to maintain the tumor within listing criteria while a suitable graft is awaited for on the waiting list .Bridging therapy is a widely accepted practice whereas downstaging for LT is not [ 23 , 24 ] .", "label": "", "metadata": {}, "score": "61.552727"}
{"text": "Effect of SBRT to tumor .SBRT as a bridging therapy to orthotopic liver transplantation provided an opportunity to study the histopathologic features of tumors treated with SBRT [ 20 , 21 , 27 ] .", "label": "", "metadata": {}, "score": "61.555443"}
{"text": "[PubMed ] [ DOI ] .Germani G , Pleguezuelo M , Gurusamy K , Meyer T , Isgr\u00f2 G , Burroughs AK .Clinical outcomes of radiofrequency ablation , percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma : a meta - analysis .", "label": "", "metadata": {}, "score": "61.640366"}
{"text": "4 , pp .908 - 943 , 2012 .View at Google Scholar .R. Kim , G. El - Gazzaz , A. Tan et al . , \" Safety and feasibility of using sorafenib in recurrent hepatocellular carcinoma after orthotopic liver transplantation , \" Oncology , vol . 79 , no . 1 - 2 , pp .", "label": "", "metadata": {}, "score": "61.796265"}
{"text": "However , TACE is somewhat controversial : a review from the Cochrane library that considered all randomized trials that compared TACE vs placebo , sham , or no intervention concluded that no firm evidence exists to support or refute TACE for patients with unresectable HCC [ 11 ] .", "label": "", "metadata": {}, "score": "61.839073"}
{"text": "[PubMed ] [ DOI ] .Trotter JF , Wachs M , Everson GT , Kam I. Adult - to - adult transplantation of the right hepatic lobe from a living donor .", "label": "", "metadata": {}, "score": "61.843452"}
{"text": "Isolated caudate lobectomy , which is a very difficult operation , is thus an alternative option ... .Can positron emission tomography with the dual tracers [ 11 C]acetate and [ 18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma ?", "label": "", "metadata": {}, "score": "61.845825"}
{"text": "In general , SBRT can be performed safely .In these trials , there were seven deaths ( 7 % ) possibly related to treatment ( 1.1 - 7.7 mo after SBRT ) [ 28 ] .", "label": "", "metadata": {}, "score": "61.850677"}
{"text": "Epidemiology .HCC is a worldwide clinical and social issue .Actually , it is the sixth most common cancer and the third cause of cancer - related death .", "label": "", "metadata": {}, "score": "61.851326"}
{"text": "Liver Transplantation .Orthotopic liver transplantation ( OLT ) is the curative options in which both the tumor and the underlying liver disease are removed .", "label": "", "metadata": {}, "score": "61.902374"}
{"text": "Synchronous resections of primary colorectal tumor and liver metastasis by laparoscopic approach .Tan To Cheung Tan To Cheung , Ronnie Tung Ping Poon , Department of Surgery , The University of Hong Kong , Hong Kong , China World J Hepatol 5:298 - 301 .", "label": "", "metadata": {}, "score": "61.958218"}
{"text": "Chemical ablation has now been superseded by thermal techniques such as radiofrequency ablation ( RFA ) .RFA is the most well - studied alternative to PEI producing better local tumor control with a 2 year recurrence of 2 - 18 % and a 5 year survival of 40 - 70 % or better when the treatment groups have been selected [ 43 ] .", "label": "", "metadata": {}, "score": "62.031906"}
{"text": "[PubMed ] [ DOI ] .Fisher RA , Kulik LM , Freise CE , Lok AS , Shearon TH , Brown RS , Ghobrial RM , Fair JH , Olthoff KM , Kam I. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation .", "label": "", "metadata": {}, "score": "62.052414"}
{"text": "Combined resection and radiofrequency ablation for multifocal hepatocellular carcinoma : prognosis and outcomes .Tan To Cheung Department of Surgery , The University of Hong Kong , 102 Pok Fu Lam Road , Queen Mary Hospital , Hong Kong , China World J Gastroenterol 16:3056 - 62 .", "label": "", "metadata": {}, "score": "62.125427"}
{"text": "1957 - 1962 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. M. Lo , S. T. Fan , C. L. Liu , S. C. Chan , and J. Wong , \" The role and limitation of living donor liver transplantation for hepatocellular carcinoma , \" Liver Transplantation , vol .", "label": "", "metadata": {}, "score": "62.186092"}
{"text": "5 , pp .1570 - 1579 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. Chen , K. Huang , J. Wu et al . , \" Survival after anatomic resection versus nonanatomic resection for hepatocellular carcinoma : a meta - analysis , \" Digestive Diseases and Sciences , vol .", "label": "", "metadata": {}, "score": "62.20829"}
{"text": "[PubMed ] [ DOI ] .Simpson KJ , Finlayson ND .Clinical evaluation of liver disease .Baillieres Clin Gastroenterol .[PubMed ] [ DOI ] .", "label": "", "metadata": {}, "score": "62.292625"}
{"text": "289 - 299 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . F. Y. Yao , R. K. Kerlan Jr. , R. Hirose et al . , \" Excellent outcome following down - staging of hepatocellular carcinoma prior to liver transplantation : an intention - to - treat analysis , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "62.30875"}
{"text": "The actuarial survival is 62 % .54 out of 104 patients ( 52 % ) with follow up suffered from recurrent tumors .True local metastases were 22 ( 21 % ) .", "label": "", "metadata": {}, "score": "62.321987"}
{"text": "[PubMed ] [ DOI ] .Mazzaferro V , Romito R , Schiavo M , Mariani L , Camerini T , Bhoori S , Capussotti L , Calise F , Pellicci R , Belli G. Prevention of hepatocellular carcinoma recurrence with alpha - interferon after liver resection in HCV cirrhosis .", "label": "", "metadata": {}, "score": "62.334175"}
{"text": "Prevalence of HCV infections is reported to be the main leading cause of HCC in Europe and also in the United States where the incidence is relatively low .", "label": "", "metadata": {}, "score": "62.356365"}
{"text": "Retrohepatic vena cava deroofing in living donor liver transplantation for caudate hepatocellular carcinoma .See Ching Chan Department of Surgery State Key Laboratory for Liver Research , The University of Hong Kong , 102 Pokfulam Road , Hong Kong , China Hepatobiliary Pancreat Dis Int 12:552 - 5 .", "label": "", "metadata": {}, "score": "62.46892"}
{"text": "[PubMed ] [ DOI ] .Lo CM , Fan ST , Liu CL , Chan SC , Ng IO , Wong J. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "62.54555"}
{"text": "Survival analysis of re - resection versus radiofrequency ablation for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma .Albert C Y Chan Department of Surgery , The University of Hong Kong , Queen Mary Hospital , 102 Pok Fu Lam Road , Hong Kong , L454 , China World J Surg 36:151 - 6 .", "label": "", "metadata": {}, "score": "62.55851"}
{"text": "However , EASL 2012 guidelines specify that for lesions between 1 and 2 cm the concordance of typical pattern at two imaging ( CT and MR ) should be advices in suboptimal settings ( technology , local skills ) [ 4 ] .", "label": "", "metadata": {}, "score": "62.63315"}
{"text": "[PubMed ] [ DOI ] .Porrett PM , Peterman H , Rosen M , Sonnad S , Soulen M , Markmann JF , Shaked A , Furth E , Reddy KR , Olthoff K. Lack of benefit of pre - transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era .", "label": "", "metadata": {}, "score": "62.729218"}
{"text": "[PubMed ] [ DOI ] .Vitale A , Boccagni P , Kertusha X , Zanus G , D'Amico F , Lodo E , Pastorelli D , Ramirez Morales R , Lombardi G , Senzolo M. Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation ?", "label": "", "metadata": {}, "score": "62.779175"}
{"text": "Family history of hepatocellular carcinoma ( HCC ) has been identified as a risk factor for the development of the disease .The aim of this study is to evaluate the impact of such a history on HCC patients ' survival ... .", "label": "", "metadata": {}, "score": "62.81768"}
{"text": "[PubMed ] [ DOI ] .Majno PE , Adam R , Bismuth H , Castaing D , Ariche A , Krissat J , Perrin H , Azoulay D. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis .", "label": "", "metadata": {}, "score": "62.869263"}
{"text": "6 , pp .1626 - 1633 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. Imamura , Y. Matsuyama , E. Tanaka et al . , \" Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy , \" Journal of Hepatology , vol .", "label": "", "metadata": {}, "score": "62.896576"}
{"text": "The prevalence of such infections is being controlled by vaccination , which should also influence future trends in HCC occurrence .Heavy alcohol consumption , obesity , and diabetes are also risk factors and substantial causes of HCC in Europe and the United States .", "label": "", "metadata": {}, "score": "62.904263"}
{"text": "12 , pp .1861 - 1866 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. S. Mangus , J. A. Fridell , R. M. Vianna , A. B. Cooper , D. T. Jones , and A. J. Tector , \" Use of the piggyback hepatectomy technique in liver transplant recipients with hepatocellular carcinoma , \" Transplantation , vol . 85 , no .", "label": "", "metadata": {}, "score": "63.13117"}
{"text": "1496 - 1499 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. A. Clavien , M. Lesurtel , P. M. Bossuyt et al . , \" Recommendations for liver transplantation for hepatocellular carcinoma : an international consensus conference report , \" The Lancet Oncology , vol .", "label": "", "metadata": {}, "score": "63.15647"}
{"text": "[PubMed ] [ DOI ] .Llovet JM , Real MI , Monta\u00f1a X , Planas R , Coll S , Aponte J , Ayuso C , Sala M , Muchart J , Sol\u00e0 R. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma : a randomised controlled trial .", "label": "", "metadata": {}, "score": "63.18595"}
{"text": "However , incomplete excision of choledochal cysts may also cause problems ... .[ 18F]fluoroacetate positron emission tomography for hepatocellular carcinoma and metastases : an alternative tracer for [ 11C]acetate ?", "label": "", "metadata": {}, "score": "63.23826"}
{"text": "e11-e22 , 2012 .View at Google Scholar .P. Bhangui , E. Vibert , P. Majno et al . , \" Intention - to - treat analysis of liver transplantation for hepatocellular carcinoma : living versus deceased donor transplantation , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "63.355362"}
{"text": "BMC Cancer .[PubMed ] [ DOI ] .Louis C , Dewas S , Mirabel X , Lacornerie T , Adenis A , Bonodeau F , Lartigau E. Stereotactic radiotherapy of hepatocellular carcinoma : preliminary results .", "label": "", "metadata": {}, "score": "63.373707"}
{"text": "17 , supplement 2 , pp .S109-S116 , 2011 .View at Google Scholar .O. Barakat , R. P. Wood , C. F. Ozaki et al . , \" Morphological features of advanced hepatocellular carcinoma as a predictor of downstaging and liver transplantation : an intention - to - treat analysis , \" Liver Transplantation , vol .", "label": "", "metadata": {}, "score": "63.421646"}
{"text": "[PubMed ] [ DOI ] .Lin DY , Liaw YF , Lee TY , Lai CM .Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma -- a randomized controlled trial .", "label": "", "metadata": {}, "score": "63.49534"}
{"text": "11 - 15 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . S. Delis , A. Bakoyiannis , J. Papailiou , et al . , \" Liver resection vs radio - frequency ablation in the treatment of small hepatocellular carcinoma , \" Surgical Oncology , vol .", "label": "", "metadata": {}, "score": "63.63396"}
{"text": "[PubMed ] [ DOI ] .Mazzaferro V , Regalia E , Doci R , Andreola S , Pulvirenti A , Bozzetti F , Montalto F , Ammatuna M , Morabito A , Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis .", "label": "", "metadata": {}, "score": "63.636925"}
{"text": "The TP53 mutations are strongly associated to the HCC and considered as the most consistently mutated tumor suppressor gene in HCC .It occurs in 30 to 50 % hepatocellular carcinomas [ 60 - 62 ] .", "label": "", "metadata": {}, "score": "63.725647"}
{"text": "Acta Oncol .[PubMed ] [ DOI ] .Dawson LA , Eccles C , Bissonnette JP , Brock KK .Accuracy of daily image guidance for hypofractionated liver radiotherapy with active breathing control .", "label": "", "metadata": {}, "score": "63.735134"}
{"text": "Br J Surg .[PubMed ] [ DOI ] .Ishizawa T , Hasegawa K , Aoki T , Takahashi M , Inoue Y , Sano K , Imamura H , Sugawara Y , Kokudo N , Makuuchi M. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "63.766968"}
{"text": "5 , pp .703 - 710 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. T. P. Poon , S. T. Fan , C. M. Lo , C. L. Liu , and J. Wong , \" Intrahepatic recurrence after curative resection of hepatocellular carcinoma : long - term results of treatment and prognostic factors , \" Annals of Surgery , vol .", "label": "", "metadata": {}, "score": "63.793175"}
{"text": "Cancer .[PubMed ] [ DOI ] .Kuang M , Lu MD , Xie XY , Xu HX , Xu ZF , Liu GJ , Yin XY , Huang JF , Lencioni R. Ethanol ablation of hepatocellular carcinoma Up to 5.0 cm by using a multipronged injection needle with high - dose strategy .", "label": "", "metadata": {}, "score": "63.831833"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Yeganeh , R. S. Finn , and S. Saab , \" Apparent remission of a solitary metastatic pulmonary lesion in a liver transplant recipient treated with sorafenib , \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "63.971203"}
{"text": "11 , pp .693 - 699 , 1996 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .K. M. Olthoff , A. Forner , S. H\u00fcbscher , and J. Fung , \" What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation ? \"", "label": "", "metadata": {}, "score": "63.983818"}
{"text": "Between May 2000 and May 2012 , a total of 1020 small tumour nodules in 837 patients were treated with percutaneous RFA .Complete ablation was achieved in 98.8 % ( 1008/1020 ) with major complications occurring in only 0.59 % ( 5/837 ) of patients .", "label": "", "metadata": {}, "score": "64.02885"}
{"text": "Majno PE , Adam R , Bismuth H , et al .Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis .", "label": "", "metadata": {}, "score": "64.09661"}
{"text": "Other therapeutic agents such as doxorubicin , epirubicin , mitoxantrone , cisplatin , gemcitabine , capecitabine , 5-Flu , Tamoxifen , and placebo . have been also used as single agent against advanced HCC .", "label": "", "metadata": {}, "score": "64.104004"}
{"text": "25 , pp .2429 - 2438 , 2011 .View at Google Scholar .R. Chiesa , F. Donato , A. Tagger et al . , \" Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis , \" Cancer Epidemiology Biomarkers and Prevention , vol .", "label": "", "metadata": {}, "score": "64.12288"}
{"text": "[PubMed ] [ DOI ] .Siegler M , Simmerling MC , Siegler JH , Cronin DC .Recipient deaths during donor surgery : a new ethical problem in living donor liver transplantation ( LDLT ) .", "label": "", "metadata": {}, "score": "64.17042"}
{"text": "Long term survival analysis of hepatectomy for neuroendocrine tumour liver metastases .Tan To Cheung Department of Surgery , The University of Hong Kong , Queen Mary Hospital , 102 Pokfulam Road , Hong Kong ScientificWorldJournal 2014:524045 .", "label": "", "metadata": {}, "score": "64.33722"}
{"text": "2547 - 2557 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. J. Lewandowski , L. M. Kulik , A. Riaz et al . , \" A comparative analysis of transarterial downstaging for hepatocellular carcinoma : chemoembolization versus radioembolization , \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "64.35643"}
{"text": "Survival analysis of high - intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomas .Tan To Cheung Department of Surgery , The University of Hong Kong , 102 Pokfulam Road , Hong Kong , China Liver Int 34:e136 - 43 .", "label": "", "metadata": {}, "score": "64.44314"}
{"text": "Living donor liver transplantation , domino and split liver transplantation , as well as use of marginal livers are policies currently applied in some transplant units .", "label": "", "metadata": {}, "score": "64.45147"}
{"text": "93 , pp .1169 - 1173 , 2009 .View at Google Scholar \u00b7 View at Scopus .F. Di Benedetto , G. Tarantino , R. Montalti et al . , \" Laparoscopic radiofrequency ablation in the caudate lobe for hepatocellular carcinoma before liver transplantation , \" Journal of Laparoendoscopic & Advanced Surgical Techniques , vol .", "label": "", "metadata": {}, "score": "64.45563"}
{"text": "Direct non - medical costs incurred by patients and their families , as well as indirect costs , were not assumed in the analysis .Future costs and benefits were discounted at a baseline rate of 3 % .", "label": "", "metadata": {}, "score": "64.51326"}
{"text": "4 , pp .1283 - 1285 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .K. Vakili , J. J. Pomposelli , Y. L. Cheah et al . , \" Living donor liver transplantation for hepatocellular carcinoma : Increased recurrence but improved survival , \" Liver Transplantation , vol .", "label": "", "metadata": {}, "score": "64.56589"}
{"text": "[PubMed ] [ DOI ] .Clavien PA , Petrowsky H , DeOliveira ML , Graf R. Strategies for safer liver surgery and partial liver transplantation .", "label": "", "metadata": {}, "score": "64.60118"}
{"text": "[PubMed ] [ DOI ] .De Carlis L , Di Sandro S , Giacomoni A , Slim A , Lauterio A , Mangoni I , Mihaylov P , Pirotta V , Aseni P , Rampoldi A. Beyond the Milan criteria : what risks for patients with hepatocellular carcinoma progression before liver transplantation ?", "label": "", "metadata": {}, "score": "64.6243"}
{"text": "TNM Classification .Proposed as the best staging system to assess outcome of HCC patients undergoing resection and based on tumor size ( T1 to T4 ) , number , vascular invasion , regional node status , and distant metastases , TNM is only based on tumor characteristics .", "label": "", "metadata": {}, "score": "64.671776"}
{"text": "Randomised controlled trials ( RCTs ) assessing the benefits of any of these therapeutic approaches are unlikely to be performed because they would be costly and require a very large sample size .", "label": "", "metadata": {}, "score": "64.814964"}
{"text": "PubMed ] [ DOI ] .Mazzaferro V , Regalia E , Doci R , Andreola S , Pulvirenti A , Bozzetti F , Montalto F , Ammatuna M , Morabito A , Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis .", "label": "", "metadata": {}, "score": "64.82466"}
{"text": "In addition , lesions located just below the diaphragm or at the surface of the liver are also excellent targets for SBRT .Figure 2 illustrates typical liver locations for which SBRT can be safely delivered .", "label": "", "metadata": {}, "score": "64.83896"}
{"text": "48 - 61 , 2009 .View at Google Scholar .L. Qin and Z. Tang , \" Metastasis and recurrence after surgical resection of hepatocellular carcinoma : recent progress in clinical and related basic aspects , \" Current Cancer Therapy Reviews , vol .", "label": "", "metadata": {}, "score": "64.851944"}
{"text": "[PubMed ] [ DOI ] .Mancuso A , Rigano P , Renda D , Di Salvo V , Pignatti CB , Guddo F , Buccellato A , Nicoli N , Maggio A. Hepatocellular carcinoma on cirrhosis - free liver in a HCV - infected thalassemic .", "label": "", "metadata": {}, "score": "64.85866"}
{"text": "12 , pp .1436 - 1441 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. L. Chagas , L. O. O. Kikuchi , C. P. M. S. Oliveira et al . , \" Does hepatocellular carcinoma in non - alcoholic steatohepatitis exist in cirrhotic and non - cirrhotic patients ? \"", "label": "", "metadata": {}, "score": "64.90351"}
{"text": "There was also a dramatic difference in the stage of disease at diagnosis .In Japanese patients , 59 % were within the Milan Criteria ( generally accepted set of parameters designed to assess the suitability of HCC patients for liver transplantation ) and 71 % were suitable for potentially curative treatment .", "label": "", "metadata": {}, "score": "64.91659"}
{"text": "Both fixed - dose and variable - dose prescription approaches have their own rationale , and it is important to understand the differences in treatment intention ( curative or semi - radical ) and objectives ( early or advanced ) .", "label": "", "metadata": {}, "score": "64.92037"}
{"text": "6 , pp .1394 - 1403 , 2001 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .V. Mazzaferro , J. M. Llovet , R. Miceli et al . , \" Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria : a retrospective , exploratory analysis , \" The Lancet Oncology , vol .", "label": "", "metadata": {}, "score": "65.0014"}
{"text": "Cirrhosis .Cirrhosis is an end stage of chronic diffuse liver disease .It is characterized by alteration of the normal liver into structurally abnormal nodules of liver cells surrounded by fibrosis .", "label": "", "metadata": {}, "score": "65.05291"}
{"text": "21 , pp .5424 - 5431 , 2012 .View at Publisher \u00b7 View at Google Scholar . A. Takeda , M. Takahashi , E. Kunieda et al . , \" Hypofractionated stereotactic radiotherapy with and without transarterial chemoembolization for small hepatocellular carcinoma not eligible for other ablation therapies : preliminary results for efficacy and toxicity , \" Hepatology Research , vol .", "label": "", "metadata": {}, "score": "65.127525"}
{"text": "1920 - 1928 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. Di Sandro , A. O. Slim , A. Giacomoni et al . , \" Living donor liver transplantation for hepatocellular carcinoma : long - term results compared with deceased donor liver transplantation , \" Transplantation Proceedings , vol .", "label": "", "metadata": {}, "score": "65.22821"}
{"text": "4 , pp .535 - 540 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. Huang , L. Yan , Z. Cheng et al . , \" A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria , \" Annals of Surgery , vol .", "label": "", "metadata": {}, "score": "65.23697"}
{"text": "56 , no . 2 , pp .464 - 473 , 2012 .View at Google Scholar .R. Salem , R. J. Lewandowski , L. Kulik et al . , \" Radioembolization results in longer time - to - progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma , \" Gastroenterology , vol .", "label": "", "metadata": {}, "score": "65.238045"}
{"text": "A T2-weighted image shows a high - intensity area corresponding to a high - dose area ( B ) , which is seen as an enhanced area in early phase after injection of gadoxetate acid ( C ) .", "label": "", "metadata": {}, "score": "65.34851"}
{"text": "Furthermore , our data collection began before the publication of BCLC staging system , and this may have influenced our results .Why do so few centres follow the AASLD recommendations ?", "label": "", "metadata": {}, "score": "65.36904"}
{"text": "We aim to evaluate the efficacy and toxicity of low - dose ( 100 mg ) thalidomide as the first - line treatment of advanced HCC ... .", "label": "", "metadata": {}, "score": "65.37573"}
{"text": "The results of the CEA are shown in figs 4 and 5 , and table 3 .Resection provided a clinically relevant net gain in LE ranging from 4.8 to 6.1 months if waiting times exceeded six months .", "label": "", "metadata": {}, "score": "65.40589"}
{"text": "4 , pp .271 - 276 , 2002 .View at Google Scholar \u00b7 View at Scopus .P. Sharma , A. M. Harper , J. L. Hernandez et al . , \" Reduced priority MELD score for hepatocellular carcinoma does not adversely impact candidate survival awaiting liver transplantation , \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "65.4367"}
{"text": "2011 ; 17 Suppl 2 : S44-S57 .[PubMed ] [ DOI ] .Llovet JM , Schwartz M , Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "65.45604"}
{"text": "[PubMed ] [ DOI ] .Eriguchi T , Takeda A , Sanuki N , Oku Y , Aoki Y , Shigematsu N , Kunieda E. Acceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary system .", "label": "", "metadata": {}, "score": "65.47505"}
{"text": "In China , the combination of lavamidin and ravadin demonstrated promising results in HCC prevention although the study focused on a reduced patient sample .Many other agents are in trials , and results should help to better prevent HCC in certain population groups at risk .", "label": "", "metadata": {}, "score": "65.55461"}
{"text": "Cancer .[PubMed ] [ DOI ] .Livraghi T , Giorgio A , Marin G , Salmi A , de Sio I , Bolondi L , Pompili M , Brunello F , Lazzaroni S , Torzilli G. Hepatocellular carcinoma and cirrhosis in 746 patients : long - term results of percutaneous ethanol injection .", "label": "", "metadata": {}, "score": "65.71619"}
{"text": "60 - 69 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. V. Tse , M. Hawkins , G. Lockwood et al . , \" Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "65.740875"}
{"text": "J Clin Oncol .[PubMed ] [ DOI ] .Dawson LA , Eccles C , Craig T. Individualized image guided iso - NTCP based liver cancer SBRT .", "label": "", "metadata": {}, "score": "65.82046"}
{"text": "2011 ; 80 : e243-e248 .[PubMed ] [ DOI ] .Tamada T , Ito K , Sone T , Kanki A , Sato T , Higashi H. Gd - EOB - DTPA enhanced MR imaging : evaluation of biliary and renal excretion in normal and cirrhotic livers .", "label": "", "metadata": {}, "score": "65.88199"}
{"text": "1521 - 1531 , 2004 .View at Google Scholar .J. S. W. Wong , G. L. H. Wong , K. K. F. Tsoi et al . , \" Meta - analysis : the efficacy of anti - viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B - related hepatocellular carcinoma , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "66.03395"}
{"text": "6 , pp .1618 - 1624 , 1994 .View at Google Scholar \u00b7 View at Scopus .M. Minagawa , M. Makuuchi , T. Takayama , and N. Kokudo , \" Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma , \" Annals of Surgery , vol .", "label": "", "metadata": {}, "score": "66.112015"}
{"text": "[PubMed ] [ DOI ] .European Association For The Study Of The Liver ; European Organisation For Research And Treatment Of Cancer .EASL - EORTC clinical practice guidelines : management of hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "66.11244"}
{"text": "After this time , surgery increased the transplantation rate , with moderate gains in LE and an acceptable cost effectiveness ratio .In contrast , LE gains and cost effectiveness ratio were less favourable ( $ 74 000 per year life gained ) with shorter waiting times .", "label": "", "metadata": {}, "score": "66.11858"}
{"text": "PubMed ] [ DOI ] .Bismuth H , Chiche L , Adam R , Castaing D , Diamond T , Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients .", "label": "", "metadata": {}, "score": "66.129425"}
{"text": "Hepatology .[PubMed ] [ DOI ] .Pomfret EA , Washburn K , Wald C , Nalesnik MA , Douglas D , Russo M , Roberts J , Reich DJ , Schwartz ME , Mieles L. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States .", "label": "", "metadata": {}, "score": "66.15256"}
{"text": "Cancer 1985 , 56 : 918 - 28 .View Article PubMed .Vauthey JN , Lauwers GY , Esnaola NF , Do KA , Belghiti J , Mirza N , Curley SA , Ellis LM , Regimbeau JM , Rashid A , Cleary KR , Nagorney DM : Simplified staging for hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "66.17102"}
{"text": "J Clin Oncol .[PubMed ] [ DOI ] .C\u00e1rdenes HR , Price TR , Perkins SM , Maluccio M , Kwo P , Breen TE , Henderson MA , Schefter TE , Tudor K , Deluca J. Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "66.20564"}
{"text": "Table 4 .Median survival ( months ) in the 145 patients with \" early \" HCC of the internal validation analysis according to the type of treatment .", "label": "", "metadata": {}, "score": "66.22145"}
{"text": "The aims of this retrospective multi - center study were to ascertain : . the proportions of HCC patients presenting with \" early \" and \" very early \" HCC in the cumulative experience of ten Italian institutions , three of them acting as primary referral centers and seven as both primary referral and third - level centers ; .", "label": "", "metadata": {}, "score": "66.230606"}
{"text": "10 , pp .1265 - 1272 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. P. McWilliams , S. Yamamoto , S. S. Raman , et al . , \" Percutaneous ablation of hepatocellular carcinoma : current status , \" Journal of Vascular and Interventional Radiology , vol .", "label": "", "metadata": {}, "score": "66.231705"}
{"text": "[PubMed ] [ DOI ] .Llovet JM , Mas X , Aponte JJ , Fuster J , Navasa M , Christensen E , Rod\u00e9s J , Bruix J. Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation .", "label": "", "metadata": {}, "score": "66.258095"}
{"text": "Survival analysis of high - intensity focused ultrasound therapy versus radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma .Albert C Y Chan Department of Surgery , The University of Hong Kong , Hong Kong , China Ann Surg 257:686", "label": "", "metadata": {}, "score": "66.262375"}
{"text": "Liver tumors located adjacent to the stomach and bowels ( dotted areas ) are not suitable for SBRT .Other unmarked areas can be treated either with SBRT or percutaneous ablation .", "label": "", "metadata": {}, "score": "66.318016"}
{"text": "The radiation particles can then kill tumor cells within a distance of 2.5 mm from them so that any part of the cancer fed by tiny blood vessels will be exposed to the radiation .", "label": "", "metadata": {}, "score": "66.32506"}
{"text": "[PubMed ] [ DOI ] .Lencioni R , Llovet JM .Percutaneous ethanol injection for hepatocellular carcinoma : alive or dead ?J Hepatol .", "label": "", "metadata": {}, "score": "66.3887"}
{"text": "[PubMed ] [ DOI ] .Llovet JM , Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma : Chemoembolization improves survival .", "label": "", "metadata": {}, "score": "66.45926"}
{"text": "PST : performance status test .N : nodules .M : metastases .PEI : percutaneous ethanol injection .( Source [ 78 ] with permission of The Lancet Journal . )", "label": "", "metadata": {}, "score": "66.48147"}
{"text": "In addition , an element of institutional bias may lead to LDLT in HCC with a higher risk of recurrence .The donor risk and the degree of benefit to the recipient needed to justify LDLT for advanced HCC are still undetermined and for now many centres have adopted the same criteria / therapeutic goals for LDLT as cadaveric LT [ 36 ] .", "label": "", "metadata": {}, "score": "66.50241"}
{"text": "Comparing US Surveillance , Epidemiology , and End Results ( SEER ) data from the 1987 through 1991 and 1991 through 1996 time periods , only 0.8 % of patients in both time periods underwent curative surgery .", "label": "", "metadata": {}, "score": "66.510895"}
{"text": "The sensitivity analysis disclosed that ethanol injection was beneficial and cost effective in all ranges used but the benefits of resection decreased when varying the assumptions of the model .", "label": "", "metadata": {}, "score": "66.536"}
{"text": "To analyze whether pancreaticoduodenectomy with simultaneous resection of tumor - involved vessels is a safe approach with acceptable patient survival ... .Outcomes of hepatectomy for hepatocellular carcinoma with bile duct tumour thrombus .", "label": "", "metadata": {}, "score": "66.54672"}
{"text": "Gastric or duodenal ulcer or perforation has been reported [ 38 , 40 ] .If the target is less than that distance , the dose or fraction size that can be delivered safely to the target often needs to be decreased to respect the radiation tolerance .", "label": "", "metadata": {}, "score": "66.56876"}
{"text": "J Hepatol .[PubMed ] [ DOI ] .Lo CM , Ngan H , Tso WK , Liu CL , Lam CM , Poon RT , Fan ST , Wong J. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "66.73452"}
{"text": "4 , pp .537 - 543 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .B. I. Carr , V. Kondragunta , S. C. Buch , and R. A. Branch , \" Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma : a two - cohort study , \" Cancer , vol .", "label": "", "metadata": {}, "score": "66.74407"}
{"text": "View Article PubMed .Gastroenterology 2004 , 127 ( 6 ) : 1714 - 23 .View Article PubMed .Lin SM , Lin CJ , Lin CC , Hsu CW , Chen YC : Randomised controlled trial comparing percutaneous radiofrequency thermal ablation , percutaneous ethanol injection , and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less .", "label": "", "metadata": {}, "score": "66.79375"}
{"text": "Ann Surg Oncol .[PubMed ] [ DOI ] .Farges O , Belghiti J , Kianmanesh R , Regimbeau JM , Santoro R , Vilgrain V , Denys A , Sauvanet A. Portal vein embolization before right hepatectomy : prospective clinical trial .", "label": "", "metadata": {}, "score": "66.80997"}
{"text": "5 , pp .191 - 197 , 2006 .View at Google Scholar .S. P. Hussain , J. Schwank , F. Staib , X. W. Wang , and C. C. Harris , \" TP53 mutations and hepatocellular carcinoma : insights into the etiology and pathogenesis of liver cancer , \" Oncogene , vol .", "label": "", "metadata": {}, "score": "66.811264"}
{"text": "There is continuing debate regarding whether previous resection compromises the subsequent LT [ 21 ] .Other groups have found salvage LT to have a high operative mortality , 23.5 % versus 2.1 % for primary LT , higher recurrence rates , and poorer overall 5 year survival of 41 % [ 22 ] .", "label": "", "metadata": {}, "score": "66.82329"}
{"text": "For the treated groups , values were derived from probabilities of survival and recurrence after resection and PEI .Patients who presented recurrences were considered for exclusion when they developed major contraindications .", "label": "", "metadata": {}, "score": "66.862686"}
{"text": "Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8 cm in diameter .Wing Chiu Dai Department of Surgery , University of Hong Kong , Hong Kong , China HPB ( Oxford ) 16:749 - 57 .", "label": "", "metadata": {}, "score": "66.89226"}
{"text": "Thus , the silent hepatitis C epidemic from that area is the likely cause of the increase in HCC incidence in those parts of the world [ 16 ] .", "label": "", "metadata": {}, "score": "66.89328"}
{"text": "[PubMed ] [ DOI ] .Khan KN , Yatsuhashi H , Yamasaki K , Yamasaki M , Inoue O , Koga M , Yano M. Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection .", "label": "", "metadata": {}, "score": "66.98851"}
{"text": "[PubMed ] [ DOI ] .Kim R , El - Gazzaz G , Tan A , Elson P , Byrne M , Chang YD , Aucejo F. Safety and feasibility of using sorafenib in recurrent hepatocellular carcinoma after orthotopic liver transplantation .", "label": "", "metadata": {}, "score": "66.999466"}
{"text": "4 , pp .788 - 794 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .European Association for the Study of the Liver and European Organisation for Research and Treatment of Cancer , \" EASL - EORTC clinical practice guidelines : management of hepatocellular carcinoma , \" Journal of Hepatology , vol .", "label": "", "metadata": {}, "score": "67.05681"}
{"text": "2 , no .4 , pp .491 - 495 , 2003 .View at Google Scholar \u00b7 View at Scopus .N. Dilou , B. Patouillard , and J. C. Audigier , \" Staging systems in hepatocellular carcinoma , \" Gastroenterologie Clinique et Biologique , vol .", "label": "", "metadata": {}, "score": "67.05984"}
{"text": "\" The percentage of \" Very early \" HCCs did not increase over time and it was stable at 3 % also in the 2002 - 2004 period , chosen to evaluate any trend .", "label": "", "metadata": {}, "score": "67.13057"}
{"text": "2003 ; 17 Suppl 2 : 130 - 137 .[PubMed ] [ DOI ] .Clavien PA , Lesurtel M , Bossuyt PM , Gores GJ , Langer B , Perrier A. Recommendations for liver transplantation for hepatocellular carcinoma : an international consensus conference report .", "label": "", "metadata": {}, "score": "67.13379"}
{"text": "We considered a 10 % increase in the probability of being transplanted as clinically relevant .Effectiveness was measured as net gain in life expectancy ( LE ) , and according to recent proposals we defined an increase of at least three months in LE as clinically relevant .", "label": "", "metadata": {}, "score": "67.18999"}
{"text": "Downstaging locoregional therapy can be employed to facilitate resection in disease which is initially regarded as unresectable and can achieve reasonable outcome , with 5 year survivals of 25 - 67 % , with the possibility of cure [ 28 ] .", "label": "", "metadata": {}, "score": "67.23691"}
{"text": "143 - 146 , 2001 .View at Google Scholar \u00b7 View at Scopus .S. Watanabe , Y. Horie , E. Kataoka et al . , \" Non - alcoholic steatohepatitis and hepatocellular carcinoma : lessons from hepatocyte - specific phosphatase and tensin homolog ( PTEN)-deficient mice , \" Journal of Gastroenterology and Hepatology , vol .", "label": "", "metadata": {}, "score": "67.24445"}
{"text": "N Engl J Med .[PubMed ] [ DOI ] .Bolondi L. Screening for hepatocellular carcinoma in cirrhosis .J Hepatol .[PubMed ] [ DOI ] .", "label": "", "metadata": {}, "score": "67.25934"}
{"text": "Int J Radiat Oncol Biol Phys .[PubMed ] [ DOI ] .Chi A , Liao Z , Nguyen NP , Xu J , Stea B , Komaki R. Systemic review of the patterns of failure following stereotactic body radiation therapy in early - stage non - small - cell lung cancer : clinical implications .", "label": "", "metadata": {}, "score": "67.26175"}
{"text": "Child - Pugh A patients are the best candidates with a 5-year survival of 50 % .The most frequent drawback for percutaneous is the high rate of recurrence which is evaluated in PEI at 33 - 43 % [ 117 ] .", "label": "", "metadata": {}, "score": "67.27238"}
{"text": "[PubMed ] [ DOI ] .Forner A , Reig ME , de Lope CR , Bruix J. Current strategy for staging and treatment : the BCLC update and future prospects .", "label": "", "metadata": {}, "score": "67.28632"}
{"text": "Radiology .[PubMed ] [ DOI ] .Cancer .[PubMed ] [ DOI ] .Llovet JM , Vilana R , Br\u00fa C , Bianchi L , Salmeron JM , Boix L , Ganau S , Sala M , Pag\u00e8s M , Ayuso C. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "67.313385"}
{"text": "6 , pp .2181 - 2183 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Vivarelli , A. Dazzi , M. Zanello et al . , \" Effect of different immunosuppressive schedules on recurrence - free survival after liver transplantation for hepatocellular carcinoma , \" Transplantation , vol .", "label": "", "metadata": {}, "score": "67.31561"}
{"text": "These controversial benefits may be representative of transplantation centres achieving poor results after surgery as a consequence of both limited technical skills and expertise of the group .", "label": "", "metadata": {}, "score": "67.34815"}
{"text": "[PubMed ] [ DOI ] .Katz AW , Chawla S , Qu Z , Kashyap R , Milano MT , Hezel AF .Stereotactic hypofractionated radiation therapy as a bridge to transplantation for hepatocellular carcinoma : clinical outcome and pathologic correlation .", "label": "", "metadata": {}, "score": "67.35787"}
{"text": "J Gastroenterol Hepatol 2005 , 20 ( 5 ) : 765 - 71 .View Article PubMed .Wildi S , Pestalozzi BC , McCormack L , Clavien PA : Critical evaluation of the different staging systems for hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "67.35895"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Nanashima , Y. Sumida , S. Morino et al . , \" The Japanese integrated staging score using liver damage grade for hepatocellular carcinoma in patients after hepatectomy , \" European Journal of Surgical Oncology , vol .", "label": "", "metadata": {}, "score": "67.37491"}
{"text": "To this date no serious SBRT related toxicities being reported [ 67 - 69 ] but it is not clear whether it can be applied to patients with more severe liver diseases as its threshold for tolerance is not defined .", "label": "", "metadata": {}, "score": "67.39646"}
{"text": "[PubMed ] [ DOI ] .Lu DS , Yu NC , Raman SS , Lassman C , Tong MJ , Britten C , Durazo F , Saab S , Han S , Finn R. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation .", "label": "", "metadata": {}, "score": "67.411575"}
{"text": "11 , pp .693 - 699 , 1996 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . F. Y. Yao , L. Xiao , N. M. Bass , R. Kerlan , N. L. Ascher , and J. P. Roberts , \" Liver transplantation for hepatocellular carcinoma : validation of the UCSF - expanded criteria based on preoperative imaging , \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "67.46973"}
{"text": "The use of single - agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child - Pugh B liver cirrhosis : a retrospective analysis of efficacy , safety , and survival benefits .", "label": "", "metadata": {}, "score": "67.680115"}
{"text": "Under these criteria , an overall and recurrence - free survival rates at 4 years of 85 % and 92 % have been shown .With these convincing results , much research has been done to improve the criteria for selecting patients for OLT .", "label": "", "metadata": {}, "score": "67.69019"}
{"text": "S6-S13 , 2011 .View at Google Scholar .V. Santi , F. Trevisani , A. Gramenzi et al . , \" Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival , \" Journal of Hepatology , vol .", "label": "", "metadata": {}, "score": "67.71519"}
{"text": "However , it is clear that some patients with favourable \" biology \" are excluded .A number of groups have tried to expand indications beyond the Milan criteria and claim to achieve similar survival rates [ 16 , 17 ] .", "label": "", "metadata": {}, "score": "67.745804"}
{"text": "453 - 459 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. Tanaka , M. Shimada , K. Shirabe et al . , \" Surgical radiofrequency ablation for treatment of hepatocellular carcinoma : an endoscopic or open approach , \" Hepato - Gastroenterology , vol .", "label": "", "metadata": {}, "score": "67.80374"}
{"text": "[PubMed ] [ DOI ] .Bujold A , Massey CA , Kim JJ , Brierley J , Cho C , Wong RK , Dinniwell RE , Kassam Z , Ringash J , Cummings B. Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "67.82208"}
{"text": "Treatment strategy to improve long - term survival for hepatocellular carcinoma smaller than 5 cm : major hepatectomy vs minor hepatectomy .Tiffany Cho Lam Wong Department of Surgery Queen Mary Hospital , The University of Hong Kong , Pokfulam Road , Hong Kong S A R , China World J Surg 38:2386 - 94 .", "label": "", "metadata": {}, "score": "67.89923"}
{"text": "cm outside LT criteria or not suitable for resection , ablative strategies may not work in a predictable manner .TACE also has inconsistent results and no advantage has been demonstrated by combining therapies [ 54 ] .", "label": "", "metadata": {}, "score": "67.90219"}
{"text": "[PubMed ] [ DOI ] .Mazzaferro V , Battiston C , Perrone S , Pulvirenti A , Regalia E , Romito R , Sarli D , Schiavo M , Garbagnati F , Marchian\u00f2 A. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation : a prospective study .", "label": "", "metadata": {}, "score": "67.90619"}
{"text": "Ablative technology is improving and further experience will determine its applicability .Based on a meta - analysis TACE is emerging as the standard of care for asymptomatic HCC outside Milan criteria [ 56 ] , demonstrating improved survival compared to best supportive care .", "label": "", "metadata": {}, "score": "67.931"}
{"text": "The TNM classification is an oncology standard useful in conjunction with the presence of microvascular invasion of examined resection or explanted tumors / liver and provides information regarding the risk of tumor recurrence but does not take account of the liver functional status .", "label": "", "metadata": {}, "score": "67.93254"}
{"text": "Ann Surg .[PubMed ] [ DOI ] .Bruix J , Castells A , Bosch J , Feu F , Fuster J , Garcia - Pagan JC , Visa J , Bru C , Rod\u00e9s J. Surgical resection of hepatocellular carcinoma in cirrhotic patients : prognostic value of preoperative portal pressure .", "label": "", "metadata": {}, "score": "68.078186"}
{"text": "[PubMed ] [ DOI ] .Okuwaki Y , Nakazawa T , Shibuya A , Ono K , Hidaka H , Watanabe M , Kokubu S , Saigenji K. Intrahepatic distant recurrence after radiofrequency ablation for a single small hepatocellular carcinoma : risk factors and patterns .", "label": "", "metadata": {}, "score": "68.09267"}
{"text": "PEI was the first standard ablation treatment , but few years later RFA was recommended as the best option for percutaneous ablation .In most institutions in Asia , RFA has replaced the PEI [ 13 , 89 , 118 ] .", "label": "", "metadata": {}, "score": "68.13925"}
{"text": "W. H. Zhao , Z. M. Ma , X. R. Zhou , Y. Z. Feng , and B. S. Fang , \" Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score , \" World Journal of Gastroenterology , vol . 8 , no . 2 , pp .", "label": "", "metadata": {}, "score": "68.17355"}
{"text": "In general , fixed doses are employed for relatively small tumors with a median diameter of approximately 3 cm , e.g . , 36 Gy/3 fractions or 40 Gy/5 fractions ( Table 2 ) .", "label": "", "metadata": {}, "score": "68.201675"}
{"text": "EPIDEMIOLOGY .The incidence of HCC is increasing in several developed countries , such as European nations and the United States , while in areas such as Japan and Singapore , the incidence of HCC seems to have stabilized or even fallen slightly [ 3 , 4 ] .", "label": "", "metadata": {}, "score": "68.21802"}
{"text": "This study reviews a cohort of patients who underwent this procedure ; outlines the indications , optimal operative technique as well as both short- and long - term outcomes ... .", "label": "", "metadata": {}, "score": "68.256454"}
{"text": "Table 3 Retrospective studies of stereotactic body radiation therapy for hepatocellular carcinoma and other liver tumors .Various prescribed doses and treatment planning strategies are presently employed by different groups [ 28 - 43 ] , and information about optimal treatment doses remains limited .", "label": "", "metadata": {}, "score": "68.25734"}
{"text": "497 - 507 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. K. Kang , M. S. Kim , C. K. Cho , et al . , \" Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization , \" Cancer , vol .", "label": "", "metadata": {}, "score": "68.28699"}
{"text": "4 , pp .533 - 539 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .N. M. Kneteman , J. Oberholzer , M. Al Saghier et al . , \" Sirolimus - based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma , \" Liver Transplantation , vol .", "label": "", "metadata": {}, "score": "68.326836"}
{"text": "Aguayo A , Patt YZ : Nonsurgical treatment of hepatocellular carcinoma .Semin Oncol 28:503 - 513 , 2001 .Treiber G : Systemic treatment of hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "68.36026"}
{"text": "[PubMed ] [ DOI ] .Livraghi T , Bolondi L , Lazzaroni S , Marin G , Morabito A , Rapaccini GL , Salmi A , Torzilli G. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis .", "label": "", "metadata": {}, "score": "68.55678"}
{"text": "11 , pp .2587 - 2596 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . K. S. W. Mak and K. C. Tan , \" Liver transplantation for hepatocellular carcinoma : an Asian perspective , \" Asian Journal of Surgery , vol .", "label": "", "metadata": {}, "score": "68.59662"}
{"text": "In chronic HBV infection , mother - to - child transmission generally accounts for 35 to 50 % through exposure to blood or blood - contaminated fluids at or around birth .", "label": "", "metadata": {}, "score": "68.6876"}
{"text": "1997 ; 226 : 688 - 701 ; discussion 701 - 703 .[PubMed ] [ DOI ] .Decaens T , Roudot - Thoraval F , Bresson - Hadni S , Meyer C , Gugenheim J , Durand F , Bernard PH , Boillot O , Boudjema K , Calmus Y. Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "68.83503"}
{"text": "353 - 367 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. C. Kew , \" Epidemiology of chronic hepatitis B virus infection , hepatocellular carcinoma , and hepatitis B virus - induced hepatocellular carcinoma , \" Pathologie Biologie , vol .", "label": "", "metadata": {}, "score": "68.8445"}
{"text": "98 , no . 3 , pp .733 - 738 , 1990 .View at Google Scholar \u00b7 View at Scopus .S. Okada , K. Shimada , J. Yamamoto et al . , \" Predictive factors for postoperative recurrence of hepatocellular carcinoma , \" Gastroenterology , vol .", "label": "", "metadata": {}, "score": "68.92107"}
{"text": "Wnt- \u03b2 -Catenin Signaling Pathway .Mutations in this pathway have been described in 20 to 40 % of HCC .Wnt- \u03b2 -catenin signaling pathway plays a role in all phases of liver development and maturation which are stem cell renewal , zonation , cell adhesion , proliferation , differentiation , liver regeneration , and epithelial - mesenchymal transition [ 50 - 52 ] .", "label": "", "metadata": {}, "score": "68.92682"}
{"text": "765 - 770 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . U.Cillo , M. Bassanello , A. Vitale et al . , \" The critical issue of hepatocellular carcinoma prognostic classification : which is the best tool available ? \"", "label": "", "metadata": {}, "score": "68.950485"}
{"text": "The laparsocopic approach was used in 15 patients .The tumors were located on the liver surface and easy to reach with this approach .The percutaneous approach was used when the tumors were easy to visualize with ultrasound and easy to reach with the electrodes .", "label": "", "metadata": {}, "score": "69.014114"}
{"text": "168 - 174 , 2002 .View at Google Scholar . H. L. Y. Chan , C. H. Tse , F. Mo et al . , \" High viral load and hepatitis B virus subgenotype Ce are associated with increased risk of hepatocellular carcinoma , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "69.07037"}
{"text": "TNM has been revised and has become American Joint Committee on Cancer ( AJCC )TNM ( Tumor , Node , Metastasis ) staging system .", "label": "", "metadata": {}, "score": "69.095215"}
{"text": "It is part of the spectrum of nonalcoholic fatty liver disease ( NAFLD ) that can lead to cirrhosis in patients without a history of alcohol abuse and whose prevalence is increasing in Western countries because of the obesity and diabetes mellitus incidence .", "label": "", "metadata": {}, "score": "69.12511"}
{"text": "Outcome of laparoscopic versus open hepatectomy for colorectal liver metastases .Tan To Cheung Department of Surgery , The University of Hong Kong , Hong Kong , China ANZ J Surg 83:847 - 52 .", "label": "", "metadata": {}, "score": "69.15744"}
{"text": "Median HCC survival for Japan , Spain , UK and Hong Kong were 47 , 26 , 20 and 7 months respectively .\" The wide geographical variation in survival among HCC patients had been attributed to intrinsic ethnic differences , different aetiologies , or disease stages at presentation , \" explained Dr Reeves . \"", "label": "", "metadata": {}, "score": "69.175705"}
{"text": "611 - 622 , 1999 .View at Publisher \u00b7 View at Google Scholar . A. Villanueva , P. Newell , and Y. Hoshida , \" Inherited hepatocellular carcinoma , \" Best Practice and Research Clinical Gastroenterology , vol .", "label": "", "metadata": {}, "score": "69.20629"}
{"text": "EASL - EORTC clinical practice guidelines : management of hepatocellular carcinoma .J Hepatol .[PubMed ] [ DOI ] .Dawson LA .Overview : Where does radiation therapy fit in the spectrum of liver cancer local - regional therapies ?", "label": "", "metadata": {}, "score": "69.22066"}
{"text": "[PubMed ] [ DOI ] Long - Acting Octreotide LAR Depot in the Treatment of Advanced Hepatocellular Carcinoma .There are strong etiologic associations with hepatitis C , hepatitis B , alcohol , other causes of cirrhosis , and dietary aflatoxins .", "label": "", "metadata": {}, "score": "69.2607"}
{"text": "View Article PubMed .The Cancer of the Liver Italian Program ( CLIP ) : Investigators : A new prognostic system for hepatocellular carcinoma ; A retrospective study of 435 patients .", "label": "", "metadata": {}, "score": "69.26752"}
{"text": "cm with significant liver functional impairment .The major limitation to LT as treatment for HCC is the scarcity of cadaveric donors and the associated waiting time that results in a 20 % drop - out rate and potentially increases the risk of recurrence from extension of vascular invasion .", "label": "", "metadata": {}, "score": "69.30107"}
{"text": "Hepatology .[PubMed ] [ DOI ] .Ravaioli M , Grazi GL , Piscaglia F , Trevisani F , Cescon M , Ercolani G , Vivarelli M , Golfieri R , D'Errico Grigioni A , Panzini I. Liver transplantation for hepatocellular carcinoma : results of down - staging in patients initially outside the Milan selection criteria .", "label": "", "metadata": {}, "score": "69.354355"}
{"text": "To evaluate our preliminary experience of high - intensity focused ultrasound ( HIFU ) for the treatment of recurrent hepatocellular carcinoma ( HCC ) ... .", "label": "", "metadata": {}, "score": "69.3673"}
{"text": "European Association for the Study of the Liver , \" Journal of Hepatology , vol .35 , no . 3 , pp .421 - 430 , 2001 .", "label": "", "metadata": {}, "score": "69.38275"}
{"text": "J Clin Oncol .[PubMed ] [ DOI ] .Wulf J , H\u00e4dinger U , Oppitz U , Thiele W , Ness - Dourdoumas R , Flentje M. Stereotactic radiotherapy of targets in the lung and liver .", "label": "", "metadata": {}, "score": "69.488846"}
{"text": "While the early outcomes of SBRT use in unresectable HCC are encouraging , further studies are required to validate these favorable results .ACKNOWLEDGMENTS .Figures are generated from our own study which received an institutional review board approval in our institution .", "label": "", "metadata": {}, "score": "69.50026"}
{"text": "6 , pp .1434 - 1440 , 1999 .View at Google Scholar \u00b7 View at Scopus . D. Franco , L. Capussotti , C. Smadja et al . , \" Resection of hepatocellular carcinomas .", "label": "", "metadata": {}, "score": "69.52603"}
{"text": "2011 ; 80 : e207-e211 .[PubMed ] [ DOI ] .Sanuki N , Takeda A , Mizuno T , Oku Y , Eriguchi T , Iwabuchi S , Kunieda E. Tumor response on CT following hypofractionated stereotactic ablative body radiotherapy for small hypervascular hepatocellular carcinoma with cirrhosis .", "label": "", "metadata": {}, "score": "69.55296"}
{"text": "Conclusions .Management of HCC continues to evolve and interventional radiology in the form of TACE .RFA increasingly dominates management either as a bridge to LT or to downstage facilitating LT or resection .", "label": "", "metadata": {}, "score": "69.6071"}
{"text": "291 - 297 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. M. Llovet , J. Fuster , and J. Bruix , \" Intention - to - treat analysis of surgical treatment for early hepatocellular carcinoma : resection versus transplantation , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "69.60861"}
{"text": "Radiology .[PubMed ] [ DOI ] .Rautou PE , Douarin L , Denninger MH , Escolano S , Lebrec D , Moreau R , Vidaud M , Itzykson R , Moucari R , Bezeaud A. Bleeding in patients with Budd - Chiari syndrome .", "label": "", "metadata": {}, "score": "69.616776"}
{"text": "1352 - 1357 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . E. Schott , A. Bergk , and T. Berg , \" Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis , \" Zeitschrift fur Gastroenterologie , vol .", "label": "", "metadata": {}, "score": "69.64243"}
{"text": "Cancer .[PubMed ] [ DOI ] .A new prognostic system for hepatocellular carcinoma : a retrospective study of 435 patients : the Cancer of the Liver Italian Program ( CLIP ) investigators .", "label": "", "metadata": {}, "score": "69.73166"}
{"text": "But individually the studies did not clearly demonstrate a benefit , mainly because of heterogenous patient study groups and varying TACE techniques .This implies that good results with TACE are achieved when it is used on a selective basis .", "label": "", "metadata": {}, "score": "69.76022"}
{"text": "N Engl J Med .[PubMed ] [ DOI ] .Llovet JM , Real MI , Monta\u00f1a X , Planas R , Coll S , Aponte J , Ayuso C , Sala M , Muchart J , Sol\u00e0 R. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma : a randomised controlled trial .", "label": "", "metadata": {}, "score": "69.82383"}
{"text": "4 , pp .657 - 664 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. H. Kwon , S. H. Bae , J. Y. Kim et al . , \" Long - term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection .", "label": "", "metadata": {}, "score": "69.86913"}
{"text": "[PubMed ] [ DOI ] .Lo CM , Ngan H , Tso WK , Liu CL , Lam CM , Poon RT , Fan ST , Wong J. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "69.91475"}
{"text": "Management of spontaneously ruptured hepatocellular carcinomas in the radiofrequency ablation era .Tan To Cheung Department of Surgery , Queen Mary Hospital , The University of Hong Kong , Hong Kong , China PLoS ONE 9:e94453 .", "label": "", "metadata": {}, "score": "69.915115"}
{"text": "But when TACE followed by RFA for this size tumor is applied , the therapeutic effect of RFA is significantly increased and reduces tumor progression rate to 6 % compared to 39 % for RFA alone [ 53 ] .", "label": "", "metadata": {}, "score": "70.067406"}
{"text": "Methods .Data were collected in 530 \" very early \" and \" early \" HCC patients recruited by a multicentric Italian collaborative group ( ITA.LI.CA ) .", "label": "", "metadata": {}, "score": "70.07525"}
{"text": "Gadoxetic acid is a contrast agent for MRI that has combined perfusion and hepatocyte - specific properties .This technique has shown higher detection sensitivity for HCC compared to dynamic CT or MRI .", "label": "", "metadata": {}, "score": "70.089485"}
{"text": "[PubMed ] [ DOI ] .de Villa V , Lo CM .Liver transplantation for hepatocellular carcinoma in Asia .Oncologist .[PubMed ] [ DOI ] .", "label": "", "metadata": {}, "score": "70.16447"}
{"text": "[PubMed ] [ DOI ] .Makuuchi M , Sano K. The surgical approach to HCC : our progress and results in Japan .Liver Transpl .", "label": "", "metadata": {}, "score": "70.1922"}
{"text": "Tumor size varied from 2 - 3 cm to approximately 5 - 7 cm .These differences are attributed to the geographic variability in HCC etiology and treatment availability , as previously mentioned .", "label": "", "metadata": {}, "score": "70.23375"}
{"text": "Marrero JA : Staging system for hepatocellular carcinoma : should we all use the BCLC system ?J Hepatol 2006 , 44 : 630 - 632 .", "label": "", "metadata": {}, "score": "70.27944"}
{"text": "2004 ; 127 : S159-S166 .[PubMed ] [ DOI ] .Huang J , Yan L , Cheng Z , Wu H , Du L , Wang J , Xu Y , Zeng Y. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria .", "label": "", "metadata": {}, "score": "70.28405"}
{"text": "The graft cold ischemia time and postoperative acute cellular rejection are significantly associated with postoperative BAS ... .An update on long - term outcome of curative hepatic resection for hepatocholangiocarcinoma .", "label": "", "metadata": {}, "score": "70.29055"}
{"text": "12 , pp .3301 - 3309 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Ravaioli , G. L. Grazi , F. Piscaglia et al . , \" Liver transplantation for hepatocellular carcinoma : results of down - staging in patients initially outside the Milan selection criteria , \" American Journal of Transplantation , vol . 8 , no .", "label": "", "metadata": {}, "score": "70.32504"}
{"text": "943 - 949 , 2000 .View at Google Scholar .S. G. Lim , R. Mohammed , M. F. Yuen , and J. H. Kao , \" Prevention of hepatocellular carcinoma in hepatitis B virus infection , \" Journal of Gastroenterology and Hepatology , vol .", "label": "", "metadata": {}, "score": "70.36994"}
{"text": "An alternative strategy to expanding the criteria for LT is to downstage to within Milan Criteria aiming to achieve patient survival and recurrence free survival rates similar to those treated at an earlier stage .", "label": "", "metadata": {}, "score": "70.45746"}
{"text": "[PubMed ] [ DOI ] .Lencioni R , Bartolozzi C , Caramella D , Paolicchi A , Carrai M , Maltinti G , Capria A , Tafi A , Conte PF , Bevilacqua G. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection .", "label": "", "metadata": {}, "score": "70.507256"}
{"text": "Retransplantation using living - donor right - liver grafts .Wing Chiu Dai Department of Surgery , Queen Mary Hospital , The University of Hong Kong , 102 Pok Fu Lam Road , Hong Kong , China J Hepatobiliary Pancreat Sci 21:579 - 84 .", "label": "", "metadata": {}, "score": "70.5152"}
{"text": "Kudo M , Chung H , Osaki Y : Prognostic staging system for hepatocellular carcinoma ( CLIP score ) : its value and limitations , and a proposal for a new staging system , the Japan Integrated Staging Score ( JIS score ) .", "label": "", "metadata": {}, "score": "70.52112"}
{"text": "4 , pp .1284 - 1290 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. S. Chen , J. Q. Li , Y. Zheng et al . , \" A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma , \" Annals of Surgery , vol .", "label": "", "metadata": {}, "score": "70.5531"}
{"text": "Institute of Liver Studies , King 's College Hospital , Denmark Hill , London SE5 9RS , UK .Received 12 July 2012 ; Accepted 17 September 2012 .", "label": "", "metadata": {}, "score": "70.58174"}
{"text": "4 , pp .359 - 366 , 2004 .View at Google Scholar \u00b7 View at Scopus .P. Hermanek , L. H. Sobin , and C. Wittekind , \" How to improve the present TNM staging system , \" Cancer , vol .", "label": "", "metadata": {}, "score": "70.62825"}
{"text": "30- 34 In fact , it compares favourably with accepted medical interventions , such as implantable cardioverter - defibrillator for coronary heart disease ( $ 26 000 - 40 000 per year of life ) or haemodialysis ( $ 42 000/quality adjusted life year saved ) .", "label": "", "metadata": {}, "score": "70.71112"}
{"text": "86 - 90 , 2009 .View at Google Scholar \u00b7 View at Scopus Detail Information .Publications 67 .Improved anterior hepatic transection for isolated hepatocellular carcinoma in the caudate .", "label": "", "metadata": {}, "score": "70.760506"}
{"text": "We tried to limit this bias selecting a more appropriate series of patients , but further validation analysis on recent years may be useful to understand how much the application of the guidelines is different from our results .", "label": "", "metadata": {}, "score": "70.780945"}
{"text": "References .El - Serag HB , Mason AC , Key C : Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States .", "label": "", "metadata": {}, "score": "70.78385"}
{"text": "S96-S100 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . Y. Takuma and K. Nouso , \" Nonalcoholic steatohepatitis - associated hepatocellular carcinoma : our case series and literature review , \" World Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "70.82616"}
{"text": "Sensitivity analysis .As previously described , for the two reference cases the probabilities of survival during the waiting list ( with or without treatment ) , dropout rate , and survival after transplantation are shown in table 1 .", "label": "", "metadata": {}, "score": "70.940094"}
{"text": "[PubMed ] [ DOI ] .Arii S , Tanaka S , Mitsunori Y , Nakamura N , Kudo A , Noguchi N , Irie T. Surgical strategies for hepatocellular carcinoma with special reference to anatomical hepatic resection and intraoperative contrast - enhanced ultrasonography .", "label": "", "metadata": {}, "score": "70.987495"}
{"text": "11 , pp .1111 - 1118 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. T. Coon , G. Rogers , P. Hewson et al . , \" Surveillance of cirrhosis for hepatocellular carcinoma : systematic review and economic analysis , \" Health Technology Assessment , vol .", "label": "", "metadata": {}, "score": "70.99669"}
{"text": "Active investigation of SBRT has recently started , yielding promising local control rates .However , information on optimal treatment indications , doses , and methods remains limited .", "label": "", "metadata": {}, "score": "70.99737"}
{"text": "[PubMed ] [ DOI ] .Sotiropoulos GC , Nowak KW , Fouzas I , Vernadakis S , Kykalos S , Klein CG , Paul A. Sorafenib treatment for recurrent hepatocellular carcinoma after liver transplantation .", "label": "", "metadata": {}, "score": "71.0567"}
{"text": "Unit\u00e0 di Gastroenterologia , Ospedale Belcolle .Istituto Oncologico Veneto .References .Pugh RN , Murray - Lyon IM , Dawson JL , Pietroni MC , Williams R : Transsection of the oesopahagus for bleeding oesophageal varices .", "label": "", "metadata": {}, "score": "71.084496"}
{"text": "329 - 338 , 1999 .View at Google Scholar \u00b7 View at Scopus .S. Chevret , J. C. Trinchet , D. Mathieu , A. A. Rached , M. Beaugrand , and C. Chastang , \" A new prognostic classification for predicting survival in patients with hepatocellular carcinoma , \" Journal of Hepatology , vol .", "label": "", "metadata": {}, "score": "71.09703"}
{"text": "[PubMed ] [ DOI ] .Oliveri RS , Wetterslev J , Gluud C. Transarterial ( chemo)-embolisation for unresectable hepatocellular carcinoma .Cochrane Database Syst Rev .", "label": "", "metadata": {}, "score": "71.15196"}
{"text": "[PubMed ] [ DOI ] .Dewas S , Bibault JE , Mirabel X , Fumagalli I , Kramar A , Jarraya H , Lacornerie T , Dewas - Vautravers C , Lartigau E. Prognostic factors affecting local control of hepatic tumors treated by Stereotactic Body Radiation Therapy .", "label": "", "metadata": {}, "score": "71.16481"}
{"text": "Int J Radiat Oncol Biol Phys .[PubMed ] [ DOI ] .Takeda A , Kunieda E , Ohashi T , Aoki Y , Koike N , Takeda T. Stereotactic body radiotherapy ( SBRT ) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer .", "label": "", "metadata": {}, "score": "71.22458"}
{"text": "4 , pp .373 - 379 , 1988 .View at Google Scholar \u00b7 View at Scopus .B. Ringe , R. Pichlmayr , C. Wittekind , and G. Tusch , \" Surgical treatment of hepatocellular carcinoma : experience with liver resection and transplantation in 198 patients , \" World Journal of Surgery , vol .", "label": "", "metadata": {}, "score": "71.27417"}
{"text": "J Vasc Interv Radiol .2009 ; 20 : S377-S390 .[PubMed ] [ DOI ] .A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "71.30753"}
{"text": "177 - 182 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . Y. F. Liaw , J. J. Sung , W. C. Chow , et al . , \" Lamivudine for patients with chronic hepatitis B and advanced liver disease , \" The New England Journal of Medicine , vol .", "label": "", "metadata": {}, "score": "71.33304"}
{"text": "[PubMed ] [ DOI ] .Bruix J , Sala M , Llovet JM .Chemoembolization for hepatocellular carcinoma .Gastroenterology .2004 ; 127 : S179-S188 .", "label": "", "metadata": {}, "score": "71.370834"}
{"text": "Moreover , for such little size nodules , diagnostic value of either CT and MR is inadequate .Nodules between 1 and 2 cm in size should be studied with CT and MR and , in case of non diagnostic imaging , undergo nodule biopsy .", "label": "", "metadata": {}, "score": "71.3797"}
{"text": "Evaluation of the seventh edition of the American Joint Committee on Cancer tumour - node - metastasis ( TNM ) staging system for patients undergoing curative resection of hepatocellular carcinoma : implications for the development of a refined staging system .", "label": "", "metadata": {}, "score": "71.440575"}
{"text": "[PubMed ] [ DOI ] .Lammer J , Malagari K , Vogl T , Pilleul F , Denys A , Watkinson A , Pitton M , Sergent G , Pfammatter T , Terraz S. Prospective randomized study of doxorubicin - eluting - bead embolization in the treatment of hepatocellular carcinoma : results of the PRECISION V study .", "label": "", "metadata": {}, "score": "71.4984"}
{"text": "To overcome the scarcity of deceased donors , the notion of living donor liver transplantation ( LDLT ) has been adopted and has allowed to face long waiting times for deceased donor liver grafts .", "label": "", "metadata": {}, "score": "71.55037"}
{"text": "Decision tree and states of health .A diagram of the event pathway is depicted in fig 1 .Analysis of the state of health was performed in three month cycles starting from inclusion of patients onto the waiting list until a time period of 10 years after OLT .", "label": "", "metadata": {}, "score": "71.57507"}
{"text": "Hepatology .[PubMed ] [ DOI ] .Sahasrabuddhe VV , Shiels MS , McGlynn KA , Engels EA .The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States .", "label": "", "metadata": {}, "score": "71.57898"}
{"text": "They have been internally and externally validated , both retrospectively and prospectively , and their efficiency has been tested in several clinical and therapeutic scenarios [ 6 - 15 ] .", "label": "", "metadata": {}, "score": "71.587524"}
{"text": "6 , pp .1142 - 1154 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .L. T. Chen , M. F. Chen , L. A. Li , et al . , \" Long - term results of a randomized , observation - controlled , phase III trial of adjuvant interferon Alfa-2b in hepatocellular carcinoma after curative resection , \" Annals of Surgery , vol .", "label": "", "metadata": {}, "score": "71.59197"}
{"text": "The aim of this paper was to review the current knowledge on management of HCC and to enlighten the areas of uncertainty .Core tip : Management of hepatocellular carcinoma ( HCC ) has been continuously evolving during recent years .", "label": "", "metadata": {}, "score": "71.615395"}
{"text": "[PubMed ] [ DOI ] .Teng CL , Hwang WL , Chen YJ , Chang KH , Cheng SB .Sorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation : a case control study .", "label": "", "metadata": {}, "score": "71.62694"}
{"text": "868 - 878 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. B. Thomas , J. P. O'Beirne , J. Furuse , A. T. C. Chan , G. Abou - Alfa , and P. Johnson , \" Systemic therapy for hepatocellular carcinoma : cytotoxic chemotherapy , targeted therapy and immunotherapy , \" Annals of Surgical Oncology , vol .", "label": "", "metadata": {}, "score": "71.65866"}
{"text": "The adherence to AASLD indication was evaluated when all data were available ( 419/465 pts - 90 % ) .Internal validation analysis .The set of consecutive patients with \" early \" HCC included in the internal validation did not show any statistically significant difference from the whole series with respect to the baseline characterization ( mean age , gender and so on ) .", "label": "", "metadata": {}, "score": "71.66681"}
{"text": "Am J Roentgenol Radium Ther Nucl Med .[PubMed ] [ DOI ] .Reed GB , Cox AJ .The human liver after radiation injury .", "label": "", "metadata": {}, "score": "71.66898"}
{"text": "There is a minimal embolic effect so when there is main portal vein involvement and TACE is contraindicated radioembolization with yttrium may be a good option .", "label": "", "metadata": {}, "score": "71.685585"}
{"text": "their median survival was 15 months ( CI 6 - 43 ) .Survival curves in patients with very early HCC treated with different modalities .", "label": "", "metadata": {}, "score": "71.803474"}
{"text": "37 , no .11 , pp .1689 - 1705 , 2004 .View at Google Scholar \u00b7 View at Scopus .J. Bruix and J. M. Llovet , \" Hepatitis B virus and hepatocellular carcinoma , \" Journal of Hepatology , vol .", "label": "", "metadata": {}, "score": "71.84649"}
{"text": "View Article PubMed .Bruix J , Sherman M : Management of hepatocellular carcinoma .Hepatology 2005 , 42 ( 5 ) : 1208 - 1236 .", "label": "", "metadata": {}, "score": "71.966805"}
{"text": "This study explored the efficacy , tolerability , and survival benefits of using sorafenib in patients with Child - Pugh class B ( CPB ) cirrhosis ... .", "label": "", "metadata": {}, "score": "71.9827"}
{"text": "This classification performed well as a single independent predictor of survival in the nonsurgical group according to Cox 's regression analysis , probably because it also considers the patient 's general health ( Karnofsky index ) , unlike the Okuda , CLIP , and CUPI scores .", "label": "", "metadata": {}, "score": "72.09094"}
{"text": "Whatever the criteria adopted , a significant problem of HCC candidates for LT is the drop out , that is patients who do not reach the goal of LT because of progression of HCC or of causes unrelated to HCC .", "label": "", "metadata": {}, "score": "72.18208"}
{"text": "[PubMed ] [ DOI ] .Takeda A , Oku Y , Sanuki N , Kunieda E , Koike N , Aoki Y , Ohashi T , Iwabuchi S , Takatsuka K , Takeda T. Dose volume histogram analysis of focal liver reaction in follow - up multiphasic CT following stereotactic body radiotherapy for small hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "72.18989"}
{"text": "819 - 827 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .W. Y. Lau and E. C. H. Lai , \" Salvage surgery following downstaging of unresectable hepatocellular carcinoma - a strategy to increase resectability , \" Annals of Surgical Oncology , vol .", "label": "", "metadata": {}, "score": "72.20969"}
{"text": "Nonalcoholic Steatohepatitis ( NASH ) .Nonalcoholic steatohepatitis was originally believed to be a benign disease , but it has been recently revealed that NASH could lead to irreversible liver diseases [ 35 ] .", "label": "", "metadata": {}, "score": "72.32352"}
{"text": "PATIENTS AND METHODS .Design of the study and Markov multistate transition model .We analysed the cost effectiveness of applying resection or percutaneous ethanol injection ( PEI ) versus standard management in cirrhotic patients with early HCC on their inclusion on the waiting list for OLT .", "label": "", "metadata": {}, "score": "72.32687"}
{"text": "227 - 231 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. S\u00f6derdahl , L. B\u00e4ckman , H. Isoniemi et al . , \" A prospective , randomized , multi - centre trial of systemic adjuvant chemotherapy versus no additional treatment in liver transplantation for hepatocellular carcinoma , \" Transplant International , vol .", "label": "", "metadata": {}, "score": "72.33887"}
{"text": "But the data is difficult to interpret as the studies utilise different inclusion criteria ( tumor size and number ) , locoregional therapies either individually or in combination , and endpoints .", "label": "", "metadata": {}, "score": "72.67273"}
{"text": "Assuming a 50 % five year survival rate after OLT ( worst scenario ) , the estimates of LE decreased in all cases .For this scenario , PEI retained a cost effectiveness ratio for all waiting times but resection was cost effective only for waiting times exceeding two years ( $ 43 074/MCLYS ) .", "label": "", "metadata": {}, "score": "72.691086"}
{"text": "Recurrence rate at two years was 30 % .21- 24 Survival outcome after PEI varied according to achievement of a complete and maintained response , and ranged from 62 % to 72 % at two years .", "label": "", "metadata": {}, "score": "72.70847"}
{"text": "[PubMed ] [ DOI ] .Blomgren H , Lax I , N\u00e4slund I , Svanstr\u00f6m R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator .", "label": "", "metadata": {}, "score": "72.709076"}
{"text": "Natural history of untreated non - surgical hepatocellular carcinoma : rationale for the design and evaluation of therapeutic trials .Hepatology 1999 ; 29 : 62 -7 .", "label": "", "metadata": {}, "score": "72.77593"}
{"text": "Kouroumalis EA : Octreotide for cancer of the liver and biliary tree .Chemotherapy 47(suppl 2):150 - 161 , 2001 .Kouroumalis E , Skordilis P , Thermos K , et al : Treatment of hepatocellular carcinoma with octreotide : A randomised controlled study .", "label": "", "metadata": {}, "score": "72.78282"}
{"text": "The aim of this paper is to give a brief overview of present day management strategies and decision making .Introduction .Hepatocellular carcinoma ( HCC ) is the fifth most common cancer in the world .", "label": "", "metadata": {}, "score": "72.8103"}
{"text": "S59-S63 , 2003 .View at Google Scholar \u00b7 View at Scopus .R. Lencioni , C. Della Pina , D. Cioni , and L. Crocetti , \" Guidelines for the use of contrast - enhanced ultrasound in hepatocellular carcinoma , \" European Journal of Cancer Supplements , vol .", "label": "", "metadata": {}, "score": "72.83479"}
{"text": "Core tip : The integration of new technologies has raised an interest in radiotherapy for hepatocellular carcinoma ( HCC ) , with literature evolving to support its efficacy .", "label": "", "metadata": {}, "score": "72.8535"}
{"text": "Feasibility of laparoscopic re - resection for patients with recurrent hepatocellular carcinoma .Albert C Y Chan Division of Hepatobiliary and Pancreatic Surgery , and Liver Transplantation , Department of Surgery , The University of Hong Kong , 102 Pokfulam Road , Hong Kong , Hong Kong World J Surg 38:1141 - 6 .", "label": "", "metadata": {}, "score": "72.885864"}
{"text": "Therefore , LDLT can be considered for patients who have acute hepatic decompensation with or without HRS ... .The outcomes and safety of single - agent sorafenib in the treatment of elderly patients with advanced hepatocellular carcinoma ( HCC ) .", "label": "", "metadata": {}, "score": "72.91969"}
{"text": "Tumor less than 2 cm is rarely detectable .For these remarks , AFP is not considered as a suitable test [ 5 , 18 , 88 , 93 ] .", "label": "", "metadata": {}, "score": "73.00437"}
{"text": "35 - 43 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . S. Roayaie , J. S. Frischer , S. H. Emre et al . , \" Long - term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters , \" Annals of Surgery , vol .", "label": "", "metadata": {}, "score": "73.03578"}
{"text": "Hepatocellular carcinoma : new advances in diagnosis , staging and treatment all predicted to improve patient outcomes .\" Medical News Today .Contact our news editors .", "label": "", "metadata": {}, "score": "73.05669"}
{"text": "Gastroenterology .[PubMed ] [ DOI ] .Kulik LM , Carr BI , Mulcahy MF , Lewandowski RJ , Atassi B , Ryu RK , Sato KT , Benson A , Nemcek AA , Gates VL .", "label": "", "metadata": {}, "score": "73.10254"}
{"text": "Tan To Cheung Department of Surgery , The University of Hong Kong , Hong Kong , China ANZ J Surg 84:827 - 31 .In the treatment of liver metastasis of gastrointestinal stromal tumour ( GIST ) , the role of hepatectomy is controversial .", "label": "", "metadata": {}, "score": "73.10686"}
{"text": "Reference case No 1 ( group 1 ) .This treatment provides an acceptable morbidity and short term mortality .Reference case No 2 ( group 2 ) .", "label": "", "metadata": {}, "score": "73.14374"}
{"text": "SBRT refers to the use of stereotactic non - coplanar conformal radiation therapy intended for a small number of significantly larger fraction sizes ( usually 8 - 12 Gy / fraction ) , while limiting the dose to adjacent normal tissues .", "label": "", "metadata": {}, "score": "73.15233"}
{"text": "336 , no .26 , pp .1855 - 1859 , 1997 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . Y. Poovorawan , A. Theamboonlers , T. Vimolket , et al . , \" Impact of hepatitis B immunization as part of the EPI , \" Vaccine , vol .", "label": "", "metadata": {}, "score": "73.18301"}
{"text": "[PubMed ] [ DOI ] .Lin SM , Lin CJ , Lin CC , Hsu CW , Chen YC .Gastroenterology .[PubMed ] [ DOI ] .", "label": "", "metadata": {}, "score": "73.20108"}
{"text": "Scand J Gastroenterol .[PubMed ] [ DOI ] .Lin SM , Lin CJ , Lin CC , Hsu CW , Chen YC .", "label": "", "metadata": {}, "score": "73.28959"}
{"text": "The 1- , 3- , 5- , and 10-year recurrence - free survival rates were 74 % , 44 % , 30 % and 15 % , respectively .", "label": "", "metadata": {}, "score": "73.31584"}
{"text": "5 , pp .725 - 734 , 2010 .View at Google Scholar .B. Sangro , J. I. Bilbao , M. I\u00f1arrairaegui , M. Rodriguez , P. Garrastachu , and A. Martinez - Cuesta , \" Treatment of hepatocellular carcinoma by radioembolization using y microspheres , \" Digestive Diseases , vol .", "label": "", "metadata": {}, "score": "73.357735"}
{"text": "200 - 207 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Samuel , P. K. Chow , E. Chan Shih - Yen , D. Machin , and K. C. Soo , \" Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma , \" Cochrane Database of Systematic Reviews , no . 1 , article CD001199 , 2009 .", "label": "", "metadata": {}, "score": "73.35887"}
{"text": "High - intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients awaiting liver transplantation .Tan To Cheung Department of Surgery , The University of Hong Kong , 102 Pokfulam Road , Hong Kong , China Hepatobiliary Pancreat Dis Int 11:542 - 4 .", "label": "", "metadata": {}, "score": "73.39883"}
{"text": "Wide geographical variation in HCC survival explained by differing intensity of country screening programmes .In Japan , approximately 80 % of hepatocellular carcinoma ( HCC ) cases are detected by screening .", "label": "", "metadata": {}, "score": "73.516335"}
{"text": "[PubMed ] [ DOI ] .Oliveri RS , Wetterslev J , Gluud C. Transarterial ( chemo ) embolisation for unresectable hepatocellular carcinoma ( Review ) .", "label": "", "metadata": {}, "score": "73.555756"}
{"text": "Validation of a new prognostic system .Cancer 2000 , 89 ( 11 ) : 2266 - 73 .View Article PubMed .Am J Gastroenterol 2004 , 99 ( 8) : 1470 - 6 .", "label": "", "metadata": {}, "score": "73.59851"}
{"text": "Sorafenib is regarded as the standard therapy for metastatic disease and for HCC progressing despite optimal locoregional therapy [ 84 ] .A number of ongoing studies are establishing Sorafenib 's adjuvant role in resection , local ablation ( Sorafenib as Adjuvant Treatment in the Prevention of Recurrence of Hepatocellular Carcinoma ( STORM ) ) , and TACE .", "label": "", "metadata": {}, "score": "73.6322"}
{"text": "The groups were equally matched for the presence of cirrhosis , gender , bilirubin , albumin , and Child - Pugh class .[5 ] .", "label": "", "metadata": {}, "score": "73.63837"}
{"text": "Br J Radiol .[PubMed ] [ DOI ] .Mazzaferro V , Bhoori S , Sposito C , Bongini M , Langer M , Miceli R , Mariani L. Milan criteria in liver transplantation for hepatocellular carcinoma : an evidence - based analysis of 15 years of experience .", "label": "", "metadata": {}, "score": "73.671326"}
{"text": "In Europe , the incidence of HCV may be related to the extensive campaign to vaccinate children in the years 1940s to 1950s and possibility to inadequate sterilization of nondisposable needles and syringes up to the mid-1970s .", "label": "", "metadata": {}, "score": "73.68019"}
{"text": "Located adjacent to the right atrium ( A ) .Axial and coronal view of radiation dose distribution ( B and C ) .The isodose lines ( white lines ) from inner to outer represent 40 , 30 , 20 , and 10 Gy , respectively .", "label": "", "metadata": {}, "score": "73.68229"}
{"text": "[PubMed ] [ DOI ] .Takeda A , Sanuki N , Eriguchi T , Kobayashi T , Iwabutchi S , Matsunaga K , Mizuno T , Yashiro K , Nisimura S , Kunieda E. Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "73.69116"}
{"text": "Semin Liver Dis .[PubMed ] [ DOI ] .Bismuth H , Majno PE , Adam R. Liver transplantation for hepatocellular carcinoma .Semin Liver Dis .", "label": "", "metadata": {}, "score": "73.73489"}
{"text": "The remaining 22 matched patients ( 18 men ; mean age 69 years ) with 22 HCC nodules 3.6 - 4.8 cm in diameter extending into the MPT , refused RFA and therefore made up the control group .", "label": "", "metadata": {}, "score": "73.76551"}
{"text": "Ultimately , the aim of LT , irrespective of disease etiology is to give the maximum benefit from a limited organ pool .D. Samuel , M. Colombo , H. El - Serag , R. Sobesky , and N. Heaton , \" Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma , \" Liver Transplantation , vol .", "label": "", "metadata": {}, "score": "73.80322"}
{"text": "[PubMed ] [ DOI ] .Kudo M , Chung H , Osaki Y. Prognostic staging system for hepatocellular carcinoma ( CLIP score ) : its value and limitations , and a proposal for a new staging system , the Japan Integrated Staging Score ( JIS score ) .", "label": "", "metadata": {}, "score": "73.820656"}
{"text": "164 - 169 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. Q. Cao , T. D. Yan , L. Bester , W. Liauw , and D. L. Morris , \" Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases , \" British Journal of Surgery , vol .", "label": "", "metadata": {}, "score": "73.86063"}
{"text": "There are a number of different locoregional strategies available or being developed but the largest experience is with transarterial chemoembolization ( TACE ) and radiofrequency ablation ( RFA ) .", "label": "", "metadata": {}, "score": "73.91847"}
{"text": "Hepatology .[PubMed ] [ DOI ] .Hilgard P , Hamami M , Fouly AE , Scherag A , M\u00fcller S , Ertle J , Heusner T , Cicinnati VR , Paul A , Bockisch A. Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma : European experience on safety and long - term survival .", "label": "", "metadata": {}, "score": "74.07387"}
{"text": "In this system , patients were divided into three different groups , and six prognosis factors were taken into account by adding the following factors into the TNM staging system : total bilirubin , ascites , alkaline phosphatase , alfa - fetoprotein , and asymptomatic disease on presentation .", "label": "", "metadata": {}, "score": "74.098976"}
{"text": "--- Our top categories - Alzheimer 's / Dementia - Breast Cancer - Cancer / Oncology - Diabetes - Ebola - HIV / AIDS - Infectious Diseases - Multiple Sclerosis - Nutrition / Diet - Parkinson 's Disease - Stem Cell Research --- View all categories .", "label": "", "metadata": {}, "score": "74.12682"}
{"text": "Transplantation of a 2-year - old deceased - donor liver to a 61-year - old male recipient .Wing Chiu Dai Department of Surgery , The University of Hong Kong , Hong Kong , China Asian J Surg 38:113 - 6 .", "label": "", "metadata": {}, "score": "74.24158"}
{"text": "This may have produced the gap between theoretically ideal and real - life treatment decisions .Even though , generally speaking , guidelines should not be considered as mandatory advices , should we try harder to stick to the AASLD recommendations ?", "label": "", "metadata": {}, "score": "74.37282"}
{"text": "The current study was a phase 2 open - label study to evaluate the efficacy and tolerability of single - agent sorafenib in the treatment of advanced HCC patients in a hepatitis B - endemic Asian population ... .", "label": "", "metadata": {}, "score": "74.46651"}
{"text": "More recently the up - to-7 criteria , where the HCC scores 7 based on the sum of the largest tumor ( diameter cm ) and the total number of tumors , have been introduced [ 17 ] .", "label": "", "metadata": {}, "score": "74.514206"}
{"text": "Hepatology 2000 , 32 ( 6 ) : 1224 - 9 .View Article PubMed .Wang JH , Changchien CS , Hu TH , Lee CM , Kee KM , Lin CY , Chen CL , Cen TY , Huang YJ , Lu SN : The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients .", "label": "", "metadata": {}, "score": "74.51745"}
{"text": "Compared to the Okuda or TNM , Clip improves the prognostic accuracy because all predictor variables are considered as adverse prognostic characteristic in patients with HCC .", "label": "", "metadata": {}, "score": "74.52678"}
{"text": "Single - centre experience of liver transplantation for familial amyloidotic polyneuropathy of non - Val30Met variants in Chinese patients .Wing Chiu Dai Department of Surgery , Hong Kong , China Amyloid 19:33 - 6 .", "label": "", "metadata": {}, "score": "74.580185"}
{"text": "35 However , implementation of these strategies is complex , and will probably be restricted to leading transplant units .This has led most centres to administer antitumoral treatments on entering HCC patients onto waiting lists .", "label": "", "metadata": {}, "score": "74.71779"}
{"text": "The prognostic predictive power of the JIS score was equal to the CLIP score and was better than the original BCLC staging classification [ 72 , 81 - 83 ] .", "label": "", "metadata": {}, "score": "74.749054"}
{"text": "2012 ; 13 : e11-e22 .[PubMed ] [ DOI ] .Iwatsuki S , Starzl TE , Sheahan DG , Yokoyama I , Demetris AJ , Todo S , Tzakis AG , Van Thiel DH , Carr B , Selby R. Hepatic resection versus transplantation for hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "74.81064"}
{"text": "[PubMed ] [ DOI ] .Mancuso A. Hepatocellular carcinoma in thalassemia : A critical review .World J Hepatol .[PubMed ] [ DOI ] .", "label": "", "metadata": {}, "score": "74.883514"}
{"text": "RF thermal ablation as a primary treatment for HCC may have similar efficacy .37Compared with PEI , its increased cost and the impact of complications may balance the benefits of reduced hospital stay .", "label": "", "metadata": {}, "score": "74.950424"}
{"text": "[PubMed ] [ DOI ] .Sato T , Tateishi R , Yoshida H , Ohki T , Masuzaki R , Imamura J , Goto T , Kanai F , Obi S , Kato N. Ultrasound surveillance for early detection of hepatocellular carcinoma among patients with chronic hepatitis C. Hepatol Int .", "label": "", "metadata": {}, "score": "75.13481"}
{"text": "AASLD indications for treatment are reported in rows ; percentages of patients treated per each modality are calculated on the totality of patients having that specific indication .", "label": "", "metadata": {}, "score": "75.28699"}
{"text": "Okuda Classification .Established in 1985 from 850 cases of hepatocellular carcinoma , Okuda classification is one of the most commonly used staging systems in the world .", "label": "", "metadata": {}, "score": "75.35095"}
{"text": "4 , pp .529 - 538 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. I. Yang , S. N. Lu , Y. F. Liaw , et al . , \" Hepatitis B e antigen and the risk of hepatocellular carcinoma , \" The New England Journal of Medicine , vol .", "label": "", "metadata": {}, "score": "75.39456"}
{"text": "47 , no . 1 , pp .82 - 89 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . Y. K. Cho , J. K. Kim , M. Y. Kim , H. Rhim , and J. K. Han , \" Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "75.425415"}
{"text": "10 , pp .1104 - 1112 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. Raimondi , S. Bruno , M. U. Mondelli , and P. Maisonneuve , \" Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development : a meta - analysis , \" Journal of Hepatology , vol .", "label": "", "metadata": {}, "score": "75.4301"}
{"text": "[PubMed ] [ DOI ] .Pelletier G , Ducreux M , Gay F , Luboinski M , Hag\u00e8ge H , Dao T , Van Steenbergen W , Buffet C , Rougier P , Adler M. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization : a multicenter randomized trial .", "label": "", "metadata": {}, "score": "75.461365"}
{"text": "BCLC ( Barcelona Clinic Liver Center ) .This staging system classifies patients according to the evolutionary course of the tumor and liver disease , thus allowing for a confident predictive life expectation and choice of convenient treatment modality for patients in each group [ 75 ] .", "label": "", "metadata": {}, "score": "75.47686"}
{"text": "40 , no . 1 , pp .124 - 131 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. Chung , M. Kudo , S. Takahashi et al . , \" Comparison of three current staging systems for hepatocellular carcinoma : Japan integrated staging score , new Barcelona Clinic Liver Cancer staging classification , and Tokyo score , \" Journal of Gastroenterology and Hepatology , vol .", "label": "", "metadata": {}, "score": "75.512344"}
{"text": "Registrative studies have shown a 3-mo increase in median overall survival of sorafenib compared to placebo .Moreover , adverse events are frequent a can be severe ( Diarrea , Hand - foot skin - reaction ) [ 121 - 125 ] .", "label": "", "metadata": {}, "score": "75.52408"}
{"text": "The prospective study was done in seven hundred and sixty - one ( 761 ) patients with hepatocellular carcinoma from 24 western medical centers enrolled over a 30-month period ( from 15 July 1990 to 1 December 1992 ) .", "label": "", "metadata": {}, "score": "75.5582"}
{"text": "Surgical outcomes in hepatocellular carcinoma patients with portal vein tumor thrombosis .Kenneth S H Chok Department of Surgery , The University of Hong Kong , 102 Pok Fu Lam Road , Hong Kong , China World J Surg 38:490 - 6 .", "label": "", "metadata": {}, "score": "75.59326"}
{"text": "Radiofrequency ablation versus transarterial chemoembolization for unresectable solitary hepatocellular carcinomas sized 5 - 8 cm .Wing Chiu Dai Department of Surgery , Queen Mary Hospital , University of Hong Kong , Hong Kong , China HPB ( Oxford ) 17:226 - 31 .", "label": "", "metadata": {}, "score": "75.610565"}
{"text": "69 - 80 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. J. Liu and J. H. Kao , \" Hepatitis B virus - related hepatocellular carcinoma : epidemiology and pathogenic role of viral factors , \" Journal of the Chinese Medical Association , vol .", "label": "", "metadata": {}, "score": "75.79292"}
{"text": "19 , no . 3 , pp . 311 - 317 , 2010 .View at Google Scholar .D. Poon , B. O. Anderson , L. T. Chen et al . , \" Management of hepatocellular carcinoma in Asia : consensus statement from the Asian Oncology Summit 2009 , \" The Lancet Oncology , vol .", "label": "", "metadata": {}, "score": "75.84746"}
{"text": "PLoS One .2013 ; 8 : e63864 .[PubMed ] [ DOI ] .Fuss M , Thomas CR .Stereotactic body radiation therapy : an ablative treatment option for primary and secondary liver tumors .", "label": "", "metadata": {}, "score": "75.89972"}
{"text": "Int J Radiat Oncol Biol Phys .[PubMed ] [ DOI ] .Honda Y , Kimura T , Aikata H , Kobayashi T , Fukuhara T , Masaki K , Nakahara T , Naeshiro N , Ono A , Miyaki D. Stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "75.97766"}
{"text": "34 , 2007 .View at Google Scholar \u00b7 View at Scopus . H. R. Rosen , \" Clinical practice .Chronic hepatitis C infection , \" The New England Journal of Medicine , vol .", "label": "", "metadata": {}, "score": "75.98649"}
{"text": "Owing to the improved safety and tolerance drug - eluting beads could be applicable in higher risk patient groups .Further ways of optimising the therapeutic benefit of TACE is by combining with systemic drugs .", "label": "", "metadata": {}, "score": "76.15419"}
{"text": "[PubMed ] [ DOI ] .Bosetti C , Levi F , Boffetta P , Lucchini F , Negri E , La Vecchia C. Trends in mortality from hepatocellular carcinoma in Europe , 1980 - 2004 .", "label": "", "metadata": {}, "score": "76.2206"}
{"text": "The results of the sensitivity analysis are shown in table 4 .Our model was most sensitive to variations in the dropout rate and survival after OLT .", "label": "", "metadata": {}, "score": "76.28117"}
{"text": "Hepatology .[PubMed ] [ DOI ] .Takayasu K , Arii S , Ikai I , Omata M , Okita K , Ichida T , Matsuyama Y , Nakanuma Y , Kojiro M , Makuuchi M. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients .", "label": "", "metadata": {}, "score": "76.30974"}
{"text": "25 Percutaneous radiofrequency ( RF ) ablation was not considered in the model because reliable data on antitumoral usefulness and cost have not been completely established .", "label": "", "metadata": {}, "score": "76.47329"}
{"text": "Scand J Gastroenterol .[PubMed ] [ DOI ] .Cho YK , Kim JK , Kim MY , Rhim H , Han JK .", "label": "", "metadata": {}, "score": "76.639755"}
{"text": "Moreover , it is still uncertain which is the role of LT after surgery and high risk of recurrence at pathology [ 2 - 4 ] .", "label": "", "metadata": {}, "score": "76.85666"}
{"text": "Poon RT , Fan ST : Evaluation of the new AJCC / UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patients .Surg Oncol Clin N Am 2003 , 12 ( 1 ) : 3 .", "label": "", "metadata": {}, "score": "76.8926"}
{"text": "The results vary depending on the research groups , countries , and characteristics of the patients tested [ 10 , 41 , 126 - 130 ] .", "label": "", "metadata": {}, "score": "76.895996"}
{"text": "View Article PubMed .Okuda K , Ohtsuki T , Obata H , Tomimatsu M , Okazaki N , Hasegawa H , Nakajima Y , Ohnishi K : Natural history of hepatocellular carcinoma and prognosis in relation to treatment .", "label": "", "metadata": {}, "score": "76.94421"}
{"text": "Accordingly , in areas where local economics are largely higher , the cost effectiveness of some scenarios may be lost .The current analysis was limited by the scarcity of data on exclusions during the waiting list .", "label": "", "metadata": {}, "score": "76.9998"}
{"text": "5 , pp .1305 - 1314 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .B. Sangro , L. Carpanese , R. Cianni et al . , \" Survival after Yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across barcelona clinic liver cancer stages : a European evaluation , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "77.04295"}
{"text": "CA Cancer J Clin .[PubMed ] [ DOI ] .Ioannou GN , Bryson CL , Weiss NS , Miller R , Scott JD , Boyko EJ .", "label": "", "metadata": {}, "score": "77.065155"}
{"text": "91 - 97 , 2004 .View at Google Scholar .J. Bruix and J. M. Llovet , \" Locoregional treatments for hepatocellular carcinoma , \" Best Practice and Research Clinical Gastroenterology , vol .", "label": "", "metadata": {}, "score": "77.09184"}
{"text": "This review describes the evolution of and current practices for radiation therapy , with particular focus on stereotactic body therapy ( SBRT ) in treating these types of tumors in patients who are not candidates for definitive treatment .", "label": "", "metadata": {}, "score": "77.112686"}
{"text": "Another area where the principles of the Milan Criteria have been challenged is in salvage LT .Salvage LT has been advocated by some to manage HCC within Milan Criteria after resection [ 20 ] .", "label": "", "metadata": {}, "score": "77.19305"}
{"text": "Figure 1 Dose distribution of stereotactic body radiation therapy for hepatocellular carcinoma at a dose of 40 Gy in 5 fractions , prescribed at the periphery of the target volume .", "label": "", "metadata": {}, "score": "77.19959"}
{"text": "[PubMed ] [ DOI ] .Izumi R , Shimizu K , Ii T , Yagi M , Matsui O , Nonomura A , Miyazaki I. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection .", "label": "", "metadata": {}, "score": "77.21231"}
{"text": "Ann Surg .[PubMed ] [ DOI ] .Lencioni R. Loco - regional treatment of hepatocellular carcinoma .Hepatology .[PubMed ] [ DOI ] .", "label": "", "metadata": {}, "score": "77.534134"}
{"text": "440 - 447 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . S. Hwang , S. G. Lee , J. W. Joh , K. S. Suh , and D. G. Kim , \" Liver transplantation for adult patients with hepatocellular carcinoma in Korea : comparison between cadaveric donor and living donor liver transplantations , \" Liver Transplantation , vol .", "label": "", "metadata": {}, "score": "77.58453"}
{"text": "The CUPI and CLIP scores mainly stratify patients at advanced stages ; only two include prognostic variables ( BCLC , CUPI ) and only one allocates treatment according to specific prognostic subclasses ( BCLC ) .", "label": "", "metadata": {}, "score": "77.68765"}
{"text": "Survival outcomes of right - lobe living donor liver transplantation for patients with high Model for End - stage Liver Disease scores .Kenneth Sh Chok Department of Surgery , The University of Hong Kong , 102 Pokfulam Road , Hong Kong , China Hepatobiliary Pancreat Dis Int 12:256 - 62 .", "label": "", "metadata": {}, "score": "77.69028"}
{"text": "J Hepatol .[PubMed ] [ DOI ] .Llovet JM , Di Bisceglie AM , Bruix J , Kramer BS , Lencioni R , Zhu AX , Sherman M , Schwartz M , Lotze M , Talwalkar J. Design and endpoints of clinical trials in hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "77.71366"}
{"text": "Please use one of the following formats to cite this article in your essay , paper or report : .MLA European Association for the Study of the Liver . \"", "label": "", "metadata": {}, "score": "77.99771"}
{"text": "[PubMed ] [ DOI ] .Skinner HD , Hong TS , Krishnan S. Charged - particle therapy for hepatocellular carcinoma .Semin Radiat Oncol .", "label": "", "metadata": {}, "score": "78.03747"}
{"text": "All Authors recruited the patients and participated to collection of data .All Authors have given final approval of the version to be published .Authors ' Affiliations .", "label": "", "metadata": {}, "score": "78.10744"}
{"text": "PubMed ] [ DOI ] .Imamura J , Tateishi R , Shiina S , Goto E , Sato T , Ohki T , Masuzaki R , Goto T , Yoshida H , Kanai F. Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "78.23627"}
{"text": "26 Chemoembolisation was also not considered because of its lower antineoplastic effect if compared with surgery or percutaneous ablation , and because of the lack of prospective data showing a beneficial effect .", "label": "", "metadata": {}, "score": "78.46225"}
{"text": "However , there is a donor risk of death of about 0.3 % and of life threatening complications of about 2 % .In fact , LDLT should be restricted to centers of excellence [ 110 - 120 ] .", "label": "", "metadata": {}, "score": "78.502106"}
{"text": "445 - 452 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. Bruix , M. Sherman , J. M. Llovet , et al . , \" Clinical management of hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "78.51958"}
{"text": "PEI is a highly effective option that provides complete necrosis in 70 - 80 % of cases in tumours smaller than 3 cm .21- 24", "label": "", "metadata": {}, "score": "78.599304"}
{"text": "Eur J Radiol .[PubMed ] [ DOI ] .Moucari R , Rautou PE , Cazals - Hatem D , Geara A , Bureau C , Consigny Y , Francoz C , Denninger MH , Vilgrain V , Belghiti J , Durand F , Valla D , Plessier A. Hepatocellular carcinoma in Budd - Chiari syndrome : characteristics and risk factors .", "label": "", "metadata": {}, "score": "78.65371"}
{"text": "PubMed ] [ DOI ] .Bruix J , Llovet JM , Castells A , Monta\u00f1\u00e1 X , Br\u00fa C , Ayuso MC , Vilana R , Rod\u00e9s J. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma : results of a randomized , controlled trial in a single institution .", "label": "", "metadata": {}, "score": "78.68881"}
{"text": "Moreover , a recent prospective study showed a 5-year survival not significantly different in patients transplanted for HCC inside Milan and UCSF criteria [ 103 ] .", "label": "", "metadata": {}, "score": "78.69748"}
{"text": "Hepatology .[PubMed ] [ DOI ] .Kamath PS , Wiesner RH , Malinchoc M , Kremers W , Therneau TM , Kosberg CL , D'Amico G , Dickson ER , Kim WR .", "label": "", "metadata": {}, "score": "78.85683"}
{"text": "Methods .This study retrospectively analyzed data collected prospectively concerning 1834 HCC patients ( 482 females , 1352 males ) recruited from January 1986 to December 2004 at 10 clinical institutions forming the ITA.LI.CA ( Italian Liver Cancer ) group .", "label": "", "metadata": {}, "score": "78.87078"}
{"text": "[PubMed ] [ DOI ] .Mancuso A , Sciarrino E , Renda MC , Maggio A. A prospective study of hepatocellular carcinoma incidence in thalassemia .", "label": "", "metadata": {}, "score": "78.87441"}
{"text": "In fact , while some experiences report encouraging results of sorafenib therapy after HCC recurrence post OLT , others suggests that adverse events could affect sorafenib efficacy [ 126 - 135 ] .", "label": "", "metadata": {}, "score": "78.893524"}
{"text": "We aimed to evaluate and compare the efficacy and tolerability of single - agent sorafenib in treating elderly patients with advanced HCC versus the younger population ... .", "label": "", "metadata": {}, "score": "78.96944"}
{"text": "2013 ; 201 : W812-W820 .[PubMed ] [ DOI ] .Mizumoto M , Okumura T , Hashimoto T , Fukuda K , Oshiro Y , Fukumitsu N , Abei M , Kawaguchi A , Hayashi Y , Ookawa A. Proton beam therapy for hepatocellular carcinoma : a comparison of three treatment protocols .", "label": "", "metadata": {}, "score": "79.14923"}
{"text": "[PubMed ] [ DOI ] .Sanuki N , Takeda A , Oku Y , Mizuno T , Aoki Y , Eriguchi T , Iwabuchi S , Kunieda E. Stereotactic body radiotherapy for small hepatocellular carcinoma : A retrospective outcome analysis in 185 patients .", "label": "", "metadata": {}, "score": "79.221405"}
{"text": "J Surg Oncol .[PubMed ] [ DOI ] .Andolino DL , Johnson CS , Maluccio M , Kwo P , Tector AJ , Zook J , Johnstone PA , Cardenes HR .", "label": "", "metadata": {}, "score": "79.23206"}
{"text": "J Hepatol .[PubMed ] [ DOI ] .Yao FY , Kerlan RK , Hirose R , Davern TJ , Bass NM , Feng S , Peters M , Terrault N , Freise CE , Ascher NL .", "label": "", "metadata": {}, "score": "79.28758"}
{"text": "Lancet Oncol .[PubMed ] [ DOI ] .Raj A , McCall J , Gane E. Validation of the \" Metroticket \" predictor in a cohort of patients transplanted for predominantly HBV - related hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "79.54123"}
{"text": "Albert C Y Chan Division of Hepatobiliary and Pancreatic Surgery , and Liver Transplantation , Department of Surgery , The University of Hong Kong , Hong Kong J Gastroenterol Hepatol 29:1279 - 83 .", "label": "", "metadata": {}, "score": "79.59288"}
{"text": "Transpl Int .[PubMed ] [ DOI ] .Saidi RF , Shah SA , Rawson AP , Grossman S , Piperdi B , Bozorgzadeh A. Treating hepatocellular carcinoma with sorafenib in liver transplant patients : an initial experience .", "label": "", "metadata": {}, "score": "79.70454"}
{"text": "This results in a marginal cost per years of life saved ( MCYLS ) and we have applied the conventional threshold of $ 50 000 per year of life saved as the accepted cut off value to consider an intervention \" cost effective \" .", "label": "", "metadata": {}, "score": "79.961235"}
{"text": "Stereotactic radiotherapy for liver cancer .BMC Cancer .[PubMed ] [ DOI ] .Seo YS , Kim MS , Yoo SY , Cho CK , Choi CW , Kim JH , Han CJ , Park SC , Lee BH , Kim YH .", "label": "", "metadata": {}, "score": "80.00489"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. S. Chen , Q. Wang , X. H. Fu et al . , \" Involvement of PI3K / PTEN / AKT / mTOR pathway in invasion and metastasis in hepatocellular carcinoma : association with MMP-9 , \" Hepatology Research , vol .", "label": "", "metadata": {}, "score": "80.1387"}
{"text": "Finally , both AASLD 2011 and EASL 2012 guidelines exclude from diagnostic criteria contrast - enhanced US ( CEUS ) and alpha - fetoprotein value [ 2 , 4 ] .", "label": "", "metadata": {}, "score": "80.15633"}
{"text": "[PubMed ] [ DOI ] .Mazzaferro V , Sposito C , Bhoori S , Romito R , Chiesa C , Morosi C , Maccauro M , Marchian\u00f2 A , Bongini M , Lanocita R. Yttrium-90 radioembolization for intermediate - advanced hepatocellular carcinoma : a phase 2 study .", "label": "", "metadata": {}, "score": "80.16514"}
{"text": "Hepatology .[PubMed ] [ DOI ] .Huo TI , Huang YH , Wu JC , Lee PC , Chang FY , Lee SD .", "label": "", "metadata": {}, "score": "80.19829"}
{"text": "To establish whether the immunosuppressive regime affects recurrence rates , data from the SiLVER Study is awaited .The SiLVER Study is a randomised multicenter clinical trial comparing Sirolimus containing to a mTOR inhibitor free immunosuppressive regimes .", "label": "", "metadata": {}, "score": "80.22638"}
{"text": "In this group the survival curves of RFTA and PEI were considered together , given the small number of patients for each treatment : they obtained a median survival of 65 months ( CI 54 - 76 ) .", "label": "", "metadata": {}, "score": "80.23424"}
{"text": "Summary of data and assumptions .Survival and recurrence on the waiting list .Data and assumptions used in the decision analysis for the reference cases are depicted in table 1 .", "label": "", "metadata": {}, "score": "80.33296"}
{"text": "4 , pp .1008 - 1014 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. D. M. Witjes , C. Verhoef , H. M. W. Verheul , and F. A. L. M. Eskens , \" Systemic treatment in hepatocellular carcinoma ; ' a small step for man ... ' , \" Netherlands Journal of Medicine , vol .", "label": "", "metadata": {}, "score": "80.410034"}
{"text": "Further studies are required to validate and maximize the efficacy of SBRT .Citation : Sanuki N , Takeda A , Kunieda E. Role of stereotactic body radiation therapy for hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "80.57747"}
{"text": "115 , pp .145 - 167 , 2003 .View at Google Scholar \u00b7 View at Scopus . Y. S. Guan , O. He , and Z. La , \" Roles of p53 in carcinogenesis , diagnosis and treatment of hepatocellular carcinoma , \" Journal of Cancer Molecules , vol .", "label": "", "metadata": {}, "score": "80.581604"}
{"text": "[PubMed ] [ DOI ] .J Vasc Interv Radiol .[PubMed ] [ DOI ] .Llovet JM .Updated treatment approach to hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "80.58342"}
{"text": "PubMed ] [ DOI ] .Zhang W , Zhang J , Yan W , You G , Bao Z , Li S , Kang C , Jiang C , You Y , Zhang Y. Whole - genome microRNA expression profiling identifies a 5-microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme .", "label": "", "metadata": {}, "score": "80.72441"}
{"text": "However , albeit overall similar , the main Societies of Hepatology differently defined their own guidelines .In fact , despite an evident agreement in the general lines of HCC management , some gray zones still persist [ 1 - 4 ] .", "label": "", "metadata": {}, "score": "80.73047"}
{"text": "Use of liver stiffness measurement for liver resection surgery : correlation with indocyanine green clearance testing and post - operative outcome .James Fung Department of Medicine , The University of Hong Kong , Hong Kong , China PLoS ONE 8:e72306 .", "label": "", "metadata": {}, "score": "80.7858"}
{"text": "Ethanol injection achieved a clear gain in LE , ranging from 5.2 to 6.7 months , increasing according to the length of the waiting list .", "label": "", "metadata": {}, "score": "80.80174"}
{"text": "At present there is no evidence of increased toxicity in LT recipients and Sorafenib can produce a response based on published case reports [ 85 , 86 ] .", "label": "", "metadata": {}, "score": "80.80888"}
{"text": "Cancer Chemother Pharmacol .[PubMed ] [ DOI ] .Hollebecque A , Cattan S , Romano O , Sergent G , Mourad A , Louvet A , Dharancy S , Boleslawski E , Truant S , Pruvot FR .", "label": "", "metadata": {}, "score": "80.81821"}
{"text": "Criteria for LT listing need to become more sophisticated by incorporating tumor biology in decision making , presently inferred from clinical behaviour but in the future by the use of molecular markers .", "label": "", "metadata": {}, "score": "80.93829"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Forner , C. Ayuso , M. Varela et al . , \" Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma : are response evaluation criteria in solid tumors reliable ? \"", "label": "", "metadata": {}, "score": "81.00216"}
{"text": "Statistical analysis showed that aetiology had little impact on survival , \" she said .\" It would appear that the marked difference in the intensity of screening programmes between different countries , and the consequent variation in curative therapeutic options goes a long way to explaining the wide geographical variation in HCC survival , \" said Dr Reeves .", "label": "", "metadata": {}, "score": "81.17714"}
{"text": "15 , pp .2166 - 2176 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Besaratinia , S. I. Kim , P. Hainaut , and G. P. Pfeifer , \" In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B 1 exposure , \" Gastroenterology , vol .", "label": "", "metadata": {}, "score": "81.310974"}
{"text": "Cancer .[PubMed ] [ DOI ] .Choi BO , Jang HS , Kang KM , Lee SW , Kang YN , Chai GY , Choi IB .", "label": "", "metadata": {}, "score": "81.51289"}
{"text": "View Article PubMed .Ann Surg 2005 , 242 ( 1 ) : 36 - 42 .View Article PubMed .Llovet JM , Bruix J : Novel advancements in the management of hepatocellular carcinoma in 2008 .", "label": "", "metadata": {}, "score": "81.820984"}
{"text": "Citation : Mancuso A. Management of hepatocellular carcinoma : Enlightening the gray zones .World J Hepatol 2013 ; 5(6 ) : 302 - 310 .", "label": "", "metadata": {}, "score": "82.18553"}
{"text": "Tumor size and number of lesions were determined on the basis of the imaging procedures performed , considering the diameter of the largest lesion in cases of multiple nodules .", "label": "", "metadata": {}, "score": "82.1913"}
{"text": "2009 ; 44 Suppl 19 : 102 - 107 .[PubMed ] [ DOI ] .Bosetti C , Levi F , Boffetta P , Lucchini F , Negri E , La Vecchia C. Trends in mortality from hepatocellular carcinoma in Europe , 1980 - 2004 .", "label": "", "metadata": {}, "score": "82.28444"}
{"text": "Hepatocellular Carcinoma : Focus on Different Aspects of Management .National Hepatobiliary and Enteric Surgery Research Center of Ministry of Health , Central South University , Changsha , Hunan 410008 , China .", "label": "", "metadata": {}, "score": "82.327866"}
{"text": "213 - 216 , 2000 .View at Google Scholar \u00b7 View at Scopus .M. M. Hassan and A. O. Kaseb , \" Epidemiology and pathogenesis of hepatocellular carcinoma , \" in Hepatocellular Carcinoma , K. M. McMasters and J. N. Vauthey , Eds . , chapter 1 , pp . 1 - 19 , Springer Science+Business Media , LLC , 2011 .", "label": "", "metadata": {}, "score": "82.555336"}
{"text": "[PubMed ] [ DOI ] .Teratani T , Yoshida H , Shiina S , Obi S , Sato S , Tateishi R , Mine N , Kondo Y , Kawabe T , Omata M. Radiofrequency ablation for hepatocellular carcinoma in so - called high - risk locations .", "label": "", "metadata": {}, "score": "82.55632"}
{"text": "It has also a therapeutic interest by the kinase components of the P13 K pathway which are essentially exciting targets for the rational design of small molecules [ 59 ] .", "label": "", "metadata": {}, "score": "82.74121"}
{"text": "[PubMed ] [ DOI ] .Fukumitsu N , Sugahara S , Nakayama H , Fukuda K , Mizumoto M , Abei M , Shoda J , Thono E , Tsuboi K , Tokuuye K. A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "82.83601"}
{"text": "Bile duct anastomotic stricture after adult - to - adult right lobe living donor liver transplantation .Kenneth Siu Ho Chok Department of Surgery , University of Hong Kong , Hong Kong , China Liver Transpl 17:47 - 52 .", "label": "", "metadata": {}, "score": "82.959335"}
{"text": "Axial and coronal views of radiation dose distribution ( C and D ) .The isodose lines ( white lines ) from inner to outer represent 40 , 30 , 20 , and 10 Gy , respectively .", "label": "", "metadata": {}, "score": "83.08851"}
{"text": "Jemal A , Ward E , Hao Y , Thun M. Trends in the leading causes of death in the United States , 1970 - 2002 .", "label": "", "metadata": {}, "score": "83.19455"}
{"text": "This article is an open - access article which was selected by an in - house editor and fully peer - reviewed by external reviewers .", "label": "", "metadata": {}, "score": "83.2865"}
{"text": "China especially comprises more than half the rate of new cases recorded with over 55 % ( around 120 million people in China are carriers of the HBV corresponding to almost a third of people infected worldwide [ 11 , 12 ] .", "label": "", "metadata": {}, "score": "83.38153"}
{"text": "13- 18 However , there are no prospective studies showing that it is effective in reducing the dropout rate or in modifying the outcome of these patients .", "label": "", "metadata": {}, "score": "83.38889"}
{"text": "[PubMed ] [ DOI ] .Kudo M , Izumi N , Kokudo N , Matsui O , Sakamoto M , Nakashima O , Kojiro M , Makuuchi M. Management of hepatocellular carcinoma in Japan : Consensus - Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology ( JSH ) 2010 updated version .", "label": "", "metadata": {}, "score": "83.39375"}
{"text": "Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma .Tan To Cheung Department of Surgery , The University of Hong Kong , Queen Mary Hospital , 102 Pokfulam Road , Hong Kong , China J Hepatobiliary Pancreat Surg 16:655 - 60 .", "label": "", "metadata": {}, "score": "83.4308"}
{"text": "Bugianesis [ 39 ] proves that the activation of the liver NKT cells generates soluble factors that promote fibrogenesis via a mechanism involving myofibroblastic activation of hepatic stellate cells .", "label": "", "metadata": {}, "score": "83.483925"}
{"text": "Cox 's multivariate analysis showed that no variable was independently associated with survival .The group of patients treated according to the AASLD recommendations ( 20 % ) did not survive longer than that of patients treated differently ( 80%)(the subgrouping is shown in Table 2 ) .", "label": "", "metadata": {}, "score": "83.70666"}
{"text": "Kenneth S H Chok Department of Surgery , University of Hong Kong , Hong Kong SAR , China Liver Transpl 20:912 - 21 .Its adoption increased the percentage of patients receiving bridging therapy from 39.2 % to 80.4 % .", "label": "", "metadata": {}, "score": "83.72923"}
{"text": "Int J Radiat Oncol Biol Phys .[PubMed ] [ DOI ] .Ingold JA , Reed GB , Kaplan HS , Bagshaw MA .", "label": "", "metadata": {}, "score": "83.86568"}
{"text": "J Surg Oncol .[PubMed ] [ DOI ] .Tse RV , Hawkins M , Lockwood G , Kim JJ , Cummings B , Knox J , Sherman M , Dawson LA .", "label": "", "metadata": {}, "score": "83.86995"}
{"text": "[PubMed ] [ DOI ] .Llovet JM , Ricci S , Mazzaferro V , Hilgard P , Gane E , Blanc JF , de Oliveira AC , Santoro A , Raoul JL , Forner A. Sorafenib in advanced hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "84.3035"}
{"text": "Colombo M : Screening .Hepatology Research 2007 , 37 ( Suppl 2 ) : S146-S151 .View Article PubMed .Chen MS , Li JQ , Zheng Y , Guo RP , Liang HH , Zhang YQ , Lin XJ , Lau WY : A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma .", "label": "", "metadata": {}, "score": "84.32591"}
{"text": "IL-6 is thought to be implicated , as IL-6 disruption abolished the gender differences in hepatocarcinogenesis [ 3 , 5 , 19 ] .Figure 1 : The striking parallel geographical distribution of the incidence of chronic hepatitis B virus infection and that of hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "84.362946"}
{"text": "Raymond Wai Man Kan Department of Surgery , The University of Hong Kong , Hong Kong , China ANZ J Surg 82:505 - 9 .Catheter - based intra - arterial therapies provided effective tumour control for unresectable hepatocellular carcinoma without distant metastasis .", "label": "", "metadata": {}, "score": "84.374596"}
{"text": "In the sensitivity analysis , these values varied by 20 % up / down in the best / worst scenarios .These assumptions were derived from our reported data on exclusions , and are in accordance with recent 1999 data from the UNOS , where patients removed from the list due to death or other reasons in the USA ranged from 26 % to 41 % .", "label": "", "metadata": {}, "score": "84.395485"}
{"text": "Men are more likely to be affected than women with HCC [ 18 ] .This trend was observed in almost all countries .In Japan , the male / female ratio was 4.5 between 1984 and 1985 and 2.5 between 2002 and 2003 [ 15 ] .", "label": "", "metadata": {}, "score": "84.623535"}
{"text": "CUPI ( Chinese University Prognostic Index ) .It has been investigated in Hong Kong from 1996 to 1998 on 926 ethnic Chinese patients who were diagnosed with HCC .", "label": "", "metadata": {}, "score": "85.16533"}
{"text": "[PubMed ] [ DOI ] .Okuda K , Ohtsuki T , Obata H , Tomimatsu M , Okazaki N , Hasegawa H , Nakajima Y , Ohnishi K. Natural history of hepatocellular carcinoma and prognosis in relation to treatment .", "label": "", "metadata": {}, "score": "85.41651"}
{"text": "Our series was recruited before the emanation of AASLD guidelines and , although its therapeutic algorithm had been proposed before by the Barcelona group , it was still under debate and revision .", "label": "", "metadata": {}, "score": "85.468796"}
{"text": "The P13/PTEN / AKT .Pathway is involved in several cellular processes such as proliferation , apoptosis , differentiation , cell motility , cell cycle progression , tumor growth , and angiogenesis [ 56 , 58 ] .", "label": "", "metadata": {}, "score": "85.523796"}
{"text": "Males are more likely to be infected with HBV and HCV , in addition cigarettes smoker , and alcohol consumer have a higher body mass index ( BMI ) .", "label": "", "metadata": {}, "score": "85.55416"}
{"text": "Kenneth S H Chok Centre for the Study of Liver Disease and Department of Surgery , The University of Hong Kong , Hong Kong , China ANZ J Surg 80:280 - 3 .", "label": "", "metadata": {}, "score": "85.63588"}
{"text": "Octreotide ( Sandostatin ) has antiangiogenic and antineoplastic properties , and there have been case reports of regression of HCC in patients treated with octreotide .", "label": "", "metadata": {}, "score": "85.8574"}
{"text": "View Article PubMed .Arii S , Yamaoka Y , Futagawa S , Inoue K , Kobayashi K , Kojiro M , Makuuchi M , Nakamura Y , Okita K , Yamada R : Results of surgical and nonsurgical treatment for small - sized hepatocellular carcinomas : a retrospective and nationwide survey in Japan .", "label": "", "metadata": {}, "score": "85.872765"}
{"text": "Vincent Wai To Lam Division of Hepatobiliary and Pancreatic Surgery , Department of Surgery , The University of Hong Kong Medical Centre , Queen Mary Hospital , Hong Kong , China J Am Coll Surg 207:e1 - 5 .", "label": "", "metadata": {}, "score": "85.93417"}
{"text": "Perpetuating proficiency in donor right hepatectomy for living donor liver transplantation .See Ching Chan Department of Surgery , The University of Hong Kong , Hong Kong , China State Key Laboratory for Liver Research , The University of Hong Kong , Hong Kong , China Electronic address Asian J Surg 37:65 - 72 .", "label": "", "metadata": {}, "score": "86.148415"}
{"text": "PubMed ] [ DOI ] .Majno P , Mazzaferro V. Living donor liver transplantation for hepatocellular carcinoma exceeding conventional criteria : questions , answers and demands for a common language .", "label": "", "metadata": {}, "score": "86.27466"}
{"text": "[PubMed ] [ DOI ] .Parkin DM , Bray F , Ferlay J , Pisani P. Global cancer statistics , 2002 .CA Cancer J Clin .", "label": "", "metadata": {}, "score": "86.75488"}
{"text": "Dipartimento di Medicina Clinica , Cardioangiologia , Epatologia , Alma Mater Studiorum - Universit\u00e0 di Bologna .Dipartimento di Medicina , Unit\u00e0 di Gastroenterologia , Ospedale Fatebenefratelli .", "label": "", "metadata": {}, "score": "86.7684"}
{"text": "PubMed ] [ DOI ] .El - Serag HB , Mason AC .Rising incidence of hepatocellular carcinoma in the United States .N Engl J Med .", "label": "", "metadata": {}, "score": "87.06131"}
{"text": "Am J Gastroenterol 2002 , 97 ( 3 ) : 734 - 44 .View Article PubMed .Am J Gastroenterol 2005 , 100 ( 8) : 1764 - 71 .", "label": "", "metadata": {}, "score": "87.202484"}
{"text": "References .Bruix J , Sherman M. Management of hepatocellular carcinoma .Hepatology .[PubMed ] [ DOI ] .Bruix J , Sherman M. Management of hepatocellular carcinoma : an update .", "label": "", "metadata": {}, "score": "87.457596"}
{"text": "Furthermore , in contrast to western countries , Asia has cultural and religious barriers to organ donation from deceased individuals .The number of deceased donors per million population ranges from 0.07 - 6.5 among Asian transplantation centers , which is far below those of western countries ( e.g . , 35.1 per million population in Spain and 25.2 per million population in the United States ) [", "label": "", "metadata": {}, "score": "87.64229"}
{"text": "Jpn J Clin Oncol .[PubMed ] [ DOI ] .Choi BO , Choi IB , Jang HS , Kang YN , Jang JS , Bae SH , Yoon SK , Chai GY , Kang KM .", "label": "", "metadata": {}, "score": "87.653534"}
{"text": "These studies are heterogeneous in design , inclusion criteria and philosophy .Despite all the above studies , guidelines still give indication to LT only to HCC inside Milan criteria [ 2 - 4 ] .", "label": "", "metadata": {}, "score": "87.934586"}
{"text": "However , for wide usage , the CUPI needs to be validated by different cohorts of patients [ 80 ] .JIS Score ( Japan Integrated Staging ) .", "label": "", "metadata": {}, "score": "88.06073"}
{"text": "Advanced pancreatic cancer : flourishing novel approaches in the era of biological therapy .Joanne W Chiu University Departments of Medicine and Surgery , Queen Mary Hospital , Hong Kong , People s Republic of China Centre for Cancer Research , University of Hong Kong , Hong Kong , People s Republic of China Oncologist 19:937 - 50 .", "label": "", "metadata": {}, "score": "88.21324"}
{"text": "[PubMed ] [ DOI ] .Ikai I , Arii S , Kojiro M , Ichida T , Makuuchi M , Matsuyama Y , Nakanuma Y , Okita K , Omata M , Takayasu K. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey .", "label": "", "metadata": {}, "score": "88.3812"}
{"text": "Cyberknife is a new stereotactic body radiation therapy ( SBRT ) or stereotactic ablative radiotherapy ( SABR ) in combination with a robotic system that tracks the tumor during respiration and is able to deliver high dose radiation accurately sparing adjacent normal tissue in a small number of fractions .", "label": "", "metadata": {}, "score": "88.42039"}
{"text": "Dimitroulopoulos D , Tsamakidis K , Zisimopoulos A , et al : Efficacy of octreotide acetate long - acting formulation in treating patients with advanced hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "88.50221"}
{"text": "2010 ; 78 Suppl 1 : 125 - 130 .[PubMed ] [ DOI ] .Makuuchi M , Kosuge T , Takayama T , Yamazaki S , Kakazu T , Miyagawa S , Kawasaki S. Surgery for small liver cancers .", "label": "", "metadata": {}, "score": "88.72698"}
{"text": "4 , pp .273 - 277 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. Ferenci , M. Fried , D. Labrecque , et al . , \" W2010orld gastroenterology organization guideline .", "label": "", "metadata": {}, "score": "89.13464"}
{"text": "Schwartz M , Sung M , Emre S , et al .Abstracts of the 23rdAnnual Meeting of the American Society of Transplant Surgeons , Chicago , May 1997 .", "label": "", "metadata": {}, "score": "89.158005"}
{"text": "How attractive does a new technology have to be to warrant adoption and utilization ?Tentative guidelines for using clinical and economic evaluations Can Med Assoc J 1992 ; 146 : 473 -81 .", "label": "", "metadata": {}, "score": "89.16269"}
{"text": "In both the subgroup the possibility of drug interections should be investigated .ACKNOWLEDGMENTS .I thank Prof Angelo Vanzulli for imaging supply .Footnotes .", "label": "", "metadata": {}, "score": "89.16417"}
{"text": "Knowledge Center .Read our more detailed articles about specific areas of medicine , conditions , nutrition and forms of treatment .", "label": "", "metadata": {}, "score": "89.18524"}
{"text": "Outcomes of central bisectionectomy for hepatocellular carcinoma .Thomas K Gallagher Department of Surgery , The University of Hong Kong , Hong Kong HPB ( Oxford )", "label": "", "metadata": {}, "score": "89.45006"}
{"text": "See Ching Chan Department of Surgery , State Key Laboratory for Liver Research , The University of Hong Kong , 102 Pokfulam Road , Hong Kong , China Hepatobiliary Pancreat Dis Int 10:649 - 56 .", "label": "", "metadata": {}, "score": "89.47043"}
{"text": "Since new methods are introduced such as contrast - enhanced Us , detection has been improved with better sensitivity and specificity [ 88 , 94 ] .", "label": "", "metadata": {}, "score": "89.50014"}
{"text": "[PubMed ] [ DOI ] .Hepatol Res .[PubMed ] [ DOI ] .Pan CC , Kavanagh BD , Dawson LA , Li XA , Das SK , Miften M , Ten Haken RK .", "label": "", "metadata": {}, "score": "89.620964"}
{"text": "[PubMed ] [ DOI ] .Olsen CC , Welsh J , Kavanagh BD , Franklin W , McCarter M , Cardenes HR , Gaspar LE , Schefter TE .", "label": "", "metadata": {}, "score": "89.80153"}
{"text": "Tan To Cheung Department of Surgery , The University of Hong Kong , Hong Kong , China Ann Surg 257:506 - 11 .The aim of this study was to analyze the survival outcome of laparoscopic liver resection versus open liver resection ... .", "label": "", "metadata": {}, "score": "89.8651"}
{"text": "177 - 186 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. Paez and W. R. Sellers , \" PI3K / PTEN / AKT pathway .", "label": "", "metadata": {}, "score": "90.0828"}
{"text": "[PubMed ] [ DOI ] .Merchante N , Merino E , L\u00f3pez - Aldeguer J , Jover F , Delgado - Fern\u00e1ndez M , Galindo MJ , Ortega E , Rivero A , M\u00ednguez C , Romero - Palacios A. Increasing incidence of hepatocellular carcinoma in HIV - infected patients in Spain .", "label": "", "metadata": {}, "score": "90.13243"}
{"text": "Eur J Surg Oncol 2005 , 31 ( 8) : 882 - 90 .View Article PubMed .Gut 2005 , 54 ( 13 ) : 411 - 8 .", "label": "", "metadata": {}, "score": "90.24353"}
{"text": "[PubMed ] [ DOI ] .Schwartz M , Dvorchik I , Roayaie S , Fiel MI , Finkelstein S , Marsh JW , Martignetti JA , Llovet JM .", "label": "", "metadata": {}, "score": "90.24564"}
{"text": "Gut .[PubMed ] [ DOI ] .Shiina S , Teratani T , Obi S , Sato S , Tateishi R , Fujishima T , Ishikawa T , Koike Y , Yoshida H , Kawabe T. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "90.32501"}
{"text": "1127 - 1137 . e5 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. A. Gouas , H. Shi , A. H. Hautefeuille et al . , \" Effects of the TP53 p .", "label": "", "metadata": {}, "score": "90.32985"}
{"text": "An axial view of radiation dose distribution ( A ) .The isodose lines ( white lines ) from inner to outer represent 40 , 30 , 20 , and 10 Gy , respectively .", "label": "", "metadata": {}, "score": "90.38226"}
{"text": "Tan To Cheung Department of Surgery , The University of Hong Kong , Hong Kong , China HPB ( Oxford ) 15:567 - 73 .At present , data on the treatment 's long - term outcome are limited .", "label": "", "metadata": {}, "score": "90.51848"}
{"text": "Vincent Wai To Lam Department of Surgery , Division of Hepatobiliary and Pancreatic Surgery , The University of Hong Kong Medical Centre , Queen Mary Hospital , Hong Kong , China Cancer Institute , New South Wales , Australia J Am Coll Surg 207:20 - 9 .", "label": "", "metadata": {}, "score": "90.683334"}
{"text": "[PubMed ] [ DOI ] .Ben - Josef E , Normolle D , Ensminger WD , Walker S , Tatro D , Ten Haken RK , Knol J , Dawson LA , Pan C , Lawrence TS .", "label": "", "metadata": {}, "score": "90.873924"}
{"text": "Tolerance of high - intensity focused ultrasound ablation in patients with hepatocellular carcinoma .Tan To Cheung Department of Surgery , The University of Hong Kong , 102 Pokfulam Road , Hong Kong , China World J Surg 36:2420 - 7 .", "label": "", "metadata": {}, "score": "90.976395"}
{"text": "[PubMed ] [ DOI ] .Herfarth KK , Debus J , Lohr F , Bahner ML , Rhein B , Fritz P , H\u00f6ss A , Schlegel W , Wannenmacher MF .", "label": "", "metadata": {}, "score": "91.09813"}
{"text": "Since 2007 Sorafenib , an oral tyrosine kinase inhibitor , has become the standard of care .Based upon the SHARP study that demonstrated Sorafenib improved median survival from 7.9 months to 10.7 months and slowed time to progression from 2.8 to 5.5 months [ 83 ] .", "label": "", "metadata": {}, "score": "91.24199"}
{"text": "Int J Radiat Oncol Biol Phys .2011 ; 81 : e447-e453 .[PubMed ] [ DOI ] .Huang WY , Jen YM , Lee MS , Chang LP , Chen CM , Ko KH , Lin KT , Lin JC , Chao HL , Lin CS .", "label": "", "metadata": {}, "score": "91.348724"}
{"text": "Acta Oncol .[PubMed ] [ DOI ] .Technol Cancer Res Treat .[PubMed ] [ DOI ] .Goodman KA , Wiegner EA , Maturen KE , Zhang Z , Mo Q , Yang G , Gibbs IC , Fisher GA , Koong AC .", "label": "", "metadata": {}, "score": "91.51294"}
{"text": "The most used is the multikinase inhibitor sorafenib that was approved by the European Medicines Agency ( EMEA ) and the US Food and Drug Administration ( FDA ) .", "label": "", "metadata": {}, "score": "91.55798"}
{"text": "J Hepatol 2006 , 44 ( 4 ) : 723 - 31 .View Article PubMed .J Hepatol 2004 , 40 ( 1 ) : 124 - 31 .", "label": "", "metadata": {}, "score": "92.274506"}
{"text": "Success in mass program vaccination has been seen in Thailand and Singapore [ 45 ] .In western countries , universal vaccination has been adopted , and , in developing countries , mass vaccination programs are being introduced .", "label": "", "metadata": {}, "score": "92.33145"}
{"text": "In patients without HBV , the mutations are associated with chromosome stability and genetic alteration [ 50 , 54 ] .Activation of the Insulin - Like Growth Factor ( IGF )", "label": "", "metadata": {}, "score": "92.381325"}
{"text": "The adjusted relative risks ( hazard ratios ) and their 95 % confidence interval ( CI ) were calculated for variables independently correlated with survival .", "label": "", "metadata": {}, "score": "92.46298"}
{"text": "Economic costs were assessed from the payer 's perspective , and included direct costs of procedures and treatments , expressed in 1999 US dollars , and were obtained from the current payments within the Spanish Health Care System ( table 2 ) .", "label": "", "metadata": {}, "score": "92.47208"}
{"text": "Routine vaccination at birth in countries with high prevalence of HBV infection can reduce the transmission .In Taiwan , where the world 's first universal hepatitis vaccination program was conducted in July 1984 , chronic HBV infection in mother - to - infant transmission has decreased from 86 - 96 % to 12 - 14 % [ 44 ] .", "label": "", "metadata": {}, "score": "92.72718"}
{"text": "M. E. Smela , S. S. Currier , E. A. Bailey , and J. M. Essigmann , \" The chemistry and biology of aflatoxin B1 : from mutational spectrometry to carcinogenesis , \" Carcinogenesis , vol .", "label": "", "metadata": {}, "score": "92.97851"}
{"text": "Another point much debated in the literature concerns the comparison between RESECTION and locoregional treatments .This point was not addressed directly in our study but , by comparing the results of RESECTION , RFTA and PEI , we found that the first two treatments performed better than PEI .", "label": "", "metadata": {}, "score": "93.21767"}
{"text": "Aflatoxin ( AF ) .Aflatoxin is believed to be a major causative agent in the high incidence of primary liver cancer seen in certain regions of the world .", "label": "", "metadata": {}, "score": "93.413025"}
{"text": "[PubMed ] [ DOI ] .Mazzaferro V , Llovet JM , Miceli R , Bhoori S , Schiavo M , Mariani L , Camerini T , Roayaie S , Schwartz ME , Grazi GL .", "label": "", "metadata": {}, "score": "93.50385"}
{"text": "James Fung Department of Medicine , Queen Mary Hospital , The University of Hong Kong , Pokfulam , Hong Kong SAR , China Gastroenterology 141:1212 - 9 .", "label": "", "metadata": {}, "score": "93.53671"}
{"text": "Int J Radiat Oncol Biol Phys .2010 ; 76 : S94 - 100 .[PubMed ] [ DOI ] .Xu ZY , Liang SX , Zhu J , Zhu XD , Zhao JD , Lu HJ , Yang YL , Chen L , Wang AY , Fu XL .", "label": "", "metadata": {}, "score": "93.647446"}
{"text": "Vincent Wai To Lam Department of Surgery , University of Hong Kong Medical Centre , Queen Mary Hospital , Hong Kong , China Ann Surg Oncol 15:782 - 90 .", "label": "", "metadata": {}, "score": "93.655716"}
{"text": "Alcohol abuse was considered as the long - standing consumption of more than 80 g ETOH / day in males and 40 g in females .", "label": "", "metadata": {}, "score": "94.04942"}
{"text": "[PubMed ] [ DOI ] .Lu DS , Yu NC , Raman SS , Limanond P , Lassman C , Murray K , Tong MJ , Amado RG , Busuttil RW .", "label": "", "metadata": {}, "score": "94.13592"}
{"text": "The variables considered in the Cox 's multivariate stepwise regression analysis to pinpoint independent prognostic factors were : . age ; .gender ; . etiology ; . number of lesions ( 1 , 2 - 3 ) ; .", "label": "", "metadata": {}, "score": "94.30456"}
{"text": "A commercially available software product ( Data 3.5;Tree Age Software , 1998 , Williamstown , Massachusetts , USA ) was used to generate the model and to tabulate all costs accrued in each group .", "label": "", "metadata": {}, "score": "94.64228"}
{"text": "[PubMed ] [ DOI ] .Yao FY , Ferrell L , Bass NM , Watson JJ , Bacchetti P , Venook A , Ascher NL , Roberts JP .", "label": "", "metadata": {}, "score": "94.71887"}
{"text": "PubMed ] [ DOI ] .Flor N , Zuin M , Brovelli F , Maggioni M , Tentori A , Sardanelli F , Cornalba GP .", "label": "", "metadata": {}, "score": "94.98333"}
{"text": "[PubMed ] [ DOI ] .Facciuto ME , Singh MK , Rochon C , Sharma J , Gimenez C , Katta U , Moorthy CR , Bentley - Hibbert S , Rodriguez - Davalos M , Wolf DC .", "label": "", "metadata": {}, "score": "95.09355"}
{"text": "Although all published guidelines go on considering the Milan criteria as the only fence inside which LT should be considered as treatment of HCC [ 2 - 4 ] , the possibility of an extension of Milan criteria as indication for LT is already a debated issue .", "label": "", "metadata": {}, "score": "95.41983"}
{"text": "[PubMed ] [ DOI ] .Lang H , Sotiropoulos GC , D\u00f6mland M , Fr\u00fchauf NR , Paul A , H\u00fcsing J , Malag\u00f3 M , Broelsch CE .", "label": "", "metadata": {}, "score": "95.55495"}
{"text": "Tan To Cheung Department of Surgery , The University of Hong Kong , 102 Pok Fu Lam Road , Queen Mary Hospital , Hong Kong , China World J Gastroenterol 16:526 - 30 .", "label": "", "metadata": {}, "score": "95.59238"}
{"text": "Aliment Pharmacol Ther .[PubMed ] [ DOI ] .Iavarone M , Cabibbo G , Piscaglia F , Zavaglia C , Grieco A , Villa E , Camm\u00e0 C , Colombo M. Field - practice study of sorafenib therapy for hepatocellular carcinoma : a prospective multicenter study in Italy .", "label": "", "metadata": {}, "score": "95.6366"}
{"text": "Fifty - four percent of patients reported improved overall well - being , 86 % reported increased appetite , and 43 % had increased weight gain .", "label": "", "metadata": {}, "score": "95.72321"}
{"text": "In fact , US is a cheap and safe test , due to the absence of contrast medium and radioactivity [ 20 - 23 ] .", "label": "", "metadata": {}, "score": "95.959755"}
{"text": "Lancet Oncol .[PubMed ] [ DOI ] .Kim JE , Ryoo BY , Ryu MH , Chang HM , Suh DJ , Lee HC , Lim YS , Kim KM , Kang YK .", "label": "", "metadata": {}, "score": "96.11334"}
{"text": "Commissione \" Epatocarcinoma \" dell'Associazione Italiana per lo Studio del Fegato : Epatocarcinoma : Linee Guida per la Diagnosi e la Terapia Bologna : Tipografia Moderna 1998 .", "label": "", "metadata": {}, "score": "96.35599"}
{"text": "[PubMed ] [ DOI ] .Truesdale AE , Caldwell SH , Shah NL , Argo CK , Al - Osaimi AM , Schmitt TM , Northup PG .", "label": "", "metadata": {}, "score": "96.83707"}
{"text": "[PubMed ] [ DOI ] .Bouza C , L\u00f3pez - Cuadrado T , Alc\u00e1zar R , Saz - Parkinson Z , Amate JM .", "label": "", "metadata": {}, "score": "96.87573"}
{"text": "[PubMed ] [ DOI ] .Zavaglia C , Airoldi A , Mancuso A , Vangeli M , Vigan\u00f2 R , Cordone G , Gentiluomo M , Belli LS .", "label": "", "metadata": {}, "score": "97.04701"}
{"text": "Thomas Yau Department of Medicine , University of Hong Kong Medical Centre , Queen Mary Hospital , Hong Kong , China Oncology 72:67 - 71 .", "label": "", "metadata": {}, "score": "97.500534"}
{"text": "[PubMed ] [ DOI ] .Jemal A , Siegel R , Ward E , Hao Y , Xu J , Murray T , Thun MJ .", "label": "", "metadata": {}, "score": "97.60486"}
{"text": "19 , 20 Establishment of two strata represents a type of sensitivity analysis of the scenarios that are faced in the clinical setting .None the less , additional sensitivity analyses were performed varying the main probabilities of outcomes over clinically relevant ranges .", "label": "", "metadata": {}, "score": "97.986176"}
{"text": "[PubMed ] [ DOI ] .Goldberg SN , Grassi CJ , Cardella JF , Charboneau JW , Dodd GD , Dupuy DE , Gervais DA , Gillams AR , Kane RA , Lee FT .", "label": "", "metadata": {}, "score": "98.1249"}
{"text": "[PubMed ] [ DOI ] .M\u00e9ndez Romero A , Wunderink W , Hussain SM , De Pooter JA , Heijmen BJ , Nowak PC , Nuyttens JJ , Brandwijk RP , Verhoef C , Ijzermans JN .", "label": "", "metadata": {}, "score": "98.31184"}
{"text": "[PubMed ] [ DOI ] .Salem R , Lewandowski RJ , Mulcahy MF , Riaz A , Ryu RK , Ibrahim S , Atassi B , Baker T , Gates V , Miller FH .", "label": "", "metadata": {}, "score": "98.542175"}
{"text": "Effects of aflatoxin carcinogen result in p53 gene mutations .Generally , in human cancer , in more than 50 % of tumors , p53 is mutated and these mutations occur at the third position of codon 249 with the GC - TA transversion [ 32 , 33 ] .", "label": "", "metadata": {}, "score": "98.72229"}
{"text": "[PubMed ] [ DOI ] .Asayama Y , Tajima T , Nishie A , Ishigami K , Kakihara D , Nakayama T , Okamoto D , Fujita N , Aishima S , Shirabe K. Uptake of Gd - EOB - DTPA by hepatocellular carcinoma : radiologic - pathologic correlation with special reference to bile production .", "label": "", "metadata": {}, "score": "99.112595"}
{"text": "Cox 's multivariate stepwise regression analysis was used to pinpoint independent prognostic factors and the adjusted relative risks ( hazard ratios ) were calculated as well .", "label": "", "metadata": {}, "score": "99.112915"}
{"text": "4 , pp .535 - 545 , 2001 .View at Google Scholar \u00b7 View at Scopus .J. S. Wang , T. Huang , J. Su et al . , \" Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village , Fusui County , People 's Republic of China , \" Cancer Epidemiology Biomarkers and Prevention , vol .", "label": "", "metadata": {}, "score": "99.31207"}
{"text": "P- Reviewers : Gong Y , Mihaila RG , Yan LN , Zhao HT S- Editor : Wen LL L- Editor :A E- Editor : Wang CH .", "label": "", "metadata": {}, "score": "99.358635"}
{"text": "11 , pp .2189 - 2191 , 1999 .View at Google Scholar .38 , no . 3 , pp .207 - 215 , 2003 .", "label": "", "metadata": {}, "score": "99.45967"}
{"text": "[PubMed ] [ DOI ] .Pelletier G , Roche A , Ink O , Anciaux ML , Derhy S , Rougier P , Lenoir C , Attali P , Etienne JP .", "label": "", "metadata": {}, "score": "100.16009"}
{"text": "[PubMed ] [ DOI ] .Ghobrial RM , Freise CE , Trotter JF , Tong L , Ojo AO , Fair JH , Fisher RA , Emond JC , Koffron AJ , Pruett TL .", "label": "", "metadata": {}, "score": "100.20787"}
{"text": "View Article PubMed .Cillo U , Vitale A , Grigoletto F , Farinati F , Brolese A , Zanus G , Neri D , Boccagni P , Srsen N , D'Amico F , Ciarleglio FA , Bridda A , D'Amico", "label": "", "metadata": {}, "score": "100.47746"}
{"text": "[PubMed ] [ DOI ] .Chen MS , Li JQ , Zheng Y , Guo RP , Liang HH , Zhang YQ , Lin XJ , Lau WY .", "label": "", "metadata": {}, "score": "101.14241"}
{"text": "Role of stereotactic body radiation therapy for hepatocellular carcinoma .Naoko Sanuki , Atsuya Takeda , Etsuo Kunieda .Naoko Sanuki , Atsuya Takeda , Radiation Oncology Center , Ofuna Chuo Hospital , Kanagawa 247 - 0056 , Japan .", "label": "", "metadata": {}, "score": "101.84514"}
{"text": "Egypt is known for being the country in the world where the rate of HCV is higher , about 24 % of the people are estimated to carry HCV and the more than 50 % of blood donors have anti - HCV in some towns [ 17 ] .", "label": "", "metadata": {}, "score": "102.06469"}
{"text": "[PubMed ] [ DOI ] .Gwon D , Ko GY , Yoon HK , Sung KB , Kim JH , Lee SS , Lee JM , Ohm JY , Shin JH , Song HY .", "label": "", "metadata": {}, "score": "102.24668"}
{"text": "[PubMed ] [ DOI ] .Fung KT , Li FT , Raimondo ML , Maudgil D , Mancuso A , Tibballs JM , Watkinson AA , Patch D , Burroughs AK .", "label": "", "metadata": {}, "score": "102.34455"}
{"text": "[PubMed ] [ DOI ] .Umemura T , Ichijo T , Yoshizawa K , Tanaka E , Kiyosawa K. Epidemiology of hepatocellular carcinoma in Japan .", "label": "", "metadata": {}, "score": "102.37714"}
{"text": "[PubMed ] [ DOI ] .van Laarhoven HW , Kaanders JH , Lok J , Peeters WJ , Rijken PF , Wiering B , Ruers TJ , Punt CJ , Heerschap A , van der Kogel AJ .", "label": "", "metadata": {}, "score": "102.6785"}
{"text": "Kelvin K Ng Department of Surgery , Li Ka Shing Faculty of Medicine , Queen Mary Hospital , The University of Hong Kong , 102 Pokfulam Road , Hong Kong , China J Hepatobiliary Pancreat Sci 17:548 - 54 .", "label": "", "metadata": {}, "score": "102.80698"}
{"text": "Immunosuppressive agents compound malignant behaviour as immune surveillance for cancer cells is impaired .Mammalian target of rapamycin ( mTOR ) inhibitors , for example , Sirolimus is an exception to this rule .", "label": "", "metadata": {}, "score": "103.01689"}
{"text": "Kevin K W Chu Department of Surgery , The University of Hong Kong , 102 Pokfulam Road , Hong Kong , China Hepatobiliary Pancreat Dis Int 11:612 - 7 .", "label": "", "metadata": {}, "score": "103.02401"}
{"text": "[PubMed ] [ DOI ] .Cheng AL , Kang YK , Chen Z , Tsao CJ , Qin S , Kim JS , Luo R , Feng J , Ye S , Yang TS .", "label": "", "metadata": {}, "score": "103.15646"}
{"text": "[PubMed ] [ DOI ] .Bae SH , Kim MS , Cho CK , Kim KB , Lee DH , Han CJ , Park SC , Kim YH .", "label": "", "metadata": {}, "score": "103.16308"}
{"text": "The isodose lines ( white lines ) from inner to outer represent 40 , 30 , 20 , and 10 Gy , respectively ( C ) .", "label": "", "metadata": {}, "score": "103.2642"}
{"text": "Aflatoxins are a group of approximately 20 related fungal metabolites with four major known as B1 , B2 , G1 , and G2 .Among them , B1 is the most potent naturally occurring chemical liver disease carcinogen known [ 31 ] .", "label": "", "metadata": {}, "score": "103.89123"}
{"text": "Tan To Cheung Department of Surgery , Queen Mary Hospital , The University of Hong Kong , Hong Kong , China J Nucl Med 54:192 - 200 .", "label": "", "metadata": {}, "score": "104.49657"}
{"text": "[PubMed ] [ DOI ] .Shi M , Guo RP , Lin XJ , Zhang YQ , Chen MS , Zhang CQ , Lau WY , Li JQ .", "label": "", "metadata": {}, "score": "104.553825"}
{"text": "Author contributions : Sanuki N contributed to the manuscript idea , literature search , manuscript writing and final revision of the article ; Takeda A contributed to the manuscript idea and the final revision of the article ; Kunieda E contributed to the final revision of the article .", "label": "", "metadata": {}, "score": "105.088264"}
{"text": "[PubMed ] [ DOI ] .Kwon JH , Bae SH , Kim JY , Choi BO , Jang HS , Jang JW , Choi JY , Yoon SK , Chung KW .", "label": "", "metadata": {}, "score": "105.129715"}
{"text": "Declarations .Acknowledgements .The study was not financially supported by any institution .Competing interests .The authors declare that they have no competing interests .", "label": "", "metadata": {}, "score": "105.737686"}
{"text": "Divisione di Medicina , Ospedale Bolognini .Divisione di Medicina , Ospedale Treviglio - Caravaggio .Dipartimento di Medicina Clinica e Sperimentale , Universit\u00e0 degli Studi di Padova .", "label": "", "metadata": {}, "score": "105.85892"}
{"text": "The software utilized was SPSS 14.0 for Windows .The ITA.LI.CA database management conformed to the past and current Italian legislation on the privacy and the study conformed to the ethical guidelines of the Declaration of Helsinki .", "label": "", "metadata": {}, "score": "105.9251"}
{"text": "J Korean Med Sci .[PubMed ] [ DOI ] .Xi M , Zhang L , Zhao L , Li QQ , Guo SP , Feng ZZ , Deng XW , Huang XY , Liu MZ .", "label": "", "metadata": {}, "score": "106.038086"}
{"text": "Hedgehog ( Hh ) pathway activation and NKT ( natural killer T ) cells seem to be involved in the development of NASH - related liver fibrosis .", "label": "", "metadata": {}, "score": "107.12653"}
{"text": "Please note : Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional .", "label": "", "metadata": {}, "score": "107.21086"}
{"text": "[PubMed ] [ DOI ] .Kang JK , Kim MS , Cho CK , Yang KM , Yoo HJ , Kim JH , Bae SH , Jung da H , Kim KB , Lee DH .", "label": "", "metadata": {}, "score": "107.563644"}
{"text": "27 , pp .4300 - 4308 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .3 , no .", "label": "", "metadata": {}, "score": "108.696434"}
{"text": "Kenneth S H Chok Department of Surgery , The University of Hong Kong , 102 Pokfulam Road , Hong Kong , SAR , People s Republic of China World J Surg 35:2058 - 62 .", "label": "", "metadata": {}, "score": "109.81214"}
{"text": "12 , pp .2851 - 2854 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus This article is an open - access article which was selected by an in - house editor and fully peer - reviewed by external reviewers .", "label": "", "metadata": {}, "score": "109.88726"}
{"text": "Kelvin K C Ng Department of Surgery , The University of Hong Kong , Queen Mary Hospital , Pokfulam , Hong Kong , China Ann Surg 253:981 - 7 .", "label": "", "metadata": {}, "score": "110.05162"}
{"text": "5452 - 5460 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .16 , no . 3 , pp .", "label": "", "metadata": {}, "score": "110.368576"}
{"text": "46 , no . 3 , pp .474 - 481 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "110.700294"}
{"text": "1991 ; 214 : 221 - 228 ; discussion 228 - 229 .[PubMed ] [ DOI ] .Iwatsuki S , Esquivel CO , Gordon RD , Shaw BW , Starzl TE , Shade RR , Van Thiel DH .", "label": "", "metadata": {}, "score": "110.85518"}
{"text": "4 , pp .141 - 145 , 2007 .View at Google Scholar \u00b7 View at Scopus .15 , no .17 , pp .", "label": "", "metadata": {}, "score": "111.72196"}
{"text": "nao5-tky@umin.org .Telephone : +81 - 467 - 452111 Fax : +81 - 467 - 483197 .Received : September 28 , 2013 Revised : December 20 , 2013 Accepted : January 8 , 2014 Published online : March 28 , 2014 .", "label": "", "metadata": {}, "score": "111.77265"}
{"text": "18 , no . 2 , pp .413 - 420 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "112.124825"}
{"text": "51 , no .4 , pp .1274 - 1283 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "112.125175"}
{"text": "All rights reserved .World J Gastroenterol .Mar 28 , 2014 ; 20(12 ) : 3100 - 3111 Published online Mar 28 , 2014 .", "label": "", "metadata": {}, "score": "112.6335"}
{"text": "133 - 141 , 1999 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . 94 , no .6 , pp .", "label": "", "metadata": {}, "score": "112.786514"}
{"text": "31 , no . 8 , pp .1475 - 1482 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "113.04704"}
{"text": "94 , no . 7 , pp .572 - 586 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "113.05319"}
{"text": "6 , pp .903 - 912 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .116 , no .", "label": "", "metadata": {}, "score": "113.15925"}
{"text": "It is also involved in occurrence of HCC .The IGF system consists of two ligands , IGF - I and IGF - II ; three cell - membrane receptors , IGF - I receptor ( IGF - IR ) , insulin receptor ( IR ) , and IGF - II receptor ( IGF - IIR ) ; six high - affinity IGF binding proteins , IGFBP-1 through 6 [ 55 ] .", "label": "", "metadata": {}, "score": "113.827675"}
{"text": "37 , no . 3 , pp .212 - 220 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "114.77724"}
{"text": "115 , no . 3 , pp .616 - 623 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "114.8342"}
{"text": "33 , no . 1 , pp .41 - 52 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "115.05926"}
{"text": "42 , no .10 , pp .958 - 962 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "115.45476"}
{"text": "47 , no . 1 , pp .71 - 81 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "115.76767"}
{"text": "Large scale randomized controlled trials are needed to demonstrate the effectiveness of this minimally invasive approach .Labome .Org \u00a9 2015 All Rights Researved Princeton , New Jersey 08540 , USA \u00a9 2006 Schumacher et al .", "label": "", "metadata": {}, "score": "118.709854"}
{"text": "View Article PubMed .Pre - publication history .Copyright .\u00a9 Farinati et al .2009 .This article is published under license to BioMed Central Ltd.", "label": "", "metadata": {}, "score": "120.50708"}
{"text": "39 Thus decision makers should consider these data to warrant implementation of economic resources for the most efficient groups .As done for most decision analyses , we used local costs for cost effectiveness estimations .", "label": "", "metadata": {}, "score": "120.99965"}
{"text": "Dietary exposure to aflatoxin B1 ( AFB1 ) ( Africa , Asia ) induces mutation in codon 249 by G - T transversion and therefore leads to the amino acid substitution R249S [ 63 , 64 ] .", "label": "", "metadata": {}, "score": "121.84345"}
{"text": "This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "124.76973"}
{"text": "Copyright Medical News Today : Excluding email / sharing services explicitly offered on this website , material published on Medical News Today may not be reproduced , or distributed without the prior written permission of Medilexicon International Ltd.", "label": "", "metadata": {}, "score": "141.28113"}
{"text": "Copyright \u00a9 2012 Sene Waly Raphael et al .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "147.12227"}
